Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,42229,-0.536443602286641,0.0123317112863958,-0.560613756407977,-0.512273448165306,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,40411,-0.335208496858518,0.00805033434381864,-0.350987152172402,-0.319429841544633,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42526,-0.209660668038985,0.00498742089201746,-0.219436012987339,-0.19988532309063,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,42490,-0.211931900940143,0.00417225653703751,-0.220109523752736,-0.203754278127549,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,42599,-0.265809439380408,0.00631161830559681,-0.278180211259378,-0.253438667501438,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40428,-0.171292601833318,0.00401096944752023,-0.179154101950458,-0.163431101716179,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,42447,-0.163190395235515,0.00415465854882943,-0.17133352599122,-0.155047264479809,1.11253692926669e-308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,42631,-0.192070572903063,0.00512099208267746,-0.202107717385111,-0.182033428421015,6.83246399199371e-293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,42466,-0.33135695981916,0.0090892648867478,-0.349171918997185,-0.313542000641134,2.07748923120206e-277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,40440,0.246225755239331,0.00680332758851972,0.232891233165832,0.259560277312829,2.06940359658662e-271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42649,0.426245905138075,0.0120177859456429,0.402691044684615,0.449800765591535,1.70396027999577e-263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42554,0.0987664007017048,0.00285727565090916,0.0931661404259228,0.104366660977487,7.52590664721395e-251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,42518,0.155825538651395,0.00467390543464443,0.146664683999492,0.164986393303298,3.74027630864579e-234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,40432,0.175408398540916,0.00530184265068586,0.165016786945572,0.18580001013626,3.90704736897771e-229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,42543,-0.267057496460419,0.00814533862895143,-0.283022360173164,-0.251092632747675,7.96493820466672e-227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42561,0.108583971738896,0.00331888340551721,0.102078960264082,0.115088983213709,6.39798036877418e-226
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,40432,0.075760165018804,0.00238088693969708,0.0710936266169978,0.0804267034206103,7.91774448670321e-213
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,40019,-0.323608034407723,0.0102717610609471,-0.34374068608718,-0.303475382728267,1.62194188042442e-208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,42518,-0.19148091095892,0.00610555740012092,-0.203447803463157,-0.179514018454683,2.28452790546559e-208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FURIN,Furin,42561,-0.101825859210596,0.0032921291277561,-0.108278432300998,-0.0953732861201941,6.09412381858345e-203
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40352,-0.1708624508919,0.00550984820110755,-0.181661753366071,-0.160063148417729,1.32559493053256e-202
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42377,-0.0942062276178357,0.00307448322093012,-0.100232214730859,-0.0881802405048127,3.05759609116493e-199
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,42448,-0.223375524797839,0.00741202865646899,-0.237903100964518,-0.20884794863116,4.7885757572653e-193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,42536,-0.102029979631247,0.00340913486078933,-0.108711883958394,-0.0953480753041002,1.54605973829359e-190
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,42490,-0.123293949183914,0.00413668682041854,-0.131401855351934,-0.115186043015894,5.14922343181761e-189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42237,-0.24215412441258,0.00822833838982877,-0.258281667656644,-0.226026581168516,2.28984896548854e-184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,40411,-0.260911290454113,0.00903143596566198,-0.27861290494681,-0.243209675961415,4.49801468560676e-177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42475,-0.156528322017402,0.00545199299823967,-0.167214228293951,-0.145842415740852,6.32353678298872e-176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42590,-0.398160432239592,0.0140327238838606,-0.425664571051959,-0.370656293427225,4.95051170978923e-172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,42568,-0.335125682189079,0.011879138367698,-0.358408793389767,-0.311842570988391,3.87375960024339e-170
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,42256,-0.224241997724419,0.00810487081090535,-0.240127544513793,-0.208356450935044,8.61682237480548e-164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,42237,-0.190237278452018,0.00694731884126648,-0.2038540233809,-0.176620533523136,1.45525421522893e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,40432,0.138236459404422,0.00511503674993454,0.12821098737455,0.148261931434294,6.67648855476932e-156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,40187,0.0852098694415024,0.00315617131956851,0.0790237736551481,0.0913959652278567,1.71749738623085e-155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42490,0.089531633906242,0.00336793713844787,0.0829304771148842,0.0961327906975998,9.38909593557752e-152
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,42490,0.0732926818409798,0.0027661187101628,0.0678710891690607,0.0787142745128989,8.42730709349727e-151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,40187,-0.0754650129217724,0.00286702594484468,-0.0810843837736679,-0.0698456420698768,3.96615448002856e-148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42651,0.165705539174437,0.00631930160672301,0.15331970802526,0.178091370323614,7.45488715522349e-148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,42301,0.142187482465014,0.00544426717062288,0.131516718810593,0.152858246119435,1.27632122763574e-146
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,42599,-0.0893930162470775,0.00351736548285152,-0.0962870525934665,-0.0824989799006885,3.33503127090955e-139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,42237,-0.139586502682447,0.00549081793543668,-0.150348505835903,-0.128824499528991,3.44515077530745e-139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,41630,-0.10878356938445,0.00430344238272573,-0.117218316454592,-0.100348822314307,1.59031210874617e-137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42493,-0.211817018211415,0.0084242597395159,-0.228328567300866,-0.195305469121964,2.46842572929238e-136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,42483,-0.264185612141746,0.0105879865045393,-0.284938065690643,-0.243433158592849,2.48243829949581e-134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,40428,0.151248502815405,0.00612268804082633,0.139248034255386,0.163248971375425,3.03849170987287e-131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40364,-0.212048206833903,0.00867582861645888,-0.229052830922162,-0.195043582745644,1.43143045742989e-128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42584,-0.116411503843047,0.00480302971551661,-0.125825442085459,-0.106997565600634,4.8373899329087e-127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42536,-0.0813782112624971,0.00337525313202266,-0.0879937074012615,-0.0747627151237327,9.37815605229224e-126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,42553,-0.11406018607395,0.0047810058863462,-0.123430957611188,-0.104689414536711,3.18225646342332e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39920,-0.0778705631682394,0.00328451750454909,-0.0843082174771556,-0.0714329088593232,3.73529689051613e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42490,0.0927589487110958,0.00392246056405375,0.0850709260055504,0.100446971416641,3.84011475064613e-121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,40089,-0.197090089533312,0.00833319233644658,-0.213423146512747,-0.180757032553877,1.21860638295226e-120
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,40171,-0.0897110566685542,0.00379935934286852,-0.0971578009805764,-0.0822643123565319,2.79328777492462e-120
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,42673,-0.125969674835698,0.00535265619954764,-0.136460880986811,-0.115478468684585,4.74353489038997e-120
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFM,Afamin,40440,-0.0475031532512839,0.00202973351825635,-0.0514814309470663,-0.0435248755555015,2.56870195591153e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,42466,-0.133668322444034,0.00572216599802497,-0.144883767800163,-0.122452877087905,2.63132607756632e-118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,42229,-0.179856597427087,0.00782253125327001,-0.195188758683497,-0.164524436170678,1.05337574233424e-114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,40125,-0.138002209978214,0.0059927016408647,-0.149747905194309,-0.126256514762119,1.2610067435336e-114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,42496,-0.132553182503946,0.00580325015858403,-0.14392755281477,-0.121178812193121,2.66604471299886e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,42191,-0.122548747210651,0.00536718448756396,-0.133068428806276,-0.112029065615025,3.58248043680489e-113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,42631,-0.0674148303728863,0.0029820766208114,-0.0732597005496766,-0.0615699601960959,4.3422589305073e-111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42466,-0.183552938167659,0.00814355975565387,-0.199514315288741,-0.167591561046578,1.98070138079234e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40385,-0.172497241538498,0.00766023901045119,-0.187511309998982,-0.157483173078013,7.38112667548837e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,42542,-0.041706400039664,0.00185600099274753,-0.0453441619854491,-0.0380686380938788,8.55027750222035e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,42466,-0.187316310496397,0.00835108295546805,-0.203684433089115,-0.17094818790368,2.13073044528637e-109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42256,-0.127718133746289,0.00570609094480901,-0.138902071998115,-0.116534195494464,6.38956623554739e-109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,42599,0.0827629822106235,0.00369920784987659,0.0755125348248654,0.0900134295963816,6.99306626709139e-109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,42632,0.0816700146378446,0.00367317409367939,0.074470593414233,0.0888694358614562,1.38257087758321e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,40253,-0.0604033291995097,0.00272247510363302,-0.0657393804026304,-0.055067277996389,9.60187380762198e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42568,0.0764266209612453,0.00345356629328131,0.0696576310264139,0.0831956108960767,1.3238932495503e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,42490,-0.0706642781042547,0.0031965383662103,-0.0769294933020268,-0.0643990629064825,2.23249069847949e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42357,-0.338529465481794,0.015410607497071,-0.368734256176053,-0.308324674787535,4.5193878395324e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42614,-0.0704025837742692,0.00323212250504907,-0.0767375438841653,-0.064067623664373,2.09783610205507e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,42209,-0.133971692420178,0.0061493753174663,-0.146024468042412,-0.121918916797944,2.18165329873508e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42599,-0.0731660575195757,0.00336519231401868,-0.0797618344550523,-0.0665702805840991,4.90799251429911e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,42535,0.044435983946268,0.00204601601985964,0.0404257925473431,0.0484461753451929,8.23859085205317e-103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,40350,-0.160540251068768,0.00740825727169763,-0.175060435321296,-0.146020066816241,4.87351954062585e-102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42464,-0.120801726684721,0.00559779507394276,-0.131773405029649,-0.109830048339794,1.51919038144217e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42466,-0.154639049501811,0.00717366847792117,-0.168699439718537,-0.140578659285086,2.4932911886059e-101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42466,-0.176725572910898,0.00829687058608831,-0.192987439259631,-0.160463706562165,5.08632171242199e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,40325,-0.0546312222746195,0.00257700564603361,-0.0596821533408454,-0.0495802912083937,8.16324387745587e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42229,-0.128478409167747,0.00607363479463626,-0.140382733365234,-0.11657408497026,1.11384809667046e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42377,-0.0738860934901474,0.00349741312510743,-0.0807410232153579,-0.0670311637649368,1.87890465823065e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42673,-0.085828968199195,0.0040635322494071,-0.0937934914080329,-0.0778644449903571,1.88939636132022e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42466,-0.18714076512944,0.00888767051267907,-0.204560599334291,-0.169720930924589,7.62930780529661e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40411,-0.0607564246705638,0.00288509406310876,-0.066411209034257,-0.0551016403068706,1.38829361062743e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42568,0.0810583571338213,0.00386065483640969,0.0734914736544583,0.0886252406131843,2.53573262369685e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42229,-0.13881236822865,0.0066313262249606,-0.151809767629573,-0.125814968827728,1.00319142394577e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,42515,-0.0737095010537534,0.00352580303368943,-0.0806200749997847,-0.0667989271077221,1.61127503402521e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42229,-0.174677810449227,0.00835809491072062,-0.191059676474239,-0.158295944424214,1.98251682931008e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42673,0.0732208121990589,0.00351081032199611,0.0663396239679466,0.0801020004301713,4.25701450398829e-95
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,39937,0.0928443349150562,0.00445238309207061,0.0841176640545978,0.101571005775515,1.06609860756165e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42590,0.0465405892278711,0.00224493412066378,0.0421405183513701,0.0509406601043721,5.36116810852379e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42518,-0.0653196640397683,0.0031525553011314,-0.0714986724299859,-0.0591406556495508,6.91979914757447e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,40125,-0.132122129842094,0.00641978149391563,-0.144704901570169,-0.11953935811402,2.28514088925047e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42451,-0.0651948883916957,0.00319039334959793,-0.0714480593569076,-0.0589417174264837,2.08898075562248e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42466,-0.0837143730837325,0.00409993610925626,-0.0917502478578748,-0.0756784983095902,2.87627845891209e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42475,-0.0574235129166684,0.00281881324117465,-0.0629483868693707,-0.0518986389639661,7.27750237760458e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,42631,-0.0930727069988013,0.00457494963655309,-0.102039608286445,-0.0841058057111573,1.21045602784348e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42466,-0.217703591247044,0.010757470352425,-0.238788233137797,-0.196618949356291,1.02907495845521e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42639,-0.104556329930489,0.0051962587670816,-0.114740997113969,-0.094371662747009,9.64452535398933e-89
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42599,-0.0753598818850606,0.00374955631781357,-0.0827090122679752,-0.068010751502146,1.52953518718144e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,42503,0.0925595980990331,0.00461687134477524,0.0835105302632736,0.101608665934793,4.16671978352663e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,42550,-0.0641195205392708,0.00319922439154577,-0.0703900003467005,-0.0578490407318411,4.62824154917072e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40181,-0.0952361461953988,0.00476701536218105,-0.104579496305274,-0.085892796085524,2.99184919881543e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,42592,-0.124442422772879,0.00624510582451567,-0.13668283018893,-0.112202015356828,4.36475456251138e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40428,-0.0696789631854504,0.00350217616643121,-0.0765432284716556,-0.0628146978992452,1.35600399527735e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42542,0.0618256375011607,0.00311378985222897,0.0557226093907919,0.0679286656115295,1.74354654817426e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,42631,-0.0711738374014445,0.0035854184408145,-0.0782012575454409,-0.0641464172574481,1.86746742427592e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40125,-0.116095051577995,0.0058676516940647,-0.127595648898362,-0.104594454257628,1.23653594069859e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,40384,-0.089488046512256,0.00452551443758205,-0.0983580548099169,-0.0806180382145952,1.4256822453901e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,42297,-0.167341740265467,0.00849909895146157,-0.183999974210332,-0.150683506320602,4.49382961934625e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42325,-0.0980772367598848,0.00498720346274058,-0.107852155546856,-0.0883023179729133,7.01826773458472e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40432,-0.0444972947602242,0.00227515654993016,-0.0489566015980874,-0.0400379879223611,8.66396905085331e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,40417,-0.0562263687645188,0.00287556978572678,-0.0618624855445433,-0.0505902519844943,9.52597179896591e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,42490,-0.111208244154594,0.00571725650928576,-0.122414066912794,-0.100002421396393,4.04206782550242e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,42537,-0.13371864887115,0.00688752849066069,-0.147218204712845,-0.120219093029455,8.03195964360187e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,42584,0.0550184997471006,0.00285828362619969,0.0494162638397492,0.060620735654452,1.81479921960136e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42469,-0.0994398067769052,0.00518180010608293,-0.109596134984828,-0.0892834785689826,5.56182637515138e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42358,-0.144062098079039,0.00757258617032462,-0.158904366972875,-0.129219829185202,1.2549040665901e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42130,-0.108195899922806,0.00570285380925183,-0.119373493388939,-0.0970183064566722,3.42765386330624e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,42673,-0.0991891452586945,0.00523519004207403,-0.10945011774116,-0.0889281727762294,4.99508709071461e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,42539,0.105000489729026,0.00555092376976633,0.094120679140284,0.115880300317768,9.02867603130745e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40352,-0.100653641135055,0.00532691903631295,-0.111094402446228,-0.0902128798238817,2.076292965878e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,42495,0.334114083587428,0.0177051611519828,0.299411967729542,0.368816199445314,2.08176898658091e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,40243,-0.0466808868012629,0.00247407978829713,-0.0515300831863253,-0.0418316904162006,3.5203247722912e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42599,-0.0670479415572826,0.00356292478906207,-0.0740312741438442,-0.0600646089707209,5.40168337677472e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42561,-0.0716327414270586,0.00380800539423347,-0.0790964319997562,-0.064169050854361,6.19894813514536e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEP,Leptin,42518,-0.128494888195883,0.00683527062497136,-0.141892018620827,-0.115097757770939,7.82659210419935e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40187,-0.096066579819188,0.00510694203199815,-0.106076186201904,-0.0860569734364717,1.01332218731189e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42599,-0.240692187784656,0.0128973899410156,-0.265971072069047,-0.215413303500266,9.42806484613475e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42561,-0.0430155447132178,0.00231026942764397,-0.0475436727914,-0.0384874166350356,2.06958403537475e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42237,-0.105895487451911,0.00572254583861424,-0.117111677295595,-0.0946792976082276,1.73724594828134e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,42631,-0.058483957792251,0.00317134389015389,-0.0646997918169526,-0.0522681237675494,5.13982777502644e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,42599,-0.0881622752287682,0.0047883445712313,-0.0975474305883816,-0.0787771198691549,8.79595509955355e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42631,-0.0624066187360637,0.00340677147373664,-0.0690838908245876,-0.0557293466475399,4.69154272594594e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,42518,-0.111330699267859,0.00608226930841707,-0.123251947112356,-0.0994094514233615,6.16342137690653e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,40350,-0.209398053582418,0.0114477381976177,-0.231835620449748,-0.186960486715087,1.14521316404884e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42568,-0.0774094642141044,0.00425283951463983,-0.0857450296627985,-0.0690738987654104,3.80323447781401e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,42542,0.0530763716490537,0.00291789048330808,0.0473573063017699,0.0587954369963376,4.71512100266406e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",42191,-0.102843905548278,0.0056614763880656,-0.113940399268887,-0.0917474118276696,7.68162075140083e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,42584,-0.0390684175825433,0.00216395178802324,-0.0433097630870689,-0.0348270720780178,5.21179852740327e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42561,-0.0655214186096948,0.00362931280228112,-0.0726348717021658,-0.0584079655172239,5.30404631555945e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42377,-0.0678028292485818,0.0037731443622588,-0.0751981921986091,-0.0604074662985546,2.37757706789543e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,40246,-0.0516356613538694,0.00287130354226255,-0.057263416296704,-0.0460079064110349,2.71780073587672e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,40125,-0.103625475212048,0.00577346480393972,-0.11494146622777,-0.0923094841963266,5.12377142545103e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,42518,-0.117779199533313,0.00657175340105729,-0.130659836199385,-0.104898562867241,5.39814190768515e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,40125,-0.108868876678848,0.00607870635152036,-0.120783141127828,-0.0969546122298679,1.00746721076682e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,42490,-0.0427242152558543,0.00238893115924947,-0.0474065203279832,-0.0380419101837253,1.0515319362639e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42466,-0.149898160494262,0.00843488077371314,-0.166430526810739,-0.133365794177784,7.59474633584344e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42448,-0.0467159908042919,0.00263761335276735,-0.0518857129757159,-0.0415462686328679,2.15176513165232e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,40288,-0.0573236976656825,0.0032423288284412,-0.0636786621694273,-0.0509687331619378,5.2833016416875e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40384,-0.104453280497568,0.00591376279116707,-0.116044255568256,-0.0928623054268808,6.96033978923236e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42631,-0.139224530494605,0.00790253125674813,-0.154713491757831,-0.123735569231379,1.06465753753901e-68
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42466,-0.0655957585328036,0.00374227598522781,-0.0729306194638501,-0.0582608976017571,5.07727077359391e-68
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42568,-0.0762530806606681,0.00436748768753997,-0.0848133565282465,-0.0676928047930898,1.63840483331866e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40187,-0.0679674326225983,0.00390330365513136,-0.0756179077866557,-0.0603169574585408,5.21133600803778e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42466,-0.0601053924903741,0.00347338670025627,-0.0669132304228764,-0.0532975545578718,2.3210909117332e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40411,-0.131714678613016,0.00764699340996158,-0.14670278569654,-0.116726571529491,1.21393273859972e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,40187,-0.111078607671573,0.00651804737205463,-0.1238539805208,-0.0983032348223461,2.68804836101104e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42123,-0.0347209139479575,0.00204804333599113,-0.0387350788865001,-0.0307067490094149,8.89080920907391e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,40440,-0.0342060145978055,0.00201651617694378,-0.0381583863046153,-0.0302536428909957,9.55529342195258e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,42466,-0.0619398966604959,0.00365823898871488,-0.0691100450783771,-0.0547697482426148,1.22317057073673e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42237,-0.161297335258571,0.00955162430182575,-0.180018518890149,-0.142576151626992,2.63921487796609e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,42549,-0.11507319956122,0.00683542499281219,-0.128470632547132,-0.101675766575308,6.03486145107243e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40125,0.104844316261084,0.00625734994631894,0.0925799103662992,0.117108722155869,3.08242433346013e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40019,-0.11708742936528,0.00699554103209994,-0.130798689788196,-0.103376168942364,4.20775729352178e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,42475,-0.0865412633333315,0.00518782212784211,-0.096709394703902,-0.0763731319627609,7.58686997890673e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42590,-0.0881206103828464,0.00535983114764099,-0.0986258794322227,-0.07761534133347,3.77812824271117e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,42631,-0.0451744728703421,0.00275041906884613,-0.0505652942452805,-0.0397836514954036,4.90146091671938e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,40187,-0.125735525663879,0.00768084053776066,-0.14078997311789,-0.110681078209868,1.58069046019225e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40411,-0.0940058227538373,0.00576719972028188,-0.10530953420559,-0.0827021113020848,4.69322723343204e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42490,0.0457967825465922,0.0028177650276282,0.0402739630924409,0.0513196020007434,7.85735950198174e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42229,-0.136792612772995,0.00842676603272069,-0.153309074197128,-0.120276151348862,1.10573792630293e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,42554,0.0711753774447584,0.00438742742775354,0.0625760196863614,0.0797747352031553,1.26739917368868e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42377,-0.12212153778406,0.00752845909873186,-0.136877317617575,-0.107365757950546,1.31537438410721e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,40187,-0.0646637265022872,0.00400125663642637,-0.0725061895096829,-0.0568212634948916,4.43698315213928e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,42466,-0.117869953288371,0.00730543618261917,-0.132188608206304,-0.103551298370437,5.19261252465972e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42478,-0.0332727232258136,0.00206506663851377,-0.0373202538373006,-0.0292251926143266,7.3985874452167e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42599,-0.0481170949949486,0.00299423473997823,-0.0539857950853059,-0.0422483949045913,1.42934403084622e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,40428,0.063865524341887,0.0039770435901268,0.0560705189052384,0.0716605297785355,2.1641640415525e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,42561,-0.0868640550617379,0.00543942615964807,-0.0975253303346481,-0.0762027797888277,7.01172407164055e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,42530,-0.099680072527902,0.00624458763926243,-0.111919464300856,-0.0874406807549476,7.81342829042538e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42475,-0.0654526564963211,0.00411695297715028,-0.0735218843315356,-0.0573834286611065,2.15420060194081e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42490,-0.0878409632510872,0.0055467926098484,-0.09871267676639,-0.0769692497357843,5.66865884092647e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,42643,0.0905173804883867,0.0057277720161721,0.0792909473366894,0.101743813640084,9.37417572095174e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,42590,-0.0389741454172048,0.00247207337462313,-0.0438194092314661,-0.0341288816029435,1.68687471485086e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42466,-0.0710719670891382,0.00451317723219862,-0.0799177944642475,-0.0622261397140289,2.25868940571579e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,40187,-0.0437944141933236,0.00278534676418987,-0.0492536938511358,-0.0383351345355115,4.17488431403874e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,42466,-0.114617643584144,0.00730229904201315,-0.12893014970649,-0.100305137461798,5.02121828005405e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40411,-0.108573951988204,0.00691866486712333,-0.122134535127765,-0.0950133688486419,6.47911967006602e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,40104,-0.13287792513093,0.00847264927570208,-0.149484317711306,-0.116271532550554,7.81397332810759e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42673,0.0402144476129162,0.0025733786062054,0.0351706255447536,0.0452582696810788,1.43258703595148e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,42673,-0.0982054308020387,0.00628914646743552,-0.110532157878212,-0.085878703725865,1.72444660891261e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42466,-0.199399365016718,0.012771308555784,-0.224431129786054,-0.174367600247381,1.80852021088449e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42475,-0.104031478005634,0.00667273016370141,-0.117110029126489,-0.0909529268847794,2.55579018413966e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42572,-0.0390439332343212,0.00250872554595543,-0.0439610353043939,-0.0341268311642486,3.85594128291209e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40352,-0.111174930792842,0.00715177630230128,-0.125192412345352,-0.0971574492403314,6.30708160213385e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,40125,-0.0957786778036649,0.00618882600706523,-0.107908776777513,-0.083648578829817,1.85412425583557e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42454,0.0999133272115502,0.00647644813673703,0.0872194888635457,0.112607165559555,3.11489160252839e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,42469,-0.1462829761078,0.00949435038646093,-0.164891902865263,-0.127674049350337,4.20502994652788e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42518,0.0431991799478807,0.00280886681872455,0.0376938009831806,0.0487045589125809,6.38902486799157e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,42377,-0.139194247534824,0.00906253108652884,-0.15695680846442,-0.121431686605227,8.78351039780565e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40352,-0.0901069893404957,0.00586515851772305,-0.101602700035233,-0.0786112786457585,1.00139727638763e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42475,-0.15319634382389,0.00998190686900335,-0.172760881287136,-0.133631806360643,1.0439840219951e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,42475,-0.0610177874114577,0.003985320707503,-0.0688290159981636,-0.0532065588247518,1.82067415073807e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42229,-0.107494745129783,0.00703337049085508,-0.121280151291859,-0.0937093389677072,2.79387808339843e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,42095,-0.160720443165437,0.0105472242437787,-0.181393002683244,-0.140047883647631,5.58986389310358e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,42554,-0.0663269763320818,0.00435437635697735,-0.0748615539917574,-0.0577923986724062,5.89786130951989e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,40428,-0.178742274394989,0.011800875776059,-0.201871990916064,-0.155612557873913,2.5625145938031e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,42466,-0.0668354359863586,0.00442232176714133,-0.0755031866499556,-0.0581676853227616,3.53189196402544e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42466,-0.177063908040156,0.0117398581784868,-0.20007403006999,-0.154053786010322,5.59949935455501e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40104,-0.0688991689092099,0.00458688773807557,-0.0778894688758381,-0.0599088689425818,1.71065096903651e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,42568,-0.0864838906718701,0.00579717886126986,-0.097846361239959,-0.0751214201037812,6.31532169108286e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42357,-0.13692693377546,0.00919088183114075,-0.154941062164496,-0.118912805386424,8.62155773244778e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,42191,-0.0789699437703055,0.00531223584012705,-0.0893819260169545,-0.0685579615236565,1.40571077517879e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42466,-0.103006907824299,0.00692986881052857,-0.116589450692935,-0.0894243649556628,1.4092019795555e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42377,-0.0902435897303377,0.00607327458138495,-0.102147207909852,-0.0783399715508232,1.52723136029693e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,42454,-0.0474333462209648,0.00319476949395797,-0.0536950944291224,-0.0411715980128071,1.81019300818185e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40411,-0.128496674512522,0.00866207018502341,-0.145474332075168,-0.111519016949876,2.57205584498613e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,40019,-0.0974112155322351,0.0065675103039183,-0.110283535727915,-0.0845388953365552,2.75671181990432e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42256,-0.106005499818788,0.00718137414189317,-0.120080993136898,-0.0919300065006771,6.45720954149967e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,42362,-0.0567149314572433,0.00384313063059767,-0.0642474674932147,-0.0491823954212719,6.76522494684198e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42475,0.0602642874091796,0.00408636630761078,0.0522550094462624,0.0682735653720967,7.74955133009607e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42466,-0.14805730147283,0.0100497633373337,-0.167754837614004,-0.128359765331656,9.68052353519854e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,42377,-0.0631048507236251,0.00428487264338307,-0.0715032011046559,-0.0547065003425943,1.04822563961686e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42466,-0.0904960400864499,0.00615111908291176,-0.102552233488957,-0.0784398466839428,1.30056320608923e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42466,-0.0670918517160544,0.00456792934402916,-0.0760449932303516,-0.0581387102017572,1.85780108520888e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42561,-0.138698986257757,0.00944367410472007,-0.157208587503008,-0.120189385012505,1.86289127423903e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42229,-0.16720504604801,0.0113870282538667,-0.189523621425589,-0.144886470670432,1.9933462465137e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,42599,-0.0408401631168051,0.00278586910075238,-0.0463004665542798,-0.0353798596793304,2.7581021762916e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,42589,-0.0829127939037444,0.00566460739904085,-0.0940154244058644,-0.0718101634016243,3.83799719823215e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40356,-0.163991516177773,0.0112042147243422,-0.185951777037484,-0.142031255318063,4.57076235245824e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,40187,-0.0687919852846033,0.00470480567521501,-0.0780134044080247,-0.0595705661611819,5.75887760150719e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,40284,-0.0405869527830521,0.002776495624301,-0.0460288842066821,-0.0351450213594222,6.01078851614458e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42475,-0.159810564445463,0.0109506526428659,-0.18127384362548,-0.138347285265446,7.22635352694574e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,42475,-0.134079464804699,0.00919247164072942,-0.152096709220529,-0.116062220388869,8.10008399644406e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42377,-0.0787651476219785,0.00540462911297128,-0.0893582206834022,-0.0681720745605548,9.71050042788435e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42475,-0.110278157538027,0.00756795487485385,-0.125111349092741,-0.0954449659833137,9.92087451869899e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42547,0.0462704654569421,0.00317746042157679,0.0400426430306516,0.0524982878832326,1.13465823001138e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,42673,-0.0943624588880251,0.00648045418310798,-0.107064149086917,-0.0816607686891334,1.14224749476217e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40104,-0.126645227193893,0.00871606695253648,-0.143728718420864,-0.109561735966921,2.1619678144605e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42639,-0.0290401089300275,0.00200048034627376,-0.0329610504087241,-0.0251191674513309,2.1712619990934e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,40411,-0.101768990888408,0.00701267213648507,-0.115513828275918,-0.088024153500897,2.71911043139663e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42590,-0.100051645531814,0.00690190119339757,-0.113579371870874,-0.0865239191927552,2.9151628006755e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,42673,-0.0673959953191233,0.00465045339928517,-0.0765108839817222,-0.0582811066565244,3.06717551847012e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42568,0.0668795196018646,0.00461473633881403,0.0578346363777891,0.0759244028259401,3.07572743441193e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42475,-0.077414803882037,0.00536214944389496,-0.0879246167920711,-0.0669049909720028,6.82692508943461e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40406,0.0738402853509095,0.00511761045062532,0.0638097688676838,0.0838708018341351,8.95623726292347e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,42229,-0.0955143598904279,0.00662930528922059,-0.1085077982573,-0.0825209215235556,1.05390291207232e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42623,-0.056629826169315,0.00394926152529352,-0.0643703787588903,-0.0488892735797397,2.72808597371842e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,42475,-0.0824908150651445,0.00575579218413922,-0.0937721677460574,-0.0712094623842316,3.06311158010834e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,42527,-0.047821110775142,0.00335011686480662,-0.054387339830163,-0.0412548817201211,6.87506493768038e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40385,-0.0702127516985596,0.00491739716160699,-0.0798508501353093,-0.0605746532618099,7.53103618985063e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42475,-0.13418159313404,0.00942303485031438,-0.152650741440657,-0.115712444827424,1.12549019239222e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42496,0.0508372283916656,0.00357187318004388,0.0438363569587796,0.0578380998245516,1.24225131282689e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42292,-0.070792871342312,0.00497757150220328,-0.0805489114866304,-0.0610368311979935,1.45289336546404e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42673,-0.0972728036869236,0.0068440079217604,-0.110687059213574,-0.0838585481602732,1.62555157150913e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40350,-0.157157166189328,0.0110730739539126,-0.178860391138997,-0.135453941239659,2.51806615506045e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42673,-0.0753003391004928,0.00531694418615719,-0.0857215497053609,-0.0648791284956247,3.30476411096389e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,40411,-0.038680791318874,0.00274182991144982,-0.0440547779453156,-0.0333068046924323,8.22514506487897e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,42599,-0.0940303801355185,0.00670374081331802,-0.107169712129622,-0.0808910481414152,2.20793539551667e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42191,-0.0743313066261608,0.0053191321931001,-0.084756805724637,-0.0639058075276846,4.65730456130731e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,42518,-0.0393425942670714,0.00281851483119098,-0.0448668833362057,-0.0338183051979371,5.68516936951188e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42631,-0.0579888036392177,0.0041595967689687,-0.0661416133063963,-0.049835993972039,7.21364279843042e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42530,-0.084368366762844,0.00605494053765506,-0.096236050216648,-0.0725006833090401,8.00551586246733e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,40432,-0.0410272189551106,0.00294338210259522,-0.0467962478761972,-0.035258190034024,8.51516941891084e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42475,0.0508522955676041,0.00365402044434766,0.0436904154966827,0.0580141756385255,1.01506512783694e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,40384,-0.0647432932560557,0.0046513307639104,-0.0738599015533201,-0.0556266849587913,1.11752635529951e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42590,0.0681347236024573,0.00489995532317724,0.0585308111690299,0.0777386360358847,1.18447351595776e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,42590,-0.0529676703721264,0.00381831888634269,-0.060451575389358,-0.0454837653548947,1.87008542653622e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42466,-0.0400143405391794,0.00288732578099815,-0.0456734990699357,-0.034355182008423,2.26158649707969e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,40187,0.0333308514055302,0.00240593174756662,0.0286152251802996,0.0380464776307608,2.7927917472647e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,42631,-0.0593456604900404,0.00428825140329054,-0.0677506332404899,-0.050940687739591,2.9302113239833e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42490,0.0590722770307278,0.00427064584178414,0.0507018111808309,0.0674427428806247,3.24694828141305e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42631,-0.059595265602647,0.00430984332912853,-0.0680425585277389,-0.0511479726775551,3.42673310620443e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,42475,-0.135555623778511,0.00980860561704569,-0.15478049078792,-0.116330756769101,3.83504170689022e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42475,-0.0802006517369005,0.00582145241060899,-0.0916106984616941,-0.0687906050121068,6.93549929240477e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,42590,-0.0645780294234481,0.00469436809183861,-0.0737789908834518,-0.0553770679634445,9.09051672050185e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42229,-0.0727832800757853,0.00529282329724928,-0.0831572137383939,-0.0624093464131767,9.93552488978966e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40350,-0.0431773665952271,0.00314172865408399,-0.0493351547572317,-0.0370195784332225,1.24396464227355e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42561,-0.116958060203594,0.00853936583605788,-0.133695217242267,-0.10022090316492,2.06376010003388e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,42490,0.0408784918318069,0.00299056472175696,0.0350169849771633,0.0467399986864505,2.99445716355562e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40019,-0.0791508995807576,0.00578759482632326,-0.0904945854403512,-0.0678072137211641,3.16828922152895e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REN,Renin,42518,-0.121337009711247,0.0088811889379841,-0.138744140029695,-0.103929879392798,3.28367068067677e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40384,-0.08775637698412,0.00642581470006381,-0.100350973796245,-0.075161780171995,3.99631763234499e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42518,-0.122077694245952,0.00897966769911189,-0.139677842936212,-0.104477545555693,8.15811399312103e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40125,-0.118357401414317,0.00870109051634165,-0.135411538826347,-0.101303264002288,8.45334519351731e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,40428,-0.104333606798836,0.00767438117980624,-0.119375393911256,-0.0892918196864154,9.16259318307011e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40367,-0.112791345190167,0.00831147582982572,-0.129081837816626,-0.0965008525637089,1.27854251078487e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,39857,-0.031973899647341,0.00237157261124528,-0.0366221819653818,-0.0273256173293003,4.32140100558431e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42495,-0.158522939830683,0.0117967823615584,-0.181644633259338,-0.135401246402029,6.7085031136774e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,42542,-0.0447944215397444,0.00333482316112791,-0.0513306749355551,-0.0382581681439336,7.20222197945331e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,42622,-0.0336591800210946,0.00251013219809269,-0.0385790391293563,-0.0287393209128329,9.74750431127355e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,42554,-0.0505553597882808,0.00377393050460861,-0.0579522635773137,-0.0431584559992479,1.16814880328355e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,42495,-0.0431816323140625,0.00322715880835924,-0.0495068635784466,-0.0368564010496783,1.43419679838685e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,40411,-0.126514674624686,0.00945047808263825,-0.145037611666657,-0.107991737582715,1.47188014077006e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,42199,-0.0688673684375645,0.00515339984269466,-0.0789680321292461,-0.058766704745883,1.8267610307242e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42229,-0.0999048958280883,0.00747636132260024,-0.114558564020385,-0.0852512276357919,1.84151608052611e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40187,-0.0530323615205566,0.0039675579563099,-0.060808775114924,-0.0452559479261892,1.96184080845608e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42631,-0.0561186829227865,0.00421989325799182,-0.0643896737084504,-0.0478476921371225,4.22637543323411e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42594,-0.0807660191873519,0.00607689305231712,-0.0926767295698934,-0.0688553088048103,4.6998271089621e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,40104,-0.10939001153247,0.0082385045289785,-0.125537480409268,-0.0932425426556718,6.34273602511093e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,42475,0.0468036461907076,0.00353489841545418,0.0398752452964174,0.0537320470849978,9.15198767348465e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,42377,-0.0733090471263449,0.00553988306448138,-0.0841672179327284,-0.0624508763199614,1.01416502983234e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42475,-0.0577110736853447,0.00437752902650171,-0.0662910305772881,-0.0491311167934013,1.93188277586855e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42449,-0.14373268504123,0.0109103054351886,-0.1651168836942,-0.122348486388261,2.1885982957379e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40350,-0.187802214998951,0.0142800652190765,-0.215791142828341,-0.159813287169561,3.27041128757968e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,42495,-0.0504533203750439,0.00384061008194961,-0.0579809161356651,-0.0429257246144226,3.55220568303945e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42229,-0.0853117286300492,0.00651804167625594,-0.0980870903155109,-0.0725363669445876,6.73229317886771e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40187,-0.11279069331104,0.0086187530899393,-0.129683449367321,-0.0958979372547586,7.65393607716059e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40411,-0.0995181268807184,0.00761937092578211,-0.114452093895251,-0.0845841598661854,1.05042781116288e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,40412,0.0474344060452006,0.00363194377440831,0.0403157962473603,0.0545530158430409,1.06217521573957e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40350,-0.0804335409235121,0.00615957439306626,-0.092506306733922,-0.0683607751131022,1.09449583438192e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,42561,-0.0770760847550577,0.0059063798007871,-0.0886525891646004,-0.065499580345515,1.10028053523725e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,40352,-0.133237496035208,0.0102038219941298,-0.153236987143702,-0.113238004926714,1.10415774465313e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42462,-0.0277847070999007,0.00212953456926122,-0.0319585948556527,-0.0236108193441487,1.13840267078305e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42229,-0.0670242351179563,0.00515119053723512,-0.0771205685709371,-0.0569279016649755,1.82916918824956e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42496,-0.037016065115702,0.00284574817218498,-0.0425937315331846,-0.0314383986982194,1.90290990806194e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40019,-0.0993316893540423,0.00763491316431742,-0.114296119156104,-0.0843672595519802,2.07700953628091e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,40104,-0.0602795722157691,0.00464115480304775,-0.0693762356297427,-0.0511829088017956,2.74796140465026e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,42191,-0.0860330444640545,0.00662910023807511,-0.0990260809306817,-0.0730400079974272,2.81617727853776e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40104,-0.0923407559041085,0.00711217836531841,-0.106280625500133,-0.0784008863080844,2.91488176342939e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42561,-0.0318050614079272,0.00245464483192746,-0.036616165278505,-0.0269939575373494,3.63569995398444e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40352,-0.106033754859373,0.00817904765192298,-0.122064688257142,-0.0900028214616036,3.68722371593787e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42590,-0.0478666803541309,0.00369494418985652,-0.0551087709662497,-0.0406245897420122,3.74794823467997e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42518,-0.0371541530994415,0.00287701672965547,-0.0427931058895663,-0.0315152003093168,6.32596741263994e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42561,-0.041148481281966,0.00318863421014981,-0.0473982043338596,-0.0348987582300724,7.12364098030144e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42490,-0.0312659161118393,0.0024246381441717,-0.0360182068744158,-0.0265136253492627,8.08372340382862e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELN,Elastin,40411,-0.0490087035306708,0.00379953352152039,-0.0564557892328508,-0.0415616178284908,8.50417672679261e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40125,-0.0966331049751204,0.00749277219878584,-0.111318938484741,-0.0819472714655001,8.83891899773308e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,42475,-0.121697416973366,0.00944646730011559,-0.140212492881593,-0.103182341065139,9.46048559092102e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42518,-0.0468467827121156,0.00363657208872345,-0.0539744640060135,-0.0397191014182176,9.53251997945078e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42464,-0.0253938823818587,0.00197144895655156,-0.0292579223366998,-0.0215298424270177,9.7133936186303e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40187,-0.0289285477446854,0.00224529522377635,-0.033329326383287,-0.0245277691060837,1.03682198175259e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,42549,0.0520454465938948,0.00404367295965762,0.0441198475929659,0.0599710455948237,1.10010328723807e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,40089,-0.160641907580623,0.0124729224777578,-0.185088835637028,-0.136194979524218,1.10881520696461e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,42475,-0.109390460611954,0.00850002835697337,-0.126050516191622,-0.0927304050322866,1.12334011528292e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,42631,-0.049041743217448,0.00381112257192881,-0.0565115434584284,-0.0415719429764675,1.13633065290444e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42377,-0.0520234402206906,0.00404265730388575,-0.0599470485363067,-0.0440998319050745,1.13920683096506e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42475,-0.0520177107508266,0.00405138412007884,-0.0599584236261811,-0.044076997875472,1.64642813560729e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,42357,-0.0678316537663917,0.00529580344698604,-0.0782114285224844,-0.0574518790102991,2.45273806606174e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42673,0.0437540335328935,0.00342322640682414,0.0370445097755182,0.0504635572902688,3.41870630938473e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42590,-0.126186097273511,0.00987403662284442,-0.145539209054286,-0.106832985492736,3.51442658293255e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40385,-0.0913108872527544,0.00714546322481134,-0.105315995173385,-0.0773057793321242,3.91018030263865e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42518,-0.0998080899621815,0.00783124379197127,-0.115157327794445,-0.0844588521299178,5.47428578050782e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42475,-0.136876400125264,0.0107407177479191,-0.157928206911185,-0.115824593339342,5.56460603842518e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42256,-0.0610739778294145,0.00479300048136519,-0.0704682587728902,-0.0516796968859387,5.70878924595584e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,42518,-0.0470780363040695,0.00369521436407614,-0.0543206564576587,-0.0398354161504803,5.80167103842255e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42590,-0.0830147407636283,0.00652019706426912,-0.0957943270095958,-0.0702351545176608,6.43028779873321e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42377,-0.0704455329849889,0.00553942913608637,-0.0813028140917182,-0.0595882518782596,7.81795994852132e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42631,-0.0992255843877275,0.00781578882466365,-0.114544530484068,-0.0839066382913868,1.01725304993583e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42475,-0.112408838115048,0.00885705591881017,-0.129768667715916,-0.0950490085141797,1.07714329058564e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42191,-0.0381229910172559,0.00300366629958466,-0.0440101769644418,-0.0322358050700699,1.07898137965269e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42598,-0.106612929203959,0.00840869634284511,-0.123093974035935,-0.0901318843719826,1.25633230821491e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,42191,-0.0817776742567047,0.0064503122794437,-0.0944202863244143,-0.069135062188995,1.28818672369257e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,40019,-0.0894079975148074,0.00704946694916863,-0.103224952735178,-0.0755910422944369,1.33833318125817e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42518,-0.0570699555114624,0.00450603966657971,-0.0659017932579586,-0.0482381177649662,1.4968543838675e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,42475,-0.105869673221701,0.00836598876720629,-0.122267011205426,-0.089472335237977,1.70976380166975e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42229,-0.0865285431277636,0.00684044915957263,-0.099935823480526,-0.0731212627750013,1.84264747384015e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,40187,-0.0673226286765222,0.00532389896864493,-0.0777574706550662,-0.0568877866979781,2.12623893753558e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42475,-0.075695280771536,0.00599455528623014,-0.0874446091325471,-0.063945952410525,2.4136103786469e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,42673,-0.0607262881804214,0.00481237838729366,-0.070158549819517,-0.0512940265413258,2.66899275511466e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40350,-0.0382650522480546,0.00303518918552463,-0.0442140230516829,-0.0323160814444263,3.40305212169314e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,40428,0.0533164142346481,0.00423256079085112,0.0450205950845799,0.0616122333847163,3.86109426653635e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42532,0.0586647269442101,0.00466236797220468,0.0495264857186889,0.0678029681697312,4.21985411284649e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,42475,-0.0966522383463358,0.00770128816698767,-0.111746763153632,-0.08155771353904,6.34390922657982e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,40411,-0.0592086821399185,0.00472240415009289,-0.0684645942741006,-0.0499527700057364,8.05512771485867e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,40388,0.0252558249531347,0.00201976617903566,0.0212970832422248,0.0292145666640446,1.2226926607766e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40309,-0.140878883370578,0.0112717205597929,-0.162971455667772,-0.118786311073384,1.32054088424874e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,42475,0.0574008191657001,0.0045955570015397,0.0483935274426823,0.0664081108887179,1.33310503171162e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40206,-0.144616937019157,0.0115779670379425,-0.167309752413524,-0.12192412162479,1.460872998071e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42256,-0.0773272740858842,0.00619669576948546,-0.0894727977940757,-0.0651817503776927,1.55360437548196e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40385,-0.110583620640229,0.00886769769571188,-0.127964308123825,-0.093202933156634,1.86245726306914e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42466,-0.109363720228217,0.00877892201837048,-0.126570407384223,-0.0921570330722107,2.00750185636973e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40385,-0.0820456918099662,0.00658555630356636,-0.0949533821649563,-0.0691380014549761,2.15939031193755e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42518,-0.0520026214037791,0.00417826483543922,-0.06019202048124,-0.0438132223263182,2.31216174494637e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,42466,-0.069375463945145,0.00557982996823004,-0.0803119306828759,-0.0584389972074141,2.71132826796161e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40072,-0.063313551195533,0.00509230021802309,-0.0732944596228583,-0.0533326427682078,2.99480845793963e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,40385,-0.187148181926895,0.0151140559846755,-0.216771731656859,-0.157524632196931,5.51435875223691e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,40415,-0.0716582246441366,0.00578806164736867,-0.0830028254729792,-0.060313623815294,5.64676879046588e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40125,-0.0877681788702319,0.00711398464972303,-0.101711588783689,-0.0738247689567747,9.69478248290165e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42191,-0.100021087661342,0.00811501284167946,-0.115926512831034,-0.08411566249165,1.03255117075967e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42072,-0.109972225802251,0.00893364408844747,-0.127482168215609,-0.0924622833888944,1.25429377111781e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40411,-0.0375975137077671,0.00305806843908347,-0.0435913278483707,-0.0316036995671635,1.61619508721703e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,42256,-0.0600916050936769,0.00489270880446302,-0.0696813143504244,-0.0505018958369294,1.75629992718608e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,40104,-0.160117373773903,0.0130354928780023,-0.185666939814788,-0.134567807733019,1.88276388358616e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,42229,-0.0812861137514282,0.0066362491730857,-0.0942931621306762,-0.0682790653721802,2.63177966189458e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42532,-0.108220662210799,0.00883739423609724,-0.12554195491355,-0.0908993695080487,2.70446189842039e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40350,-0.0657465044831359,0.00536938228961876,-0.0762704937707886,-0.0552225151954831,2.97423628558096e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,42219,-0.0506066322368705,0.00414170457880509,-0.0587243732113285,-0.0424888912624126,3.79375136341012e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40352,-0.0482844886055111,0.00395152208834345,-0.0560294718986643,-0.0405395053123579,4.05369105533694e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,42466,-0.0696821615626292,0.00571514030594087,-0.0808838365622733,-0.0584804865629851,5.17690964761025e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42423,-0.0571426447082158,0.00468900156462119,-0.0663330877748733,-0.0479522016415583,5.57727846236177e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,42475,-0.10730499364512,0.00880552698592264,-0.124563826537529,-0.0900461607527118,5.59742344267876e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40350,-0.124680456546246,0.0102427349508165,-0.144756217049847,-0.104604696042646,7.13311595428345e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,42631,-0.0449481008698312,0.00369994498400789,-0.0521999930384867,-0.0376962087011758,8.80383181245903e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,42256,-0.106686861594451,0.00879465712525978,-0.123924389559961,-0.0894493336289423,1.09968180321204e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,42475,-0.104929703167275,0.00865767157932518,-0.121898739462753,-0.0879606668717978,1.24761798154208e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40384,-0.122014740586474,0.0100699111408323,-0.141751766422505,-0.102277714750443,1.39672502523511e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42599,0.0435377194885331,0.00359519080095093,0.0364911455186693,0.0505842934583969,1.40001804672817e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,42631,-0.117681278624914,0.00972199931587928,-0.136736397284037,-0.0986261599657902,1.49189729631732e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40125,-0.0932810812803782,0.00771642466506779,-0.108405273623911,-0.0781568889368453,1.9810653398897e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40385,-0.0499672895752439,0.00413711311789235,-0.0580760312863129,-0.0418585478641749,2.23069870109697e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,42561,-0.0497903249177435,0.00412896455913976,-0.0578830954536574,-0.0416975543818296,2.59542916002627e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40440,-0.0383149085266126,0.00317981447293178,-0.0445473448935588,-0.0320824721596663,3.12837135651937e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,42344,-0.0447880742275858,0.0037242760881366,-0.0520876553603335,-0.037488493094838,3.8718853383847e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40019,-0.0451444002829204,0.00376161774701552,-0.0525171710670708,-0.03777162949877,5.65898491747252e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,42069,-0.0498236547198412,0.00415948477243404,-0.0579762448738119,-0.0416710645658705,6.90167741776271e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,42561,-0.0458208497550849,0.00383980440665602,-0.0533468663921307,-0.0382948331180391,1.16518559104014e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,42370,0.03449592951091,0.00289782045957383,0.0288162014101453,0.0401756576116747,1.65369425730215e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42552,0.040188642195946,0.00337821953625732,0.0335673319048817,0.0468099524870104,1.80235187988e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,42542,-0.0309708422124115,0.0026132223858344,-0.0360927580886469,-0.025848926336176,3.06341089403581e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,42136,-0.085128672341764,0.00719383398922962,-0.0992285869606541,-0.071028757722874,3.83372408122004e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42558,-0.0828648920751391,0.00702327735875389,-0.0966305156982967,-0.0690992684519814,5.71734402710046e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,42229,-0.0737967909194355,0.0062564431238335,-0.0860594194421491,-0.0615341623967218,5.99676768646037e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42561,-0.0325792222148567,0.00276389541627011,-0.0379964572307462,-0.0271619871989673,6.5195937940387e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42516,0.0419730204310661,0.00356734076886169,0.0349810325240972,0.048965008338035,8.40308299835507e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,42528,-0.0561644133030115,0.00477433804395324,-0.0655221158691598,-0.0468067107368631,8.60992327534039e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42448,-0.0936911315838822,0.00796547884846228,-0.109303470126868,-0.0780787930408961,8.7986883545102e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,42466,-0.124303587676089,0.0105893564275753,-0.145058726274137,-0.103548449078042,1.15953136151532e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40352,-0.137903206363028,0.0117646862242355,-0.16096199136253,-0.114844421363526,1.50860980991948e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,42518,0.0378926331361078,0.00323755212289101,0.0315470309752414,0.0442382352969742,1.73161553467101e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,42475,-0.0700483163377508,0.00598599096936175,-0.0817808586376998,-0.0583157740378018,1.77572129848057e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,42497,-0.0408532573926007,0.00349429438928797,-0.0477020743956051,-0.0340044403895962,2.00873156874026e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40352,-0.0865011315812922,0.00740060855879058,-0.101006324356522,-0.0719959388060627,2.22622169086471e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40411,-0.0942863272385906,0.00806810003573112,-0.110099803308624,-0.0784728511685576,2.27545762529296e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,42229,-0.0905903174281386,0.00776985235677162,-0.105819228047411,-0.0753614068088662,2.9435124741156e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42631,0.0308817758608372,0.0026490427645425,0.0256896520423339,0.0360738996793405,2.96352272592689e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,42538,-0.0365847267844431,0.0031406884554709,-0.0427404761571661,-0.0304289774117201,3.30112574628509e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42466,0.0287783701718202,0.00247320472079415,0.0239308889190636,0.0336258514245767,3.82681873683802e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42490,-0.0547587575889494,0.00470833978785882,-0.0639871035731527,-0.0455304116047462,4.09543214964124e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42377,-0.0526325453992779,0.00452646145778687,-0.0615044098565401,-0.0437606809420156,4.22424907243193e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40385,-0.106746064841012,0.00917865678628964,-0.124736232142139,-0.0887558975398839,4.38687282195175e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40352,-0.0578611946717652,0.00497805066408039,-0.0676181739733627,-0.0481042153701676,4.73798550155946e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,40411,-0.0893658277581569,0.0076912894352671,-0.10444075505128,-0.0742909004650334,4.96132190816557e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40350,-0.101507703282624,0.00874141765785467,-0.118640881892019,-0.0843745246732288,5.38059186730125e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42493,-0.0735473185916826,0.00633705242664475,-0.0859679413479063,-0.0611266958354588,5.42306772771127e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,42358,-0.0758917789785784,0.00654004851722957,-0.0887102740723484,-0.0630732838848085,5.5539186230644e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40385,-0.0760059852625756,0.00654848200397105,-0.0888410099903588,-0.0631709605347923,5.73383839547442e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42554,-0.0363645210933422,0.00313591311138051,-0.0425109107916479,-0.0302181313950364,6.06247679603703e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,40350,-0.124952068220964,0.01078044576073,-0.146081741911995,-0.103822394529933,6.90865560924018e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,40384,-0.124494223021581,0.0107452275801607,-0.145554869078696,-0.103433576964466,7.27788805085375e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42466,-0.0641973164073302,0.00554396918291961,-0.0750634960058527,-0.0533311368088078,7.35112035387471e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40440,0.0320830339629169,0.00277384475774026,0.026646298237746,0.0375197696880878,9.11788059163532e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42631,-0.117558544835596,0.0101754163603073,-0.137502360901798,-0.0976147287693938,9.9355144582628e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42490,-0.0606506257191677,0.00525211934911236,-0.0709447796434279,-0.0503564717949075,1.06049137118782e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42568,-0.0514149619325455,0.00445515841471589,-0.0601470724253886,-0.0426828514397024,1.1511331463971e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42498,-0.0592090892382865,0.00513187326818303,-0.0692675608439252,-0.0491506176326477,1.19402195783787e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,42377,-0.082602402893238,0.00715930474070944,-0.0966346401850285,-0.0685701656014475,1.19425513541843e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,42464,-0.0508918185146986,0.00441707620882669,-0.0595492878839989,-0.0422343491453983,1.43500711169948e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42191,-0.0724871173219301,0.00632349963423103,-0.0848811766050229,-0.0600930580388372,2.82460133722056e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42496,-0.112119782114004,0.0098134791809598,-0.131354201308685,-0.0928853629193225,4.3285012631394e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,40428,-0.0331643196171162,0.00290296253990341,-0.0388541261953269,-0.0274745130389055,4.6324344235175e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,42568,-0.0664921986993885,0.00582414378919564,-0.0779075205262119,-0.055076876872565,4.75683734653912e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42623,-0.0626171864734984,0.00548839636049521,-0.073374443340069,-0.0518599296069278,5.18219200995679e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,42377,0.041121223120188,0.00360430376799576,0.0340567877349163,0.0481856585054597,5.21822440847387e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNST,Consortin,42518,-0.128544641356459,0.0112755972516417,-0.150644811969676,-0.106444470743241,5.73983262178179e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42256,-0.080557842548374,0.00706768881246206,-0.0944105126207997,-0.0667051724759484,5.92321388286328e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,40364,-0.0861865606461124,0.00757015268823584,-0.101024059915055,-0.0713490613771701,7.25081343892908e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40411,-0.0744259269842364,0.0065531690914331,-0.0872701384034453,-0.0615817155650275,9.91963104892936e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42229,-0.044316919734794,0.00391368763304529,-0.0519877474955628,-0.0366460919740253,1.37872499807369e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,42448,-0.0450234484037509,0.00397814932957292,-0.0528206210897138,-0.037226275717788,1.465822911024e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,42490,-0.0521979423014646,0.00463235693745702,-0.0612773618988803,-0.0431185227040488,2.56044670659274e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42568,-0.0666953128467283,0.00592187908095764,-0.0783021958454053,-0.0550884298480514,2.72181472727074e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42237,-0.110465634260742,0.00981552886891425,-0.129704070843814,-0.0912271976776703,3.01269265007608e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42466,-0.0897172693468647,0.00797522749644592,-0.105348715239899,-0.0740858234538307,3.15833809572159e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,42417,-0.0841308226779564,0.00748360083637561,-0.0987986803172526,-0.0694629650386602,3.43843000789412e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39964,-0.0619826529614819,0.00552181154121021,-0.0728054035822539,-0.0511599023407099,4.45382199913418e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,42590,-0.0682701932333209,0.00609640809735456,-0.0802191531041359,-0.056321233362506,5.58167072116326e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,42599,0.0191040758446328,0.00171101343539774,0.0157504895112533,0.0224576621780124,8.07332360672415e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40187,-0.0904319048810124,0.00810313841474924,-0.106314056173921,-0.0745497535881039,9.12199732914176e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42466,-0.0686966796289296,0.0061613428773561,-0.0807729116685476,-0.0566204475893117,9.64773144443902e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42466,-0.158531746138732,0.0142353970441455,-0.186433124345257,-0.130630367932207,1.11717435628884e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42516,-0.03691804380252,0.00331528415585139,-0.0434160007479887,-0.0304200868570513,1.12513788662541e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40359,-0.0668390287597089,0.00599986401969843,-0.0785987622383178,-0.0550792952811,1.13332551621884e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,42329,-0.0445488765744584,0.00400194762696944,-0.0523926939233185,-0.0367050592255982,1.17999585993094e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,40385,-0.0442022823901026,0.00397376259153478,-0.0519908570695108,-0.0364137077106945,1.36082483603631e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42191,-0.0770757411551955,0.00693477643981345,-0.0906679029772298,-0.0634835793331611,1.43630911917299e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,40187,-0.0820937807253103,0.00738508346674441,-0.0965685443201293,-0.0676190171304912,1.48582537501975e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,42246,-0.046038649273185,0.00414830569955296,-0.0541693284443088,-0.0379079701020612,1.71683107097634e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,42590,-0.0663560601221745,0.00598495173814262,-0.0780865655289341,-0.054625554715415,1.92554659776735e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,42191,-0.0660600946201784,0.00598182227420202,-0.0777844662776144,-0.0543357229627425,3.14727873574189e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40111,-0.0914620581206065,0.00828070974094208,-0.107692249212853,-0.07523186702836,3.26163743678224e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40428,-0.0446267193239591,0.0040449425762865,-0.0525548067734806,-0.0366986318744375,3.70592920702443e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42553,-0.0833561829578991,0.00755989048869293,-0.0981735683157372,-0.0685387976000609,3.78165087393003e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42377,-0.0656000289558528,0.00596376761170408,-0.0772890134747928,-0.0539110444369128,5.07189700706513e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,42323,-0.0413758191727389,0.00376302256731501,-0.0487513434046763,-0.0340002949408015,5.32886429934942e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42536,-0.117595281994291,0.0106954165710665,-0.138558298473581,-0.0966322655150003,5.33115291554812e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42475,-0.0666470473210577,0.00606218769997281,-0.0785289352130044,-0.054765159429111,5.39858317246205e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,42359,-0.0529346050059553,0.00481942472428573,-0.0623806774655553,-0.0434885325463553,6.05954627205481e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40411,-0.0841259393979483,0.00765691838290515,-0.0991334994284424,-0.0691183793674542,6.13100719627967e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,40104,-0.0623884580411259,0.00567919713904327,-0.0735196844336507,-0.0512572316486011,6.2887019957785e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,42467,0.0442267069955142,0.00402887367088323,0.0363301146005831,0.0521232993904453,6.46835935680568e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42466,0.022557575038659,0.00205539348593175,0.0185290038062327,0.0265861462710852,6.656767782794e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,42554,-0.0524165657187674,0.00477625769857748,-0.0617780308079793,-0.0430551006295556,6.67541990326835e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,42191,-0.0399718819328564,0.00364643584517109,-0.0471188961893917,-0.0328248676763211,7.71339290175474e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42584,-0.0410722385495602,0.00375890174290974,-0.0484396859656633,-0.0337047911334572,1.12483996673753e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,42599,-0.0640196192808585,0.00586135559533621,-0.0755078762477174,-0.0525313623139995,1.17901761773139e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42516,-0.0600142973792727,0.00549580577578304,-0.0707860766998075,-0.049242518058738,1.21106542496322e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42377,-0.107261763544164,0.00983162429121774,-0.126531747154951,-0.0879917799333772,1.35660112981076e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,40104,-0.0390760603676909,0.0035878695858128,-0.0461082847558839,-0.0320438359794978,1.75873668284911e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,42466,-0.0929259267497281,0.00854543921907241,-0.10967498761911,-0.0761768658803462,1.99381739761435e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,40072,-0.0332211142812461,0.00305484252110001,-0.0392086056226021,-0.0272336229398901,2.10017782289281e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,42191,-0.0958170669202157,0.00882037485135958,-0.11310500162888,-0.0785291322115509,2.26382997273472e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,42357,-0.0383230004231106,0.00353298179516199,-0.0452476447416281,-0.0313983561045931,2.68207521563698e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42358,-0.124963909263624,0.011525344766967,-0.14755358500688,-0.102374233520369,2.82158595518559e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42490,-0.0301922838662186,0.00278572057799012,-0.0356522961990793,-0.024732271533358,2.94842332707914e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,42518,-0.135381192755146,0.0124993236932354,-0.159879867193888,-0.110882518316405,3.18405432972545e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40195,-0.0497699930230727,0.00459566044337207,-0.058777487492082,-0.0407624985540634,3.41084089050119e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,42673,-0.0618981870660943,0.00572896370812405,-0.0731269559340175,-0.0506694181981712,4.23507073147369e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,42377,-0.0672715082178257,0.00623013678073846,-0.0794825763080731,-0.0550604401275783,4.57744771244481e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42631,-0.0637311983449912,0.00591012974466536,-0.0753150526445353,-0.0521473440454471,5.31913585839815e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,42495,-0.0353483564816445,0.00328461570364376,-0.0417862032607862,-0.0289105097025027,6.72897415845888e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,40104,-0.104813625373301,0.00974163934692295,-0.12390723849327,-0.0857200122533323,7.30268657387147e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,42229,-0.0451047507454912,0.00419454855094724,-0.0533260659053478,-0.0368834355856346,7.42002920406336e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42518,-0.0419084787049493,0.00389906660650425,-0.0495506492536976,-0.0342663081562009,7.77330326700627e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42443,-0.0788793295594083,0.00734050841177563,-0.0932667260464885,-0.064491933072328,8.00302238530322e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),40225,0.203473007982065,0.0189416014026758,0.166347469232821,0.24059854673131,8.75493137342434e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40410,0.0832879900239652,0.00776029018866469,0.0680778212541824,0.098498158793748,9.6488001995889e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,42229,-0.10831972152592,0.0101191585108212,-0.128153272207129,-0.0884861708447102,1.25185242334587e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,40440,-0.0228414945508708,0.00213381518625023,-0.0270237723159212,-0.0186592167858203,1.30169173807364e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40350,-0.120584246198729,0.0112666499452592,-0.142666880091437,-0.0985016123060212,1.32972936792074e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40385,-0.118575076869929,0.0111073481315935,-0.140345479207852,-0.0968046745320053,1.7794988254263e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,42518,0.0572839104304922,0.00537174123506796,0.046755297609759,0.0678125232512254,1.91875360933597e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,42599,0.0525083251940554,0.00492424200966734,0.0428568108551074,0.0621598395330034,1.93042748425772e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,42490,-0.0431139096339963,0.00404570207250039,-0.0510434856960971,-0.0351843335718956,2.07330918759332e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,40125,-0.0524803082522992,0.00492316825850941,-0.0621297180389776,-0.0428308984656207,2.11360738200162e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,42519,0.0423429852116348,0.00397646980275486,0.0345491043982352,0.0501368660250343,2.2645921004213e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40187,-0.0639014015288216,0.006001002999376,-0.0756633674075986,-0.0521394356500447,2.3823847408421e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,42571,-0.0692323072345248,0.00650905462795593,-0.0819900543053184,-0.0564745601637312,2.57286535838266e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42518,-0.0699816010868977,0.00658218744097514,-0.082882688471209,-0.0570805137025865,2.69700863897466e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,42673,0.0308371165795102,0.00290211878417346,0.0251489637625303,0.0365252693964902,2.87408874596368e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,42590,0.0421059237283364,0.00396429868062321,0.034335898314315,0.0498759491423579,3.01757431470895e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,42490,-0.0639198792594957,0.00602485567814627,-0.0757285963886624,-0.052111162130329,3.43075629054039e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,40244,-0.11969361951387,0.0112877575033411,-0.141817624220419,-0.0975696148073216,3.81868063852422e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40104,-0.058648640175524,0.00553322953976835,-0.06949377007347,-0.0478035102775781,4.01948319659324e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,42016,-0.101117352180299,0.00954633669195008,-0.119828172096521,-0.0824065322640771,4.14897356596379e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,42631,-0.0543006571290352,0.00513463192253647,-0.0643645356972067,-0.0442367785608637,4.90582637827042e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42584,-0.07307597673215,0.00691238624684774,-0.0866242537759716,-0.0595276996883284,5.10211387059546e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40384,-0.0603906463454657,0.00571460240288372,-0.0715912670551178,-0.0491900256358136,5.57133332588568e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,42229,-0.0313805051970176,0.00297251294933054,-0.0372066305777055,-0.0255543798163298,6.00720725091725e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40411,-0.0900148184045879,0.00852873196899131,-0.106731133063811,-0.0732985037453649,6.41801448327742e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",40440,-0.0183332809809191,0.00173795298581527,-0.0217396688331171,-0.0149268931287212,6.79793774690429e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42561,0.0263623961099372,0.00250209918311657,0.0214582817110288,0.0312665105088457,7.43576856868808e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,42452,-0.037064324334705,0.00352798755127067,-0.0439791799351955,-0.0301494687342145,1.02502768704127e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39937,-0.0362990585600832,0.00345369535200825,-0.0430683014500193,-0.029529815670147,1.03304788149953e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,42498,-0.0353039529004062,0.00336104950239362,-0.0418916099250977,-0.0287162958757147,1.0454177779174e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40411,-0.0656991720908225,0.00626141628082528,-0.07797154800124,-0.0534267961804049,1.22647099268757e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40019,-0.067562952087015,0.00644221037719618,-0.0801896844263195,-0.0549362197477105,1.30738311808165e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42590,-0.0705601958006345,0.00674036195465557,-0.0837713052317594,-0.0573490863695095,1.51552358635909e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40191,-0.0704264487731932,0.00673720522962632,-0.0836313710232608,-0.0572215265231256,1.86107605550232e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,40385,-0.0407926640893905,0.00390268394249532,-0.0484419246166814,-0.0331434035620997,1.86975747065043e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,40384,-0.0596103841867864,0.00570305344757508,-0.0707883689440335,-0.0484323994295392,1.87178136610603e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,42185,-0.0379831299937756,0.00363779204492539,-0.0451132024018294,-0.0308530575857219,2.02539184473718e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,42590,-0.0250695972619773,0.00240436183999765,-0.0297821464683727,-0.0203570480555819,2.34124145115483e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42673,0.0315258332729465,0.00302369219637285,0.0255993965680557,0.0374522699778373,2.34892339872303e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,40104,-0.048529314948971,0.0046536161562977,-0.0576504026153145,-0.0394082272826275,2.42232582980248e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,40206,-0.139570457372545,0.0133886708962982,-0.165812252329289,-0.1133286624158,2.51334331240048e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42475,-0.0554931011404022,0.00533353602607736,-0.0659468317515138,-0.0450393705292906,2.95518908996276e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,42466,-0.0352034769538972,0.00338967388992027,-0.0418472377781409,-0.0285597161296535,3.60377569344688e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,42358,-0.0680934277604716,0.00655844102510277,-0.080947972169673,-0.0552388833512701,3.72242623937643e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42554,-0.113023308404976,0.0108882151245666,-0.134364210049126,-0.0916824067608251,3.79726091826575e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,40428,-0.0447686835021637,0.0043113931817638,-0.0532190141384207,-0.0363183528659066,3.81754531059897e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,42330,0.0297165328484126,0.00287088145196123,0.0240896052025686,0.0353434604942566,5.16666418377327e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,42229,-0.0613591831414323,0.00593170954138713,-0.072985333842551,-0.0497330324403135,5.55010840993242e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40352,-0.0483829641228279,0.00467990527837613,-0.0575555784684451,-0.0392103497772107,6.11739193112449e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40206,-0.0565900899467977,0.00547441659221835,-0.0673199464675456,-0.0458602334260497,6.21864344679548e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,40411,-0.0321913188426008,0.00311810155343687,-0.0383027978873371,-0.0260798397978645,7.09143902076933e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40350,-0.0501825263016421,0.00486135763979678,-0.0597107872756438,-0.0406542653276404,7.19524965929514e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40385,-0.087892774338426,0.00851976466741997,-0.104591513086569,-0.0711940355902828,7.68026536956645e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,42229,-0.0611249769023456,0.00592802580694129,-0.0727439074839506,-0.0495060463207407,7.81314992515442e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42377,-0.077108399681077,0.00748159485751224,-0.091772325601801,-0.062444473760353,8.18764462301576e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42554,-0.13252658483275,0.0128667436139472,-0.157745402316087,-0.107307767349414,8.72873184188767e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,40125,-0.054951222250756,0.00533402701396539,-0.0654059151981282,-0.0444965293033839,8.95584045234304e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,42673,0.0175065831318575,0.00170022755062151,0.0141741371326394,0.0208390291310757,9.01585798972025e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,40125,-0.0645986610496434,0.00627342975689933,-0.076894583373166,-0.0523027387261207,9.41244164590574e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,40400,-0.0470517956761573,0.00457075499873448,-0.0560104754736769,-0.0380931158786378,9.65485777331948e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40350,-0.0425684719808484,0.00414501195310688,-0.0506926954089379,-0.0344442485527589,1.24074268367478e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,42466,-0.0587221947289036,0.00572838564511931,-0.0699498305933374,-0.0474945588644698,1.44483030024892e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42466,-0.0894473005900291,0.00873115240233869,-0.106560359298613,-0.0723342418814453,1.54408381544521e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,42237,-0.0583512836497693,0.00570046003225887,-0.0695241853129967,-0.0471783819865419,1.68872615176273e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,40350,-0.0742722965221205,0.00726033701722526,-0.088502557075882,-0.060042035968359,1.86831405464301e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,40352,-0.0878844759500969,0.0085942975923749,-0.104729299231152,-0.0710396526690421,1.94552045445129e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42590,-0.0691959012995694,0.00677277091264718,-0.0824705322883579,-0.055921270310781,2.04977113596766e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42229,-0.0614778256353287,0.00602479231502729,-0.0732864185727822,-0.0496692326978753,2.34581493668712e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,42424,-0.0246994568183875,0.00242184818994674,-0.0294462792706832,-0.0199526343660919,2.47481369161359e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42466,0.0442074169936766,0.0043348788311488,0.0357110544846249,0.0527037795027282,2.48646885250563e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42495,-0.0860495350053212,0.00844078331645557,-0.102593470305574,-0.0695055997050683,2.57785370561712e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42554,-0.0418963106277435,0.00411227429213646,-0.0499563682403309,-0.033836253015156,2.74897273031178e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42191,-0.0546642618927463,0.00537234702067821,-0.0651940620532755,-0.044134461732217,3.15632020040937e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42237,-0.0615358775348413,0.00605461554395806,-0.0734029240009991,-0.0496688310686835,3.55141729349168e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,42237,-0.0614785154434285,0.00605001134030147,-0.0733365376704194,-0.0496204932164376,3.61512140298466e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42475,-0.0832406542488017,0.00820110672583262,-0.0993148234314337,-0.0671664850661698,4.06076818996069e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40385,-0.094528972411342,0.00931874153085814,-0.112793705811824,-0.0762642390108601,4.47961685195923e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42490,0.0556312609402358,0.00548856528289186,0.0448736729857677,0.0663888488947039,4.68436652647025e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42631,-0.0703771667312211,0.00695252922828437,-0.0840041240186585,-0.0567502094437838,5.3511476200798e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,40187,-0.120978545419961,0.0119522037707523,-0.144404864810635,-0.0975522260292862,5.62846250341269e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,40125,-0.0558397245631624,0.0055242309978829,-0.0666672173190128,-0.0450122318073119,6.47517066209166e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,40417,0.0387663262606135,0.00383581162320787,0.0312481354791261,0.046284517042101,6.5479256141796e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,40125,-0.0420740661835348,0.00416311863180078,-0.0502337787018643,-0.0339143536652052,6.59159224834825e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42554,-0.109430532092853,0.010841294007803,-0.130679468348147,-0.0881815958375589,7.16177248097307e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,40187,-0.0423215166498914,0.00419196161445632,-0.0505377614142258,-0.0341052718855571,7.32002856839618e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40187,-0.0693925562452194,0.00687498263058219,-0.0828675222011605,-0.0559175902892783,7.49853222819625e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,42502,-0.0579558446503735,0.005744536435556,-0.0692151360640633,-0.0466965532366838,7.53884749983361e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42561,-0.100270843027369,0.00994352796451559,-0.119760157837819,-0.0807815282169181,7.9093514271697e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,42590,-0.0627704161326976,0.00622505037890736,-0.074971514875356,-0.0505693173900392,7.94697666011195e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,40352,-0.0414355788450369,0.00411139181088823,-0.0494939067943779,-0.033377250895696,8.71546703750207e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42237,-0.0971751997989956,0.00965081686433104,-0.116090800853084,-0.0782595987449068,9.23923945111136e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,40384,-0.0684558353297756,0.00680513021608694,-0.081793890553306,-0.0551177801062452,1.05250052240807e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42631,-0.0574743899465657,0.00571793574280802,-0.0686815440024694,-0.046267235890662,1.09599937648856e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42381,-0.0306871303152117,0.00305286922421993,-0.0366707539946828,-0.0247035066357406,1.09666773748717e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,42229,-0.0495936120446652,0.00493955001865531,-0.0592751300812296,-0.0399120940081008,1.23767838792805e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42475,-0.0726038344805707,0.00723375146478253,-0.0867819873515444,-0.0584256816095969,1.27468637576492e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40125,-0.106598812667573,0.010624530596816,-0.127422892637333,-0.085774732697814,1.37670889584928e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,40385,-0.064820279871669,0.00646119817376977,-0.0774842282922577,-0.0521563314510802,1.38355419006165e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,40280,0.113397319018955,0.0113337209187388,0.0911832260182266,0.135611412019683,1.81640576356677e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,40019,-0.0809129500702481,0.0080894450296124,-0.0967682623282884,-0.0650576378122078,1.88239598039927e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40384,-0.0642804309496609,0.00642730563337931,-0.0768779499910843,-0.0516829119082374,1.88957904199669e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,40104,-0.0509519931139537,0.00509481328234871,-0.0609378271473572,-0.0409661590805502,1.90796061115559e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42490,-0.0475728698811958,0.00476101771952544,-0.0569044646114657,-0.038241275150926,1.99500249015628e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,42568,0.0504440718940604,0.0050505758416954,0.0405449432443374,0.0603432005437834,2.08210153414242e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42237,-0.0397044540359693,0.00397511170411014,-0.0474956729760252,-0.0319132350959134,2.08212812165554e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,42630,-0.0287653557495247,0.00288369723816496,-0.034417402336328,-0.0231133091627214,2.36031039239833e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,40187,-0.0697971303299337,0.00699502256278057,-0.0835073745529836,-0.0560868861068838,2.38848701977802e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,42518,-0.0722381987639967,0.00724301326580342,-0.0864345047649714,-0.058041892763022,2.40366738420289e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,40187,-0.0526299077627463,0.00528168163621908,-0.0629820037697357,-0.0422778117557569,2.73300109187747e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,40411,-0.048560511829604,0.00487469733173298,-0.0581149185998007,-0.0390061050594074,2.79949313688868e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40440,-0.0175867481480109,0.0017675454672714,-0.0210511372638628,-0.0141223590321589,3.15131890581973e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,42599,-0.0415332895472154,0.00417757965175511,-0.0497213456646554,-0.0333452334297754,3.28974753947503e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40352,-0.0685349497175977,0.00689523891232035,-0.0820496179857455,-0.0550202814494498,3.49952522371987e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42532,-0.053639728041076,0.00540168187685921,-0.06422702451972,-0.0430524315624319,3.70202325689973e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42475,-0.114713058239784,0.0115533636551472,-0.137357651003872,-0.0920684654756952,3.75003877070398e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,40187,-0.0239915290504751,0.00241605222541572,-0.0287269914122899,-0.0192560666886603,3.85537787018842e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,42518,-0.0565934671416719,0.00570934167903877,-0.0677837768325878,-0.0454031574507559,4.41804169362604e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,40440,0.0284495595784111,0.00287028287419579,0.0228238051449873,0.0340753140118348,4.60042167244339e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,42358,-0.0240354312727091,0.00243396125205641,-0.0288059953267396,-0.0192648672186785,6.41706805781497e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42475,-0.0713162632999735,0.00722517629618001,-0.0854776088404863,-0.0571549177594607,6.69888306293672e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40384,-0.0814209647718375,0.0082536501203058,-0.0975981190076368,-0.0652438105360381,7.32846497724291e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,42237,-0.0743779664009797,0.0075478071819449,-0.0891716684775917,-0.0595842643243677,7.89438990424437e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40428,0.0339585447035316,0.00344523063751934,0.0272058926539937,0.0407111967530695,7.93683587647108e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,40432,-0.0746270681018655,0.00757581044821089,-0.0894756565803588,-0.0597784796233721,8.41850872991648e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,40350,-0.0685281018530908,0.00698143109747744,-0.0822117068041466,-0.054844496902035,1.18939681766935e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42554,-0.0413017698452647,0.00421225181823754,-0.0495577834090103,-0.0330457562815191,1.27536129439754e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,40352,-0.0215351857392912,0.00220007453382469,-0.0258473318255876,-0.0172230396529948,1.55611501178094e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42465,-0.0658237117257757,0.00672712390386862,-0.0790088745773582,-0.0526385488741932,1.55912244977298e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,42357,-0.0542453854678489,0.00554512636876091,-0.0651138331506202,-0.0433769377850775,1.5968170190286e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,42377,0.0350590822783453,0.00358690342210816,0.0280287515710133,0.0420894129856773,1.73248591766855e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42554,0.0211118665091028,0.00216245206414753,0.0168734604633736,0.025350272554832,1.93015404075117e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40350,-0.0772640821445262,0.00792852672253861,-0.0928039945207019,-0.0617241697683505,2.37737374776277e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42459,-0.0841156317235419,0.00864412040007817,-0.101058107707695,-0.0671731557393887,2.64153815135384e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,40162,-0.0505381072276174,0.00519298088975367,-0.0607163497715345,-0.0403598646837002,2.71013464865847e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,42568,-0.100853419770293,0.0103727289744114,-0.12118396856014,-0.0805228709804469,2.85274439497621e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42256,-0.0607756785131862,0.00625281452220372,-0.0730311949767055,-0.0485201620496669,2.95530969638886e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40384,-0.0790427763511721,0.00813298038626043,-0.0949834179082425,-0.0631021347941016,3.06974161339678e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,42229,-0.0596128128993921,0.00613574194280316,-0.0716388671072863,-0.0475867586914979,3.075913818068e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42493,-0.0983214426314917,0.0101464157525769,-0.118208417506542,-0.078434467756441,3.92534324984423e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,40411,-0.0324916143006436,0.00335636051880362,-0.0390700809174987,-0.0259131476837885,4.44710240332249e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40384,-0.0722560243290854,0.00747526851299564,-0.0869075506145569,-0.057604498043614,5.12556764831076e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42175,-0.0578475876594376,0.00600556576915351,-0.0696184965669785,-0.0460766787518968,6.91101169980193e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,40385,-0.0560075672875075,0.00581693926407536,-0.0674087682450952,-0.0446063663299198,7.37628838547737e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42466,-0.0445331284600163,0.00462875465240465,-0.0536054875787294,-0.0354607693413032,7.68400205856703e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40385,0.0368949059439259,0.00383695539021051,0.0293744733791133,0.0444153385087385,8.3361396634251e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,42358,-0.0803408581269229,0.00837104475436162,-0.0967481058454717,-0.0639336104083741,9.65169445166261e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,40187,-0.0687426697598635,0.00716708826401629,-0.0827901627573354,-0.0546951767623916,1.05628521145028e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42532,0.087004375566273,0.00908381334290483,0.0692001014141796,0.104808649718366,1.16207892731746e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,42320,-0.0424643313720462,0.00443356408596025,-0.0511541169805283,-0.0337745457635641,1.16547356453221e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40384,-0.0480791438245898,0.00501856907995312,-0.0579155392212979,-0.0382427484278817,1.17213667807367e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,40019,-0.0430804471359884,0.00450909836112033,-0.0519182799237842,-0.0342426143481925,1.51561841766562e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,40440,-0.0211555140600257,0.00221563464049642,-0.0254981579553986,-0.0168128701646527,1.59100178239994e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40187,-0.0703469696970161,0.00737512358411475,-0.084802211921881,-0.0558917274721512,1.75615059316595e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,40104,-0.0958506378375413,0.0100566377679181,-0.115561647862661,-0.0761396278124218,1.88633281460063e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42466,0.0247821650933359,0.00261095135629371,0.0196647004350002,0.0298996297516715,2.65751136978851e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40089,-0.0684932213367909,0.00722301649457702,-0.0826503336661619,-0.05433610900742,2.994098256174e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42554,-0.066902154365544,0.0070628563892961,-0.0807453528885643,-0.0530589558425236,3.18819451244914e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40350,-0.100882730635786,0.0106500900970828,-0.121756907226069,-0.0800085540455039,3.28310949750084e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42536,-0.0689901542724994,0.00730056688764998,-0.0832992653722934,-0.0546810431727054,3.94591870705227e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,40042,-0.0395386046843309,0.00418337010553768,-0.0477380100911848,-0.0313391992774771,4.03155816502149e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40125,-0.074841736681997,0.00792849205358249,-0.0903815811070187,-0.0593018922569753,4.5012292494606e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40384,-0.0474901430437847,0.00504159108710004,-0.0573716615745008,-0.0376086245130687,5.41135195298419e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,40352,-0.0352437543914517,0.00374368165267665,-0.0425813704306979,-0.0279061383522055,5.70159891713891e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40171,-0.0829799379366486,0.00882331850153967,-0.100273642199666,-0.0656862336736308,6.25936517633228e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,40411,-0.0626643989368541,0.00666655443562164,-0.0757308456306725,-0.0495979522430357,6.52402929029607e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,42377,-0.093396482119245,0.00994349325670888,-0.112885728902394,-0.0739072353360956,6.79486692850988e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,40125,-0.0319611685465593,0.00340520571917108,-0.0386353717561346,-0.025286965336984,7.46730498906616e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40187,-0.052478961572013,0.00559993008904361,-0.0634548245465385,-0.0415030985974876,8.55908846470918e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40104,-0.0865596256149737,0.0092411049064538,-0.104672191231623,-0.0684470599983242,8.94553557845443e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,40350,-0.0567798337082758,0.00607611764826895,-0.0686890242988829,-0.0448706431176686,1.09592974777e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,42445,-0.0452185774737413,0.00484071036877776,-0.0547063697965457,-0.0357307851509369,1.10138546994746e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40384,-0.0750200954925882,0.00803498939582616,-0.0907686747084075,-0.059271516276769,1.18151553399153e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,42476,-0.039938603939037,0.00428068149499456,-0.0483287396692263,-0.0315484682088476,1.22463735376905e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,40187,-0.0527052055045973,0.00564715458595279,-0.0637736284930647,-0.0416367825161298,1.22604220763211e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40432,-0.0455414394047331,0.00488015492870311,-0.0551065430649912,-0.035976335744475,1.23390531688806e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42229,-0.0607230366095673,0.00652855777613466,-0.0735190098507912,-0.0479270633683433,1.60820179578536e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,42466,-0.090812213339767,0.00977532822272164,-0.109971856656301,-0.0716525700232326,1.78092610504343e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40270,-0.0331050616761481,0.00356361275439791,-0.040089742674768,-0.0261203806775282,1.83514162170688e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42475,-0.0970447822714351,0.0104506711901343,-0.117528097804098,-0.0765614667387718,1.84770180045133e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,40385,-0.0642672762199068,0.0069266722814277,-0.077843553891505,-0.0506909985483085,2.0394108864319e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,42024,0.0311724932108674,0.0033628360342937,0.0245813345836517,0.037763651838083,2.16126238611401e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42568,-0.0286698025890726,0.00309587257205809,-0.0347377128303064,-0.0226018923478387,2.33736244137456e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,42191,-0.0649479943276499,0.00702064658400695,-0.0787084616323035,-0.0511875270229963,2.56730195014932e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40428,-0.0224439635990453,0.00242922995675188,-0.027205254314279,-0.0176826728838116,2.93129226375798e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40411,-0.0941011865728696,0.0101896089667968,-0.114072820147791,-0.074129552997948,3.04598138413772e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42475,-0.0683481774595318,0.00741728233700172,-0.0828860508400552,-0.0538103040790084,3.58386507699352e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,42466,-0.0862635545584568,0.00936389511002129,-0.104616788974099,-0.0679103201428151,3.66344795257937e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40411,-0.101871361877384,0.0110672140763239,-0.123563101466979,-0.0801796222877889,4.0292935767351e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,40385,-0.0714252743524401,0.00776824756499919,-0.0866510395798386,-0.0561995091250417,4.43197462547229e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,42518,-0.0368279374415699,0.00402338533576117,-0.0447137726996618,-0.028942102183478,6.30572575069191e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,42387,-0.0506876933749071,0.00553886739564691,-0.0615438734703751,-0.0398315132794392,6.44298194471739e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,42514,-0.099548594724884,0.0108964458603291,-0.120905628611129,-0.0781915608386389,7.41304625891943e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,42490,-0.0238197707952485,0.00260747879855103,-0.0289304292404085,-0.0187091123500885,7.46293569154182e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,42631,-0.0330462298335228,0.00362156983961591,-0.0401445067191699,-0.0259479529478756,8.19442329305872e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,40385,-0.101181517780309,0.0110884220174097,-0.122914824934432,-0.0794482106261856,8.40217990974439e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,42467,-0.0830710804319555,0.00910966438224936,-0.100926022621164,-0.0652161382427468,8.65851756837437e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42561,-0.0660843020593127,0.00724788707822486,-0.0802901607326334,-0.051878443385992,8.75195879259348e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40432,-0.0257771582457407,0.00282754872842439,-0.0313191537534525,-0.0202351627380289,9.07963643248483e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40089,-0.0790286977400756,0.00868594843513515,-0.0960531566729405,-0.0620042388072107,1.07549066700462e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42466,-0.032371338691886,0.00355912924444847,-0.039347232011005,-0.025395445372767,1.0758058984045e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,40432,0.0465405553573543,0.00511735171329716,0.0365105459992919,0.0565705647154168,1.10805205806661e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40432,-0.061696694717154,0.00680110918297871,-0.0750268687157923,-0.0483665207185158,1.36792426078819e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,42229,-0.0893970260194376,0.00987450185461985,-0.108751049654493,-0.0700430023843827,1.58164321143879e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40404,0.014301780524492,0.00158043946531427,0.011204119172476,0.0173994418765079,1.67670446066492e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42237,0.0202397274667919,0.00223870031020738,0.0158518748587854,0.0246275800747984,1.77170605455521e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42673,-0.0387197243566668,0.00428467406455451,-0.0471176855231936,-0.03032176319014,1.8303153467798e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42590,-0.0490458583331968,0.00543209367728739,-0.05969276194068,-0.0383989547257135,1.96788344448623e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42673,-0.035705801924561,0.00395567730337566,-0.0434589294391773,-0.0279526744099447,2.01032608470559e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40384,-0.0629012090591946,0.00696657423367019,-0.0765556945571882,-0.049246723561201,2.01558739003206e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,40125,-0.0634239726414578,0.00703611104868588,-0.0772147502968821,-0.0496331949860334,2.31596279978581e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42554,-0.0802079613487224,0.00890143896096224,-0.0976547817122083,-0.0627611409852364,2.32265059926016e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42561,-0.0520780065476919,0.00578213469453268,-0.0634109905489759,-0.0407450225464078,2.40745011655994e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40384,-0.0616893704957431,0.0068492244193928,-0.075113850357753,-0.0482648906337332,2.46541437117455e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42490,0.0421872513054536,0.0046884833757257,0.0329978238890312,0.051376678721876,2.60535309983002e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,42495,-0.0365029509526948,0.00405815001555679,-0.0444569249831861,-0.0285489769222035,2.67901537455263e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42598,0.0237007588425122,0.00263533975698915,0.0185354929188134,0.0288660247662109,2.71393592314995e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,40352,-0.0572761238931566,0.0063726056959324,-0.0697664310571841,-0.0447858167291291,2.92607971464419e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40384,-0.0569399496987955,0.00633538337290875,-0.0693573011096966,-0.0445225982878943,2.93162127160883e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,40384,-0.0513560857158644,0.00571535481489438,-0.0625581811530573,-0.0401539902786714,2.98438268646974e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,42631,-0.0541198743752052,0.00602802379219783,-0.065934801007913,-0.0423049477424975,3.11809140027726e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,42191,-0.0669300941573909,0.007463385074662,-0.0815583289037284,-0.0523018594110533,3.43466596304751e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,40019,-0.0612069370176484,0.00683668399518923,-0.0746068376482193,-0.0478070363870775,4.03473166296836e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42475,-0.0966565999589675,0.0108030980097827,-0.117830672058141,-0.0754825278597934,4.12693455408847e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40385,-0.0403150613328673,0.00450498088386182,-0.0491448238652365,-0.0314852988004981,4.15174578938991e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42561,0.0376002546169673,0.00420794436987036,0.0293526836520214,0.0458478255819132,4.57642033822517e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,42599,-0.101366200808793,0.0113528470415467,-0.123617781010224,-0.0791146206073613,4.86477974336768e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42187,-0.0726534061611864,0.0081383963596978,-0.0886046630261941,-0.0567021492961787,4.948070231198e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40073,-0.0365557783512868,0.00409504551481119,-0.0445820675603168,-0.0285294891422569,5.0874694327367e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42490,0.0274269337190401,0.0030789899440732,0.0213921134286567,0.0334617540094236,5.87593495920035e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,42432,-0.0778543213890191,0.00874360152774919,-0.0949917803834076,-0.0607168623946307,6.07299371725876e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40411,-0.0450580828618809,0.0050604411211085,-0.0549765474592536,-0.0351396182645082,6.21559985934428e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,40187,-0.0522145294275071,0.00586623746433291,-0.0637123548575996,-0.0407167039974146,6.41058353278193e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40042,-0.0755291248716417,0.00849226836925122,-0.0921739708753741,-0.0588842788679093,6.83702643254275e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40350,-0.0762371593584669,0.00858356316284275,-0.0930609431576387,-0.0594133755592952,7.58738759939892e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42229,-0.071452414072927,0.00805365901422457,-0.0872375857408072,-0.0556672424050468,8.10809621059493e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40125,-0.0892422846644306,0.0100796596835195,-0.108998417644129,-0.0694861516847323,9.77208631367933e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,42475,-0.030647834057225,0.00346432711231546,-0.0374379151973633,-0.0238577529170867,1.01419713420461e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40385,-0.0755067623870369,0.00854275371784019,-0.0922505596740037,-0.0587629651000701,1.11307041934508e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40104,-0.0402783107311658,0.00456321895830017,-0.0492222198894341,-0.0313344015728974,1.24220013288749e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,40350,-0.0639414341684832,0.00724575715838505,-0.0781431181989179,-0.0497397501380485,1.26117524183197e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,42256,-0.0493045647106299,0.00559098013901806,-0.0602628857831053,-0.0383462436381545,1.30458352836454e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,40350,-0.0939132684993734,0.0106506939228929,-0.114788628588244,-0.0730379084105034,1.34315065164914e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42502,-0.0519803933337151,0.00590600439826827,-0.0635561619543209,-0.0404046247131093,1.517767696514e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,42673,0.0275989955319913,0.00313730063517811,0.0214498862870422,0.0337481047769404,1.57339798087983e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40878,0.0290784893844606,0.00330511261693174,0.0226004686552744,0.0355565101136468,1.58710964414265e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,42475,-0.0615003617567769,0.00699235468980191,-0.0752053769487887,-0.0477953465647652,1.59966696209834e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,40187,-0.0524504311260887,0.00596377380789756,-0.064139427789568,-0.0407614344626095,1.64601072902625e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40384,-0.0687649178548182,0.00782166343630058,-0.0840953781899673,-0.053434457519669,1.68975685203827e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,40104,-0.0400413345886919,0.00455507700108276,-0.0489692855108141,-0.0311133836665697,1.71241356726598e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40384,-0.0762358086230346,0.0086903270530151,-0.0932688496469442,-0.059202767599125,2.00039872094796e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40187,-0.027401011638198,0.00312418481226875,-0.0335244138702448,-0.0212776094061513,2.03873053096055e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42561,0.040062302773835,0.00457096482203222,0.0311032117226518,0.0490213938250181,2.0997364647157e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42377,-0.0730116735194716,0.00833092696746084,-0.0893402903756949,-0.0566830566632484,2.11394058634401e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,42191,-0.0524989349317196,0.00599261038501848,-0.0642444512863559,-0.0407534185770834,2.18030761269011e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,40019,-0.0600322464145288,0.00685103422487904,-0.0734602734952917,-0.0466042193337659,2.19433677086033e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40125,-0.0533422653251238,0.00609508864735278,-0.0652886390739352,-0.0413958915763123,2.4106640378375e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42377,-0.0709523000092005,0.00811943868626488,-0.0868663998342796,-0.0550382001841213,2.64324953428818e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40125,0.0321986995869101,0.00368395130164173,0.0249781550356923,0.0394192441381278,2.66534627444615e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40384,-0.0481825649440625,0.00551380714493238,-0.05898962694813,-0.037375502939995,2.69777102031461e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42568,0.0276027675701647,0.00316323252653084,0.0214028318181643,0.0338027033221652,2.94422205316326e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40104,-0.0516555204243484,0.00592104136745564,-0.0632607615045615,-0.0400502793441354,3.07371871024833e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40385,-0.0379092300492894,0.00434922479697896,-0.0464337106513682,-0.0293847494472107,3.2785723715616e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,42520,-0.0621486909795088,0.00714995353014441,-0.0761625998985919,-0.0481347820604258,3.96689951515372e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42490,0.0261511655187802,0.0030089728069926,0.0202535788170747,0.0320487522204857,4.00698238736607e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,40187,0.0470791351638867,0.00542045757529047,0.0364550383163174,0.057703232011456,4.30561164288696e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42443,-0.061158909915971,0.00704725334757952,-0.0749715264772268,-0.0473462933547151,4.47783409723124e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,42651,0.0427553708827556,0.00492919915903967,0.0330941405310379,0.0524166012344734,4.64983809471383e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42475,-0.0562699309403413,0.00649429444202069,-0.0689987480467018,-0.0435411138339807,5.05390462286727e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,42466,-0.0537208445104858,0.00620329131171423,-0.0658792954814457,-0.0415623935395259,5.25497531569036e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40111,-0.050208373682117,0.00579705466809838,-0.0615706008315898,-0.0388461465326442,5.33390843473882e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42590,-0.0415773197379424,0.00480709487197066,-0.0509992256870049,-0.0321554137888799,5.77297936045619e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42518,-0.0708920119732557,0.00819839164937543,-0.0869608596060316,-0.0548231643404799,5.88264073383124e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40382,-0.0357644324076262,0.00413652388277014,-0.0438720192178557,-0.0276568455973968,6.05905097101964e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,42492,-0.0389024935344265,0.00450321141135551,-0.0477287879006833,-0.0300761991681697,6.32095738294016e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,39780,-0.0219726941039485,0.00254636190263919,-0.0269635634331213,-0.0169818247747757,7.07185336186255e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,42554,-0.0822233865403095,0.00954740441954863,-0.100936299202625,-0.0635104738779942,7.96871484037811e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42377,-0.0516116382668802,0.00599764342737287,-0.063367019384531,-0.0398562571492293,8.4647276036597e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,40428,0.0473584290370238,0.00550536819957921,0.0365679073658486,0.0581489507081991,8.8557145580149e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40352,-0.0257197371257283,0.00299384991166668,-0.031587682952595,-0.0198517912988617,9.77950752085384e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42516,0.0214832473754681,0.00250717486349605,0.0165691846430159,0.0263973101079204,1.16068284226406e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40104,0.0293106283866151,0.00342108295829679,0.0226053057883534,0.0360159509848768,1.1983492782029e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40352,-0.0305571446365867,0.00356714564006203,-0.0375487500911083,-0.0235655391820651,1.20923801905776e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,40352,-0.0289501949036024,0.0033815890294666,-0.0355781094013569,-0.0223222804058478,1.26415333955103e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,40089,-0.11521005012758,0.0134591585696278,-0.14159000092405,-0.0888300993311096,1.28049561067987e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42229,-0.0536646538966208,0.00627599925660188,-0.0659656124395605,-0.0413636953536811,1.35791619816936e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,40104,-0.067602360960178,0.00790591613684779,-0.0830979565883997,-0.0521067653319563,1.38484024695622e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,40019,-0.0352512720344743,0.00412359833728044,-0.043333524775544,-0.0271690192934047,1.41256465261812e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42490,-0.05049154884315,0.00591401829026281,-0.0620830246920652,-0.0389000729942349,1.51786498423425e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,42561,-0.0622380492772558,0.00729516054991318,-0.0765365639550856,-0.047939534599426,1.59998679770011e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,40125,-0.0680130629674773,0.00797177685914772,-0.0836377456114068,-0.0523883803235477,1.63196504343776e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40125,-0.0386417034174839,0.00453377851632687,-0.0475279093094846,-0.0297554975254832,1.75796823004451e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,42229,-0.0408058626150942,0.00479621696061561,-0.0502064478579008,-0.0314052773722876,1.96256421554774e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,40440,-0.0367503914322225,0.00432035729302442,-0.0452182917265504,-0.0282824911378946,2.02225395633726e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,42429,-0.0495998026816742,0.00584508612154988,-0.061056171479912,-0.0381434338834365,2.36988488537916e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40350,-0.066901335847933,0.00788325641298161,-0.082352518417377,-0.0514501532784891,2.39828590379239e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,42321,-0.0424160752652342,0.00499999283016497,-0.0522160612123575,-0.0326160893181108,2.42307873045023e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40350,-0.128150047559489,0.0151125181305944,-0.157770583095454,-0.0985295120235239,2.54133789700648e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40104,-0.0398786129278956,0.00470298047187121,-0.0490964546527632,-0.0306607712030281,2.55452019445017e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40385,-0.0287473490404034,0.00339599531349664,-0.0354034998548568,-0.02209119822595,2.87878168889848e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,42471,-0.0585889799897087,0.00692474758892325,-0.0721614852639983,-0.0450164747154191,2.93103294285568e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40125,-0.0326662478241262,0.00386099387224324,-0.0402337958137229,-0.0250986998345294,2.99947803281819e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42229,-0.0797745300785027,0.00944508910790679,-0.09828690473,-0.0612621554270054,3.32749841419343e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,42475,-0.0520164332994776,0.00616404745882198,-0.0640979663187687,-0.0399349002801865,3.53901882340701e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42553,-0.0522867634927879,0.00620406662853428,-0.0644467340847151,-0.0401267929008607,3.87920977563625e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,40331,-0.0375214998051781,0.00445368930686429,-0.0462507308466321,-0.0287922687637241,4.05673092612899e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42229,-0.0383051578695436,0.00454988307028032,-0.047222928687293,-0.0293873870517941,4.1934173654401e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42475,-0.0728487509665207,0.00865431558793657,-0.0898112095188764,-0.055886292414165,4.23263079133474e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40019,-0.0588822851308089,0.00700075403477359,-0.0726037630389651,-0.0451608072226526,4.5817747711179e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,40089,-0.0423077110512409,0.00503229021254015,-0.0521709998678196,-0.0324444222346622,4.72010361598072e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,39957,-0.0632700626526475,0.00752807813270727,-0.0780250957927538,-0.0485150295125413,4.83633056050538e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40428,0.0185526508039259,0.00220882696010744,0.0142233499621153,0.0228819516457365,5.02987967620111e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42229,-0.0569457108999711,0.00678475801364452,-0.0702438366067143,-0.0436475851932278,5.21621014421121e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42434,-0.0285939274572294,0.00341031632582299,-0.0352781474558425,-0.0219097074586164,5.60352054670558e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,42631,-0.0540921197821652,0.00645421811956621,-0.0667423872965149,-0.0414418522678154,5.77077103948746e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42673,0.0219223624648106,0.00261682090378152,0.0167933934933988,0.0270513314362224,5.9380234937428e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,40154,-0.0571044134484624,0.00681815421430585,-0.0704679957085019,-0.043740831188423,6.1767195662545e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,42479,-0.0408711635084394,0.00488348608993092,-0.050442796244704,-0.0312995307721748,6.37351753276849e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,40104,-0.0368866020143764,0.00440984844509664,-0.0455299049667658,-0.028243299061987,6.76640597843812e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,42631,-0.0418142276878811,0.00500152607601194,-0.0516172187968645,-0.0320112365788977,6.8670300642456e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,40394,-0.0408675576404923,0.00489151365140685,-0.0504549243972497,-0.0312801908837348,7.32748100164637e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40385,-0.0557593148865637,0.00667440269528603,-0.0688411441693243,-0.0426774856038031,7.36429033140431e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42466,0.0231373944353158,0.00277493578947793,0.0176985202879391,0.0285762685826925,8.29533810112676e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42490,-0.0663197538416218,0.00795477677126603,-0.0819111163133032,-0.0507283913699404,8.35658935704952e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,40125,-0.0264516973568533,0.00317299047925508,-0.0326707586961933,-0.0202326360175134,8.56745729392677e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42592,-0.0274239245736987,0.00329104771408045,-0.0338743780932964,-0.020973471054101,8.65174853171729e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42496,-0.0348734428100279,0.00418659429007173,-0.0430791676185685,-0.0266677180014873,8.88584099973638e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40089,-0.0620943017346989,0.00746848410438406,-0.0767325305792917,-0.0474560728901061,1.03374007141508e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42532,-0.0656239374816184,0.00789884089105911,-0.0811056656280942,-0.0501422093351425,1.06618400246856e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42229,-0.0849658529583171,0.0102268271854542,-0.105010434241807,-0.0649212716748269,1.06766238625359e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40206,-0.0567053332054339,0.00683285263728011,-0.0700977243745029,-0.0433129420363649,1.17312815762677e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,42095,-0.0719966516178505,0.00867825849306144,-0.0890060382642509,-0.0549872649714501,1.18093314153133e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42590,-0.0542716012598833,0.00654427214310291,-0.067098374660365,-0.0414448278594016,1.20896044810598e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,40125,-0.0762993412517784,0.00920340966864726,-0.0943380242023271,-0.0582606583012298,1.26150261744635e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,42256,-0.0678316945580365,0.00818770395310311,-0.0838795943061186,-0.0517837948099544,1.30005872097221e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,42523,0.0239945159192702,0.00289647425043907,0.0183174263884096,0.0296716054501307,1.30351248276833e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40350,-0.0545252624887749,0.00658061674452401,-0.0674232713080419,-0.0416272536695078,1.30797554110248e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,42466,-0.0276433709012123,0.00334963235954653,-0.0342086503259235,-0.0210780914765011,1.69433419695636e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40350,-0.0548732653612038,0.00664852647571008,-0.0679043772535956,-0.041842153468812,1.71198080341658e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,40089,-0.0359649767102877,0.00436558800725802,-0.0445215292045134,-0.0274084242160619,1.94680504403525e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,42229,-0.0369571124871707,0.00448913695184035,-0.0457558209127778,-0.0281584040615636,2.00577785064641e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,40440,0.0204251700744091,0.00248099243068424,0.015562424910268,0.0252879152385503,2.03308404696729e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,40089,-0.0691016366078488,0.00839319383832333,-0.0855522965309626,-0.0526509766847351,2.03324800313301e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42480,-0.0299610615632603,0.00364218242189089,-0.0370997391101664,-0.0228223840163542,2.11231775328744e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42466,0.0353534600879704,0.00429967039673669,0.0269261061103665,0.0437808140655743,2.17954729858201e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,40104,-0.0401071883751118,0.00487702135302019,-0.0496661502270314,-0.0305482265231922,2.19690473330506e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,40311,-0.0801123583835998,0.00974584080423281,-0.0992142063598961,-0.0610105104073035,2.25795719990429e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40019,-0.0570826861435628,0.00694613498242059,-0.0706971107091071,-0.0434682615780184,2.30700846127638e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,40125,-0.0622567291863939,0.00757725148925373,-0.0771081421053312,-0.0474053162674566,2.33609376418044e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42561,-0.0518584088218526,0.00631382758707882,-0.064233510892527,-0.0394833067511781,2.34504176208791e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,40385,-0.0597594180873657,0.00727532125425948,-0.0740190477457142,-0.0454997884290171,2.37470977537295e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42490,-0.0257614333844418,0.00313814764934896,-0.0319122027771658,-0.0196106639917179,2.4321598748355e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40440,-0.0222863682253624,0.00271649510899146,-0.0276106986389857,-0.0169620378117392,2.57622967941624e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,42673,0.0206355296151362,0.00251925383434772,0.0156977920998146,0.0255732671304577,2.81942038033132e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,40372,-0.0716376960506437,0.00874461164951356,-0.0887771348836903,-0.0544982572175972,2.84384604530008e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40322,-0.0257123953142027,0.00313934868312686,-0.0318655187331313,-0.019559271895274,2.88897988817687e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40384,-0.0555931519499092,0.0067877309230219,-0.0688971045590321,-0.0422891993407863,2.89016288938895e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40093,-0.023672613974489,0.00289058945770395,-0.0293381693115888,-0.0180070586373893,2.91478844061461e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42475,-0.0812057793313403,0.00994362084743966,-0.100695276192322,-0.0617162824703585,3.45608721134737e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40352,-0.074370062076535,0.00910631242930723,-0.0922184344379772,-0.0565216897150928,3.50565394733257e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42553,0.0206668880915335,0.00253449988805477,0.0156992683109461,0.0256345078721208,3.82569155236257e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,40187,-0.0623226117022346,0.00764606959729606,-0.0773089081129349,-0.0473363152915344,4.00290216215657e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,40411,0.0239335903885112,0.00293720329708261,0.0181766719262293,0.0296905088507931,4.07786000916027e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42466,-0.0859279565425282,0.010553703214732,-0.106613214843403,-0.0652426982416535,4.23383501293268e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,42518,-0.0401707247330337,0.00493464249260675,-0.0498426240185429,-0.0304988254475245,4.28204988989074e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,42441,-0.0647095304025205,0.00795254534390149,-0.0802965192765674,-0.0491225415284735,4.41262248056663e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42561,-0.0209479187568991,0.00257448149384656,-0.0259939024848383,-0.0159019350289598,4.41673379642029e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40384,-0.090864285422196,0.0111745638664041,-0.112766430600348,-0.068962140244044,4.69285711512555e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42673,-0.0607391800423464,0.00747297160552434,-0.0753862043891741,-0.0460921556955187,4.74845706944106e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40125,-0.0458213502264295,0.00563937955466129,-0.0568745341535656,-0.0347681662992933,4.9453102935857e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,42590,0.0259379132746085,0.00319322855811932,0.0196791853006946,0.0321966412485223,4.95236029892535e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42466,-0.0291551345447328,0.00359515318507927,-0.0362016347874882,-0.0221086343019774,5.52331791620883e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,42172,-0.0399650398277724,0.00492822031139881,-0.0496243516381141,-0.0303057280174307,5.54012127485226e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42490,-0.0328666787930044,0.00406437646694149,-0.0408328566682097,-0.024900500917799,6.66761356061016e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40350,-0.0757360356668978,0.00936730367530957,-0.0940959508705045,-0.057376120463291,6.85014098564303e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42612,0.030423334623094,0.00376590434112984,0.0230421621144795,0.0378045071317085,7.10630825626602e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42229,-0.0711317236817479,0.00880582425979261,-0.0883911392309414,-0.0538723081325544,7.17123971648956e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40411,-0.0759840707494084,0.00940544802154474,-0.0944187488716361,-0.0575493926271807,7.21437975512248e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,42358,0.0420917589336934,0.00521216341501608,0.0318759186402619,0.052307599227125,7.2906507808916e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,40369,-0.0287274021648097,0.00355991550665688,-0.0357048365578572,-0.0217499677717622,7.76878928720195e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,40320,-0.0285596726853983,0.00354028592925351,-0.0354986331067352,-0.0216207122640614,7.94056853279367e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,42475,-0.0398368174627439,0.00495232232353465,-0.0495433692168718,-0.030130265708616,9.42340015680326e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,42460,0.0524459516720327,0.00652618968389544,0.0396546198915976,0.0652372834524677,1.00437876600887e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42229,-0.0496965451497737,0.00618949897419081,-0.0618279631391877,-0.0375651271603597,1.06508750220719e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42377,-0.0779490965348077,0.00970839924336412,-0.0969775590518014,-0.058920634017814,1.06526838221583e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40078,-0.0229101066671638,0.00285355847760037,-0.0285030812832606,-0.0173171320510671,1.08733290841509e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,42517,0.0179421970445789,0.00223804259419098,0.0135556335599646,0.0223287605291932,1.17424574214522e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,42612,-0.0577105598080119,0.00720530867414123,-0.0718329648093287,-0.0435881548066951,1.2466956110939e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,40440,-0.0221932447715615,0.00277112329480753,-0.0276246464293843,-0.0167618431137388,1.27288447769063e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40352,-0.0563322035504147,0.00703645381532819,-0.0701236530284579,-0.0425407540723714,1.30495925324954e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40284,-0.0496035635876837,0.00620686430127885,-0.0617690176181902,-0.0374381095571771,1.46242558263406e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42554,-0.108459749874247,0.0135889660487979,-0.135094123329891,-0.0818253764186027,1.56356791266067e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPART,Spartin,40187,-0.0635737160529258,0.00796815933890533,-0.0791913083571802,-0.0479561237486714,1.6286953094897e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,40019,-0.0405140833916572,0.00508061436160464,-0.0504720875404023,-0.0305560792429121,1.68745517352475e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,40385,-0.112229437492486,0.0140960032313779,-0.139857603825986,-0.084601271158985,1.85949747212275e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,42237,0.0194711855993406,0.00244768377063508,0.0146737254088958,0.0242686457897854,1.93928510989515e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42518,-0.105035229238261,0.013236616175016,-0.130978996941292,-0.0790914615352293,2.2686003091639e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,42374,-0.0578837643764155,0.00729456069041568,-0.0721811033296302,-0.0435864254232008,2.27061997831052e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,42599,-0.0313136528344039,0.00394791198421419,-0.0390515603234637,-0.0235757453453441,2.33214084621508e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40384,-0.0933742545861518,0.011769579607282,-0.116442630616425,-0.070305878555879,2.33295787631641e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42494,-0.0365718893832286,0.00461160106594366,-0.0456106274724782,-0.027533151293979,2.35777636791792e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42466,-0.0952651812613852,0.0120309043219269,-0.118845753732362,-0.0716846087904085,2.59683034851686e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,40187,-0.0563073014229375,0.0071195122337742,-0.0702615454011349,-0.0423530574447401,2.84609376403009e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42502,-0.0620718417390311,0.0078562036514735,-0.0774700008959192,-0.0466736825821431,2.98320561695165e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42229,-0.0432354900967469,0.00548146174097857,-0.0539791551090649,-0.0324918250844289,3.3254109380139e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40089,-0.0661012349044011,0.00838682450953544,-0.0825394109430906,-0.0496630588657116,3.54140924954135e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,42490,-0.0424701792753861,0.00539862487855677,-0.0530514840373574,-0.0318888745134148,3.91649591995616e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,42476,-0.0842830727088537,0.0107172955288304,-0.105288971945361,-0.0632771734723462,3.99990676869838e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40187,-0.0846712717554336,0.010775894385059,-0.105792024750149,-0.0635505187607179,4.28514850723198e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,40187,-0.0873637234783099,0.011136406596714,-0.109191080407869,-0.0655363665487504,4.73525628055072e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,40104,-0.071788888734158,0.00915171915135112,-0.0897262582708062,-0.0538515191975098,4.75985407355743e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40187,-0.0688533815659212,0.00877850131755733,-0.0860592441483335,-0.0516475189835088,4.79057707364709e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40384,-0.0759297820968905,0.00968830826725881,-0.0949188663007178,-0.0569406978930633,5.02192473347827e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,40365,-0.0797962471593358,0.0101911811790791,-0.0997709622703309,-0.0598215320483406,5.3225509185762e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40384,-0.0949147851708944,0.0121301033113534,-0.118689787661147,-0.0711397826806417,5.54521510325775e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,40385,-0.0752016896904795,0.00961345807855286,-0.0940440675244431,-0.0563593118565159,5.6418686761799e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42256,-0.0433534225827074,0.00554533772990453,-0.0542222845333203,-0.0324845606320946,5.77703044889301e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,40187,-0.0267557850071045,0.00342164451168616,-0.0334622082500094,-0.0200493617641996,5.78494312943276e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42377,-0.0641506511290659,0.0082059006130792,-0.0802342163307012,-0.0480670859274307,5.79006623647977e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42489,-0.0921925281704764,0.0117932688519579,-0.115307335120314,-0.069077721220639,5.79747589546589e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42475,0.0430697175083002,0.0055101878918613,0.032269749240252,0.0538696857763483,5.84422027756672e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42590,-0.054328018443625,0.00696777500183955,-0.0679848574472305,-0.0406711794400195,6.80405056139156e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,42320,0.0310127157082202,0.00397801001540163,0.023215816078033,0.0388096153384074,6.86801647004718e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,40352,-0.0328365446379766,0.00421148938978501,-0.0410910638419552,-0.024582025433998,6.90912440842439e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,40428,-0.0670886777979791,0.00861036021556438,-0.0839649838204853,-0.0502123717754729,7.19798622854446e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,40350,-0.0695593679014216,0.00894007072239174,-0.0870819065173094,-0.0520368292855338,7.85296231589806e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40384,-0.0608877271193854,0.00783251710745509,-0.0762394606499973,-0.0455359935887734,8.28956903555506e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40350,-0.0844441333576612,0.0108628626456918,-0.105735344143217,-0.0631529225721052,8.29543325345223e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42466,-0.0710381473449856,0.00915007678654316,-0.0889722978466102,-0.053103996843361,8.85331939082273e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,42554,-0.0341400477204467,0.00440392042775121,-0.0427717317588391,-0.0255083636820543,9.68287084899524e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,40440,-0.029035904667773,0.00374940120838442,-0.0363847310362065,-0.0216870782993396,1.04483100940015e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42466,-0.044230159224159,0.00573501192057001,-0.0554707825884762,-0.0329895358598418,1.32347980052444e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42518,-0.0536770839001845,0.00697014784084921,-0.0673385736682489,-0.04001559413212,1.44509354328513e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40206,-0.0393330382078741,0.00510779971325399,-0.0493443256458519,-0.0293217507698963,1.47051876612235e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42465,-0.0542622598033005,0.00704942674432075,-0.0680791362221692,-0.0404453833844318,1.48655216338077e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40104,-0.040141570731063,0.00521484904044566,-0.0503626748503365,-0.0299204666117896,1.50678077809785e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39896,-0.0393891218436975,0.00512082788971618,-0.0494259445075413,-0.0293522991798538,1.57647983362324e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42561,-0.0287495715725564,0.00375015208768128,-0.0360998696644118,-0.0213992734807011,1.89304626989962e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40350,-0.0631156307205976,0.00823435953339072,-0.0792549754060435,-0.0469762860351518,1.93799450055403e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42490,-0.0246618334117335,0.00321971876110097,-0.0309724821834914,-0.0183511846399756,1.99344643042448e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,40350,-0.0601859910395455,0.00786919077434973,-0.075609604957271,-0.0447623771218201,2.20384188003e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,42237,-0.0284277072593939,0.00371962051092383,-0.0357181634608046,-0.0211372510579832,2.27660390448565e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42191,-0.0305144308333932,0.00400199842884979,-0.0383583477539388,-0.0226705139128477,2.6136257942503e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,42256,-0.0360345396252666,0.00472645097133082,-0.045298383529075,-0.0267706957214582,2.62857000892509e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,42475,-0.0535131385742635,0.00702087937572644,-0.0672740621506873,-0.0397522149978396,2.66687392108912e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40411,-0.0318621922448275,0.00418670091125909,-0.0400681260308953,-0.0236562584587597,2.95289005625781e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,42475,-0.0379255278368666,0.00498565668659849,-0.0476974149425996,-0.0281536407311335,2.99541334655025e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42561,-0.0223329454453784,0.00293947665557877,-0.0280943196903128,-0.016571571200444,3.21719346807866e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40350,-0.0605767541225196,0.0079751180403967,-0.0762079854816971,-0.0449455227633421,3.30554728630051e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40385,-0.0415093525366055,0.00547205930760185,-0.0522345887795051,-0.0307841162937059,3.56926794731497e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42237,-0.0595742467508841,0.00786894336002231,-0.0749973757365278,-0.0441511177652404,3.95809440140349e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42518,-0.0577644684427005,0.00763433821784534,-0.0727277713496774,-0.0428011655357237,4.08839816659823e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42490,-0.0255233592586063,0.00337478099120246,-0.0321379300013631,-0.0189087885158495,4.19792047995935e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40350,-0.0377143624681716,0.00498795086764075,-0.0474907461687475,-0.0279379787675957,4.31053561080791e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42518,0.0623322844130403,0.00826571076800862,0.0461314913077434,0.0785330775183372,4.96261853287735e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,42532,-0.0674394099706151,0.00894893744229826,-0.0849793273575197,-0.0498994925837105,5.15708261391638e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40019,-0.0224329436785252,0.00297803520688303,-0.0282698926840159,-0.0165959946730344,5.36224524238349e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42466,-0.0702056809344098,0.00932922162719275,-0.0884909553237076,-0.0519204065451121,5.59609898210753e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,42631,-0.0721258948834245,0.00958829687729649,-0.0909189567629256,-0.0533328330039234,5.72410737355989e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,40411,-0.0423693581380857,0.00563136865858045,-0.0534068407089034,-0.031331875567268,5.72696797881891e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40125,-0.0716617298030755,0.00952901607596523,-0.0903386013119674,-0.0529848582941837,5.89026849891965e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,42452,-0.0544781872619193,0.00725400391002999,-0.0686960349255781,-0.0402603395982606,6.28634200437924e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42377,-0.0776958007726961,0.0103524796978723,-0.0979866609805259,-0.0574049405648663,6.53435787154203e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42631,-0.0369254137287292,0.00492069843877465,-0.0465699826687275,-0.0272808447887309,6.57363779126348e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,40139,0.0272614898899277,0.00363420199812975,0.0201384539735934,0.034384525806262,6.80477800217347e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42561,0.0219900218948729,0.00293505023368104,0.0162373234368581,0.0277427203528878,7.19703669885642e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,40125,-0.0185737705790555,0.00248213332383957,-0.023438751893781,-0.0137087892643299,7.82325060856286e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,40206,-0.042559189537134,0.00569062181586308,-0.0537128082962256,-0.0314055707780423,8.06904755767253e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40352,-0.0637339987637452,0.00853796157265575,-0.0804684034461504,-0.0469995940813399,8.96515415948028e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40384,-0.0481619519915639,0.00645268881807453,-0.0608092220749899,-0.0355146819081378,9.02594644629062e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,40206,-0.0267456429902391,0.00358349270828252,-0.0337692886984729,-0.0197219972820054,9.05614002468654e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42448,-0.0688973865810535,0.00924301439142348,-0.0870136947882435,-0.0507810783738634,9.61685708612251e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,40171,-0.0790138798074048,0.0106075911092817,-0.0998047583815969,-0.0582230012332127,1.01259468080766e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,39777,-0.0959402032542748,0.0128999132184658,-0.121224033162468,-0.0706563733460818,1.10745339254897e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,42237,-0.0271613288266673,0.00365696532449139,-0.0343289808626704,-0.0199936767906642,1.17733065679218e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42191,-0.0493185288878384,0.00665890748159792,-0.0623699875517703,-0.0362670702239064,1.37772648348263e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,40104,-0.0440456789243063,0.0059459854269952,-0.0556998103612169,-0.0323915474873958,1.38069200591499e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,40385,-0.0178948991596214,0.00241779412290484,-0.0226337756405149,-0.0131560226787279,1.4449035378564e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,42229,-0.0307648595987033,0.00416024144028897,-0.0389189328216697,-0.0226107863757369,1.50077373143517e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40206,-0.0435646382772727,0.00589000632640792,-0.0551090506770322,-0.0320202258775132,1.50137703838816e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,42490,-0.0211622008083762,0.00286234984579814,-0.0267724065061405,-0.0155519951106118,1.5179496544054e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40187,-0.03226973647956,0.00436750525907316,-0.0408300467873434,-0.0237094261717766,1.59146709681998e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42599,-0.0412671158040801,0.00559080354660773,-0.0522250907554313,-0.030309140852729,1.66045543806679e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,42229,-0.0299401177095692,0.00406064965679744,-0.0378989910368922,-0.0219812443822463,1.76587753546039e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42475,-0.0470980467844385,0.00639611451050972,-0.0596344312250375,-0.0345616623438394,1.89641077973765e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,40187,-0.0256189149507075,0.00348044066379244,-0.0324405786517407,-0.0187972512496743,1.95830305859903e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42237,-0.0324755069434566,0.00442230839305802,-0.0411432313938504,-0.0238077824930629,2.20318388544267e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42377,0.0915696401807534,0.0124738497040973,0.0671208947607227,0.116018385600784,2.24546579425448e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,40352,-0.0362790935848849,0.0049450285953425,-0.0459713496317562,-0.0265868375380136,2.34503982627736e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42229,-0.0252959241025521,0.00344884084835939,-0.0320556521653365,-0.0185361960397677,2.35493553949163e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40384,-0.032878008540552,0.00448216282668571,-0.041663047680856,-0.024092969400248,2.36520962691126e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40432,0.0209778612974626,0.00286248269172506,0.0153673952216815,0.0265883273732437,2.48602552237458e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40385,-0.0236548483917455,0.00322777079377863,-0.0299812791475516,-0.0173284176359394,2.48698358211314e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40104,-0.0413875987736179,0.00564799137005898,-0.0524576618589335,-0.0303175356883023,2.50415354536485e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40350,-0.067410227708124,0.00922890407839837,-0.0854988797017848,-0.0493215757144632,2.97824437011557e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,42490,0.0196820577448828,0.00270170278011829,0.0143867202958509,0.0249773951939146,3.39645487457922e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40187,-0.0624325223288941,0.00856892383681335,-0.0792276130490483,-0.0456374316087399,3.41363151909087e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,42482,-0.0696239667109204,0.00956130780282821,-0.0883641300044637,-0.0508838034173771,3.47809138755184e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,42490,-0.0685682278633407,0.00941687329320272,-0.087025299518018,-0.0501111562086633,3.48887410691333e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,42237,-0.0373984155134577,0.00514298463391149,-0.0474786653959242,-0.0273181656309912,3.75139602960276e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42518,0.0302735378687838,0.00416468055863487,0.0221107639738594,0.0384363117637081,3.82011304872633e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42561,-0.0543625210547855,0.0074890051238288,-0.06904097109749,-0.0396840710120811,4.11561753947647e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40352,-0.0390675091419046,0.00538161904248805,-0.0496154824651812,-0.028519535818628,4.14555697195965e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,42561,-0.046814933486466,0.00646760360295419,-0.0594914365482562,-0.0341384304246758,4.78882946252732e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,40411,-0.0402845633676017,0.00557058226264003,-0.0512029046023761,-0.0293662221328272,5.08184494809726e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,42213,-0.0382178979544445,0.00528581839389145,-0.0485781020064718,-0.0278576939024173,5.08943107228979e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,42256,-0.0364249820818341,0.00504289443044791,-0.046309055165512,-0.0265409089981561,5.36588855539284e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,40195,-0.0184897131168427,0.00255987182260338,-0.0235070618891453,-0.0134723643445401,5.42517597224231e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,42490,0.0181455404304624,0.0025138984352786,0.0132182994973163,0.0230727813636085,5.55847047857576e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,40089,-0.0341245738870258,0.00474016910510024,-0.0434153053330222,-0.0248338424410293,6.46414182088181e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,40337,-0.0655441195394931,0.00914894073975601,-0.0834760433894149,-0.0476121956895713,8.32278022434275e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42561,-0.0246804227244847,0.00344662255272219,-0.0314358029278202,-0.0179250425211492,8.44270237131024e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,42490,-0.0552682448157181,0.00771917898098332,-0.0703978356184454,-0.0401386540129908,8.50012090085641e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40104,-0.0672152814870798,0.00938655719858354,-0.0856129335963035,-0.0488176293778561,8.53694097246647e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42475,-0.0272235389706325,0.00380391554399791,-0.0346792134368684,-0.0197678645043966,8.6971116587036e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,40089,-0.0365157020935906,0.0051023935748562,-0.0465163935003087,-0.0265150106868724,8.80323753595156e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40350,-0.0435043112359415,0.00608051535894748,-0.0554221213394786,-0.0315865011324044,8.91087179295972e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,42673,-0.0438350107034426,0.00612845860524225,-0.0558467895697174,-0.0318232318371678,8.94786401909266e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40104,-0.0678401058329382,0.00948299899308138,-0.0864267838593777,-0.0492534278064987,8.97771732808669e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40206,-0.0781711855278311,0.0109338230765766,-0.0996014787579212,-0.056740892297741,9.26236930133456e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40125,-0.0364329299215919,0.00509958474092389,-0.0464281160138028,-0.0264377438293811,9.62177910416158e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,40432,-0.0513349776215157,0.00718579487545221,-0.065419135577402,-0.0372508196656294,9.62937971708992e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42245,-0.0358346626874263,0.00501715695992538,-0.0456682903288801,-0.0260010350459726,9.6560464072223e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42466,-0.0158428977128825,0.00222176613611398,-0.0201975593396659,-0.0114882360860991,1.04977950730793e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40385,-0.0239681859387661,0.00336531644633322,-0.0305642061735792,-0.017372165703953,1.12800775589932e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,40350,-0.0754699874813571,0.0106034168482941,-0.0962526845040135,-0.0546872904587008,1.16636101658625e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42466,-0.0417180989516322,0.00586295490962981,-0.0532094905745067,-0.0302267073287578,1.17195882198505e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40385,-0.0338235345080481,0.00475304307064362,-0.0431394989265096,-0.0245075700895866,1.1774016257473e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40432,-0.0196482613259894,0.002761402202787,-0.0250606096434519,-0.0142359130085269,1.18448146536531e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,40417,-0.0264762560870279,0.00372270394507312,-0.0337727558193712,-0.0191797563546846,1.21239550462931e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,40125,-0.0462150398395071,0.00650413103344476,-0.0589631366650588,-0.0334669430139553,1.27361527074586e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,40350,-0.0414838875618986,0.00584845023809038,-0.0529468500285558,-0.0300209250952414,1.39038969505648e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42536,-0.0379002369015651,0.0053606025830846,-0.0484070179644109,-0.0273934558387193,1.62472758852017e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,42466,0.0343369184122744,0.00486142858675401,0.0248085183822366,0.0438653184423123,1.70900277618397e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,42191,-0.038863547363642,0.00551124524121351,-0.0496655880364205,-0.0280615066908635,1.85707660300159e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,40385,-0.0340933286514004,0.00484078628882907,-0.0435812697775054,-0.0246053875252954,1.99276264841826e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,42191,-0.0451884736331295,0.00642279435906464,-0.0577771505768962,-0.0325997966893628,2.0828688061674e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,42631,-0.0448538847369854,0.006379111332254,-0.0573569429482032,-0.0323508265257676,2.14398827133025e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,42415,-0.0513635662438954,0.00731260911778193,-0.065696280114748,-0.0370308523730428,2.26195912439809e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,40350,-0.026043223841772,0.00372272726227366,-0.0333397692758283,-0.0187466784077156,2.78977417279449e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40385,-0.0706006768748052,0.0100939768221679,-0.0903848714462543,-0.050816482303356,2.81717333001115e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,42191,-0.0234671869386458,0.00336157332300225,-0.0300558706517302,-0.0168785032255614,3.07292636905098e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40385,-0.0492465561299847,0.00706049688095005,-0.0630851300166468,-0.0354079822433226,3.23256279608155e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40094,-0.0255760879274817,0.0036685450400338,-0.0327664362059479,-0.0183857396490155,3.31185962722384e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,42256,-0.0667912563997822,0.0095822927398448,-0.085572550169878,-0.0480099626296863,3.31503084633561e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,42103,-0.0556579530205483,0.00798880439023512,-0.0713160096254091,-0.0399998964156875,3.39492217485281e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42072,-0.0878931957259347,0.0126230167729999,-0.112634308601014,-0.063152082850855,3.49434682621486e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42561,-0.0505312623254247,0.0072634265282649,-0.0647675783208238,-0.0362949463300255,3.63915283452828e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42518,-0.0251565773387663,0.0036180143519988,-0.0322478854686839,-0.0180652692088487,3.73878330398276e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,40187,-0.0612032194843216,0.00882347135612234,-0.0784972233423214,-0.0439092156263218,4.24781903985238e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40411,-0.021969589157866,0.0031673778708583,-0.0281776497847482,-0.0157615285309837,4.24928047430754e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40232,-0.0412444454602883,0.00594869332456366,-0.0529038843764331,-0.0295850065441435,4.33903731250421e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,42466,0.021421501696263,0.00309356766747594,0.0153581090680102,0.0274848943245158,4.57555258928804e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40428,0.0195675645446122,0.00282625826239625,0.0140280983503156,0.0251070307389089,4.6468768664219e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,40089,-0.0495519098069329,0.00717476839592094,-0.0636144558629379,-0.0354893637509278,5.24757722844623e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40411,-0.0648259040060248,0.00939128364729769,-0.0832328199547283,-0.0464189880573214,5.37489050474564e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42631,-0.0248764794496015,0.00362240840905305,-0.0319763999313454,-0.0177765589678575,6.82630778675179e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,42532,-0.0417697487952363,0.00608697337073622,-0.0537002166018793,-0.0298392809885933,7.08250467939577e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42673,-0.0169051463160118,0.00246376528028927,-0.0217341262653788,-0.0120761663666449,7.11127163560071e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,42532,-0.0400809285439433,0.00584499565411829,-0.0515371200260152,-0.0286247370618715,7.32606188441027e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42191,-0.0478528564938056,0.00698457400008652,-0.0615426215339751,-0.034163091453636,7.65212576339403e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,40380,-0.0220202910014981,0.00321979560446178,-0.0283310903862432,-0.015709491616753,8.38859668286469e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,42568,-0.0356511411654793,0.00521756152646443,-0.0458775617573496,-0.0254247205736091,8.68098302396225e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42482,0.0407932114732724,0.00597538414832859,0.0290814585425484,0.0525049644039965,9.05514700103851e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDK,Midkine,42521,-0.036416518558683,0.00533439890598876,-0.046871940414421,-0.025961096702945,9.06305055247748e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42554,-0.0780259167873162,0.0114358596121159,-0.100440201627063,-0.055611631947569,9.30539465642423e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40384,-0.0611087885260446,0.00897178878432084,-0.0786934945433135,-0.0435240825087758,1.01739491743919e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40089,-0.0304740316709681,0.0044787999138768,-0.0392524795021666,-0.0216955838397696,1.07046716667459e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42475,-0.0272383927210341,0.00400443492731521,-0.035087085178572,-0.0193897002634963,1.075521507634e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,42475,-0.0486370329084936,0.00715277218532069,-0.0626564663917221,-0.034617599425265,1.09285237091632e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42518,-0.0461094662470278,0.00679045648548866,-0.0594187609585856,-0.0328001715354701,1.16616030986351e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42578,-0.0660018769388036,0.00972006479591472,-0.0850532039387965,-0.0469505499388108,1.16644744797373e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42673,-0.0296756424516893,0.00437108750659979,-0.0382429739646249,-0.0211083109387538,1.17578164398341e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,42631,0.00621562653080262,0.000915557606963246,0.00442113362115466,0.00801011944045059,1.17737933052014e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42475,0.0194784540899977,0.00286914860609667,0.0138549228220482,0.0251019853579471,1.17766634120577e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,40385,-0.0589717003660428,0.00868998480024919,-0.0760040705745312,-0.0419393301575544,1.20967737890027e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,40428,0.0352976942796771,0.0052015882223993,0.0251025813637745,0.0454928071955798,1.21131119094368e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAT,Catalase,40266,-0.0382912173152106,0.00565231527189301,-0.0493697552481209,-0.0272126793823003,1.31231767978966e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40350,-0.0611612825112144,0.00903501439436468,-0.0788699107241692,-0.0434526542982596,1.35842078800551e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42599,0.0414386904062523,0.00612344658937608,0.0294367350910752,0.0534406457214294,1.36738527075732e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,40187,0.0203437133638672,0.00300697587322322,0.0144500406523496,0.0262373860753847,1.3959540302816e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40040,-0.0300276991129274,0.00444229167256561,-0.038734590791156,-0.0213208074346988,1.45571665768313e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40384,-0.0566029769328324,0.00837745589418584,-0.0730227904854367,-0.0401831633802282,1.48297855676172e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40384,-0.0470616392716367,0.00697219346399813,-0.060727138461073,-0.0333961400822003,1.55258020361767e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42358,-0.067055657868746,0.00994077012049842,-0.0865395673049229,-0.0475717484325691,1.58852451529197e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42466,-0.0420287091009236,0.00623527298413751,-0.0542498441498331,-0.0298075740520141,1.64391266809996e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40385,-0.0268317422857091,0.00398017770367674,-0.0346328905849155,-0.0190305939865027,1.64649190017288e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,40104,-0.0257662485856265,0.0038238755359534,-0.0332610446360952,-0.0182714525351578,1.6837827885269e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40125,-0.0224294320487324,0.00332909705152962,-0.0289544622697305,-0.0159044018277344,1.6936088811855e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40206,-0.0319860189614723,0.00475001187750779,-0.0412960422413876,-0.0226759956815571,1.73420021863154e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42377,-0.0165986779566209,0.00246619562389699,-0.021432421379459,-0.0117649345337828,1.76099065811608e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40019,-0.0484253435964355,0.0072074344055398,-0.0625519150312935,-0.0342987721615775,1.92421624853638e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40351,-0.0312852479095876,0.00465814084730193,-0.0404152039702994,-0.0221552918488758,1.95522640012152e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42191,-0.0366083006835374,0.00545827546454044,-0.0473065205940366,-0.0259100807730381,2.06978030506017e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40019,-0.0482044176632773,0.00718632214567703,-0.0622896090688043,-0.0341192262577504,2.07435608715745e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40104,-0.0255393636844545,0.00381129528865999,-0.0330095024502281,-0.0180692249186809,2.17249397122503e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,42590,0.0207289206316837,0.00309506660120737,0.0146625900933172,0.0267952511700501,2.20614070682033e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40384,-0.0591690500086319,0.00883674371703118,-0.076489067694013,-0.0418490323232508,2.24767989939776e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40411,-0.050653911320881,0.00756989395613254,-0.0654909034749007,-0.0358169191668612,2.3142477896283e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,42466,-0.0208710912439815,0.0031225951967201,-0.0269913778295529,-0.0147508046584101,2.41973067070286e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42469,-0.0580397347298584,0.00870135832468385,-0.0750943970462388,-0.0409850724134781,2.65589081416119e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40104,-0.0553498371940665,0.00829984798465643,-0.0716175392439932,-0.0390821351441399,2.7041376205669e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAX,Protein max,42191,-0.0729013061814613,0.0109446995350528,-0.0943529172701648,-0.0514496950927579,2.83154036095983e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,42321,0.019678625353171,0.00295499734344237,0.013886830560024,0.025470420146318,2.85818254006151e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,40385,-0.0491853837433269,0.00738552405503985,-0.063661010891205,-0.0347097565954487,2.87239794251559e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40125,-0.02255359060034,0.00338679853412445,-0.0291917157272239,-0.0159154654734561,2.88402250612327e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,42377,-0.0227748219460728,0.00342188867799939,-0.0294817237549516,-0.016067920137194,2.93248070708335e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,40385,-0.048497074069305,0.00730155377523163,-0.0628081194687591,-0.034186028669851,3.23753415753978e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,42466,-0.0564673231207952,0.00851504492662151,-0.0731568111769734,-0.039777835064617,3.45212212234942e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39987,-0.03646169300325,0.00549728919366098,-0.0472363798228255,-0.0256870061836745,3.45441369659723e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42531,0.0247175138560629,0.00372783592361948,0.0174109554457687,0.0320240722663571,3.47371336521346e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42561,0.0203032326697349,0.003062123608441,0.0143014703971906,0.0263049949422793,3.47539799058336e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42325,-0.0795588949865803,0.0120004131255121,-0.103079704712584,-0.0560380852605766,3.49569274130308e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40187,-0.0414236415533631,0.00624871455046263,-0.0536711220722698,-0.0291761610344563,3.53449817034544e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40400,-0.032885232735376,0.00496290066376895,-0.0426125180363632,-0.0231579474343889,3.60202193976015e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,40187,-0.0306206115062803,0.00462811662325664,-0.0396917200878633,-0.0215495029246973,3.85641670237555e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40187,-0.0815054268039662,0.0123213750542852,-0.105655321910365,-0.0573555316975673,3.88907654106781e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,40125,-0.0383948122237949,0.00581554272762283,-0.0497932759699356,-0.0269963484776541,4.24154064774449e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,42256,-0.0454227633698848,0.00688553662883547,-0.0589184151624023,-0.0319271115773672,4.36208570301097e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42377,-0.0240698740377124,0.00365944514660491,-0.0312423865250581,-0.0168973615503668,4.96591851847733e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40411,-0.0183606685516281,0.00279269084298195,-0.0238343426038728,-0.0128869944993835,5.09691821934993e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,42673,0.0206692600772213,0.00314811012202312,0.014498964238056,0.0268395559163867,5.37187110213209e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40104,-0.0229504833194023,0.00349681953237108,-0.0298042496028496,-0.016096717035955,5.5037277363023e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,42358,-0.0510693700488772,0.00778480655546003,-0.0663275908975788,-0.0358111492001755,5.5769932545126e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42466,-0.0230587238795798,0.00351921594265791,-0.0299563871271893,-0.0161610606319703,5.87749180964297e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,42377,-0.0273216603002631,0.00417128243897759,-0.0354973738806592,-0.0191459467198671,5.96951917543208e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,40125,-0.0621097069081953,0.00948786569360674,-0.0807059236676645,-0.0435134901487261,6.16532455959901e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,40104,-0.0385159441355957,0.00588984163097446,-0.0500600337323056,-0.0269718545388858,6.45335477654379e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,40125,-0.0551769476269069,0.00844566270896154,-0.0717304465364715,-0.0386234487173423,6.72540866036292e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,42560,-0.0472343962357716,0.00724240829288775,-0.0614295164898316,-0.0330392759817116,7.19108480002419e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,40276,-0.0668502566719615,0.0102559008226455,-0.0869518222843466,-0.0467486910595763,7.42346238481511e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,42561,-0.0384950697247558,0.00590877197379973,-0.0500762627934033,-0.0269138766561084,7.53424547856578e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40125,-0.0283571370394035,0.00435290454787081,-0.0368888299532302,-0.0198254441255767,7.61206168167446e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42229,-0.0395422280775632,0.00607169003786585,-0.0514427405517802,-0.0276417156033461,7.65929872515005e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42518,-0.0563121440577736,0.00865101002755135,-0.0732681237117742,-0.0393561644037729,7.81982312794862e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,42331,-0.0459194691730647,0.00705497092972083,-0.0597472121953175,-0.0320917261508119,7.84993013815041e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42475,0.031231729293123,0.00480200913756426,0.0218197913834971,0.040643667202749,8.10731821128547e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42497,0.0210104388459304,0.00323272897883367,0.0146742900474164,0.0273465876444444,8.35777237085844e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,42496,-0.0190040816704193,0.00292465228351557,-0.0247364001461098,-0.0132717631947288,8.4353525505038e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,42377,0.0287415126130261,0.00442824450301194,0.0200621533871227,0.0374208718389295,8.86147510255206e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42673,-0.0219691270235929,0.00339254645975441,-0.0286185180847115,-0.0153197359624742,9.76430074522827e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42460,-0.0165832240407859,0.00256245597965109,-0.021605637760902,-0.0115608103206697,1.00370316110361e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42673,0.0202394540943679,0.00312987849752069,0.0141048922392274,0.0263740159495085,1.03736237783601e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40352,-0.0724652885495781,0.0112059162007643,-0.0944288843030761,-0.05050169279608,1.04352294694346e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42561,-0.0562512161873343,0.00870853644860964,-0.0733199476266092,-0.0391824847480594,1.0881608675892e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40104,-0.0236936006048688,0.00366905695721721,-0.0308849522410145,-0.016502248968723,1.10839534562676e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42584,0.0136543013178861,0.00211571257158665,0.00950750467757622,0.0178010979581959,1.12866201932387e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42639,-0.0225176549124382,0.00349080759320419,-0.0293596377951184,-0.015675672029758,1.15253993768115e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40411,-0.0220066424034111,0.00341432915479911,-0.0286987275468173,-0.0153145572600048,1.2004247337326e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42229,-0.0567204154362589,0.00880632914023523,-0.0739808205511199,-0.0394600103213978,1.22962124401599e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,42191,-0.0305895087428443,0.00474990640924044,-0.0398993253049555,-0.021279692180733,1.23659624589201e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,42475,-0.0625931419419025,0.00973080492253882,-0.0816655195900786,-0.0435207642937264,1.29847087523524e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,42497,-0.0271361184989013,0.00422249518196005,-0.035412209055543,-0.0188600279422596,1.34973752977643e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42518,-0.0456226316426659,0.00710491854205878,-0.0595482719851011,-0.0316969913002307,1.39722908491623e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40125,-0.048873458468702,0.00762984672202262,-0.0638279580438663,-0.0339189588935377,1.55971236939666e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,40432,-0.0605937053298243,0.009463948714157,-0.079143044809572,-0.0420443658500766,1.58862008211887e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,42554,-0.051832275775649,0.00810065742471823,-0.0677095643280967,-0.0359549872232012,1.62116599861059e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,40283,0.0282601227378286,0.0044214008232119,0.0195941771243333,0.036926068351324,1.70673097704027e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,42559,-0.0385606496432111,0.00603409906269469,-0.0503874838060926,-0.0267338154803295,1.70878720181825e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,40125,-0.0349318416889652,0.00546868832016994,-0.0456504707964983,-0.0242132125814321,1.75345396495443e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,42599,-0.0288619622164215,0.00452012750603103,-0.0377214121282423,-0.0200025123046007,1.76806439976192e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40350,-0.0306906976835166,0.00480707811091705,-0.040112570780914,-0.0212688245861192,1.78810420803288e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_E,,42475,-0.0205418472258332,0.00321873626699407,-0.0268505703091416,-0.0142331241425248,1.8064293137589e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,40019,-0.0388922378395574,0.00609555388650328,-0.0508395234571038,-0.026944952222011,1.83808331238852e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42554,-0.0184443519447215,0.00289230873722077,-0.0241132770696742,-0.0127754268197688,1.86493387017279e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,40104,-0.0296936788832112,0.00465662921046891,-0.0388206721357303,-0.0205666856306922,1.88325498250394e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,40206,-0.0350671481597336,0.00550388122641626,-0.0458547553635095,-0.0242795409559577,1.94851924612336e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C3,Complement C3,39892,-0.0312185160096029,0.00490559814585017,-0.0408334883754692,-0.0216035436437366,2.04802080735288e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42590,-0.0204981186586493,0.00322277671363575,-0.0268147610173753,-0.0141814762999232,2.07779611171118e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42474,-0.0215060830197795,0.00338380888360613,-0.0281383484316475,-0.0148738176079114,2.14421057076749e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42475,-0.0282445022603507,0.00444562293721143,-0.0369579232172851,-0.0195310813034163,2.17580754029398e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42590,0.0200826218002391,0.00316503243297959,0.0138791582315991,0.0262860853688791,2.29352309400664e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40089,-0.0454447080489101,0.00716666765383856,-0.0594913766504336,-0.0313980394473865,2.37130811732648e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42237,-0.0324624168569963,0.00513118113313679,-0.0425195318779444,-0.0224053018360482,2.58980514181733e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,40125,0.0281881646996023,0.00445543326872027,0.0194555154929106,0.036920813906294,2.60263867927456e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42475,-0.0515780540213928,0.00817991457170441,-0.0676106865819335,-0.0355454214608522,2.96454697849972e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42546,-0.0778495733313465,0.0123915504996629,-0.102137012310686,-0.0535621343520072,3.43575267920577e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,40042,-0.0354561112961873,0.00564817980383314,-0.0465265437117002,-0.0243856788806743,3.57342600892303e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,42550,-0.0196151630363327,0.00312636493426611,-0.0257428383074942,-0.0134874877651711,3.62491196560179e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42590,-0.0376632262961563,0.00600524857942056,-0.0494335135118206,-0.025892939080492,3.68059266366868e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40089,-0.0419993588978908,0.00671422837581289,-0.0551592465144841,-0.0288394712812975,4.11694159964093e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42673,0.0175833155631316,0.0028148277421736,0.0120662531884713,0.0231003779377918,4.31884140362054e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40132,-0.036844853930735,0.0058986422789536,-0.0484061927974841,-0.025283515063986,4.35823765630343e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42237,-0.0353699004607317,0.00566712922310859,-0.0464774737380246,-0.0242623271834389,4.47567053892411e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40187,0.028202075640537,0.00453067645316466,0.0193219497923342,0.0370822014887397,5.00083775871119e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42490,-0.0195000931571922,0.00313979629834202,-0.0256540939019426,-0.0133460924124418,5.43467966636081e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42229,-0.0488531451013788,0.00788144986032544,-0.0643007868276167,-0.0334055033751409,5.87239800018519e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,40321,-0.0295061182535727,0.00476470290507271,-0.0388449359475152,-0.0201673005596302,6.12495300709494e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40019,-0.0237948552726104,0.00384313551052817,-0.0313274008732456,-0.0162623096719752,6.17462544206394e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42545,-0.0717591283085739,0.0115934549001567,-0.094482299912881,-0.0490359567042667,6.20730024902743e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,40125,-0.0187810264404396,0.00303944674502304,-0.0247383420606848,-0.0128237108201945,6.6766230541012e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,40384,-0.0490366526945357,0.0079481412275677,-0.0646150095005684,-0.033458295888503,7.08402260888113e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40104,-0.0555337189772193,0.00900459618966991,-0.0731827275089724,-0.0378847104454663,7.19419804615216e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,40187,-0.0265406801724947,0.00431789022074141,-0.0350037450051478,-0.0180776153398415,8.18660071376511e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42237,-0.0701696138572809,0.0114331643206753,-0.0925786159258044,-0.0477606117887574,8.63277336794771e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40411,-0.0570696587190138,0.00930830870396813,-0.0753139437787914,-0.0388253736592363,9.02397271633196e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40125,-0.0334371493184368,0.00545566871830161,-0.044130260006308,-0.0227440386305657,9.15496905615187e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,42466,-0.0890907217463947,0.0145488937705288,-0.117606553536631,-0.0605748899561583,9.41021788670768e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42657,-0.0183064475509071,0.00299028930571321,-0.024167414590105,-0.0124454805117092,9.49965798729685e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,40342,-0.0184672235947634,0.00301790048879923,-0.0243823085528099,-0.0125521386367169,9.71870937151636e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40384,0.0171126571746609,0.00279677379526356,0.0116309805359443,0.0225943338133775,9.74888160901148e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42461,-0.0173058111994325,0.00282892015792977,-0.0228504947089749,-0.0117611276898901,9.77513021506043e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,42229,-0.0332168810358384,0.00544542812973459,-0.0438899201701182,-0.0225438419015586,1.09099806320795e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,40007,-0.034674052870538,0.00568392463434452,-0.0458145451538532,-0.0235335605872227,1.09443108783319e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,42673,-0.0551719948910405,0.00904783839880857,-0.0729057581527053,-0.0374382316293757,1.10470125922577e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42191,-0.0465842899819144,0.00764130977738853,-0.0615612571455959,-0.0316073228182329,1.11573953466349e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40385,-0.0627993383557581,0.0103044698702583,-0.0829960993014643,-0.0426025774100518,1.13479941934002e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42466,-0.01273286032477,0.00209231795305484,-0.0168338035127574,-0.00863191713678247,1.1930493245404e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,42466,0.049142685038909,0.00807630675813108,0.0333131237929721,0.064972246284846,1.19849488781708e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,42191,-0.0454999347347035,0.00750077777997956,-0.0602014591834634,-0.0307984102859436,1.34752760572459e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40384,-0.0303329304495851,0.00500227775028831,-0.0401373948401502,-0.02052846605902,1.37212525775842e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,40369,-0.0414721600011272,0.00684060733855407,-0.0548797503846932,-0.0280645696175613,1.38226536973205e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,40186,-0.0135534850878708,0.00223620940959025,-0.0179364555306677,-0.00917051464507395,1.39784837732942e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,42466,0.0176149041457115,0.00290728433077262,0.0119166268573972,0.0233131814340258,1.40777073207051e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,42211,0.0760687347717829,0.0125669345015025,0.0514375431488379,0.100699926394728,1.46004060996126e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,40440,0.0191903444480941,0.00317013307798931,0.0129768836152351,0.0254038052809532,1.46268416986165e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42377,-0.034309021535187,0.00567550706769959,-0.0454330153878782,-0.0231850276824958,1.53347295289887e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40187,-0.054170425952209,0.00897636537421299,-0.0717641020856665,-0.0365767498187515,1.64307322983403e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,42518,-0.0156471906784103,0.0025936750883266,-0.0207307938515304,-0.0105635875052901,1.65386729897964e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40350,-0.030927343613968,0.00512997707725915,-0.0409820986853959,-0.02087258854254,1.70461337274944e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42256,-0.0242223687161761,0.00402071710401774,-0.0321029742400509,-0.0163417631923013,1.74313075471435e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,40206,-0.0438907318239934,0.00728496067930781,-0.0581692547554367,-0.0296122088925501,1.7468817588425e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42554,-0.015837961532196,0.0026347644588248,-0.0210020998714927,-0.0106738231928994,1.89013160296904e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40384,-0.0297035317170812,0.00494115437836565,-0.0393881942986778,-0.0200188691354845,1.89598094585014e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42470,-0.0274942786783733,0.00457806519015248,-0.0364672864510722,-0.0185212709056744,1.95540651359147e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,42599,-0.0247388486343575,0.00412511118342056,-0.0328240665538618,-0.0166536307148532,2.05996606887193e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,42229,-0.036289838272224,0.00605759234350656,-0.0481627192654969,-0.0244169572789512,2.14312380868263e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,42518,0.0234850007452445,0.00392438798986388,0.0157932002851113,0.0311768012053778,2.22801971832295e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,42237,-0.0525231390847271,0.00878200841330052,-0.0697358755747961,-0.0353104025946581,2.27902436073663e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,42256,-0.0706664071585229,0.0118184110106752,-0.0938304927394463,-0.0475023215775996,2.29879427592892e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,42209,0.0306358013379717,0.00512403645918275,0.0205926898779735,0.0406789127979699,2.30616594537938e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42590,-0.0497997173863544,0.00834097960629125,-0.0661480374146852,-0.0334513973580235,2.42529853371282e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42434,-0.0375254569734843,0.00629570927649698,-0.0498650471554184,-0.0251858667915503,2.57892467261597e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40350,-0.0192393778801957,0.00322785032405318,-0.0255659645153399,-0.0129127912450514,2.59182716648979e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,42256,0.0249969827530557,0.00420583041554928,0.0167535551385791,0.0332404103675323,2.862662288939e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,42451,-0.0412963324961121,0.00695048160566508,-0.0549192764432157,-0.0276733885490085,2.89498066624818e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40352,-0.0433227083429707,0.00729735858866527,-0.0576255311767546,-0.0290198855091867,2.99352903473143e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42518,0.0713908746212914,0.0120515142086757,0.0477699067722871,0.0950118424702957,3.22326244649347e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,40384,0.0298373183237554,0.00503707744632122,0.0199646465289658,0.0397099901185449,3.2435853802123e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40384,-0.0358909135126269,0.00606122108015216,-0.0477709068297252,-0.0240109201955287,3.28590826016566e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,42222,-0.025091957023385,0.00423953131878298,-0.0334014384081997,-0.0167824756385704,3.32920637646525e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40411,-0.0599155228617871,0.0101257564794022,-0.0797620055614154,-0.0400690401621587,3.37160495099954e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42358,-0.0448848909547537,0.00758947265627446,-0.0597602573610516,-0.0300095245484557,3.41975284136388e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40319,-0.0268089933825124,0.0045371646917928,-0.0357018361784263,-0.0179161505865985,3.54804791868836e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,40305,-0.0297579662141672,0.00503629588673851,-0.0396291061521747,-0.0198868262761598,3.54933206684063e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40384,-0.0352184436422813,0.00596992967543019,-0.0469195058061245,-0.0235173814784381,3.75600317487541e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,42466,-0.0455237033009878,0.00772045573945629,-0.0606557965503221,-0.0303916100516535,3.80310017640601e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42475,-0.0232782354555149,0.00394933835851039,-0.0310189386381953,-0.0155375322728345,3.85608533946385e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40206,-0.0453032324189886,0.00769310526596303,-0.0603817187402761,-0.030224746097701,4.00352034421366e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40071,-0.034371952007707,0.00584137118702989,-0.0458210395342856,-0.0229228644811284,4.11714284702874e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42554,-0.0174057451543653,0.00295872450614436,-0.0232048451864083,-0.0116066451223224,4.12902296752885e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40125,-0.0395661424992009,0.00672502196627216,-0.0527471855530943,-0.0263850994453074,4.13656076371973e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42518,0.0203142314962962,0.00345719827564556,0.013538122876031,0.0270903401165615,4.30538108799183e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40411,-0.0371915208609798,0.00633726033297261,-0.0496125511136061,-0.0247704906083535,4.51634197793371e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,42191,0.0458182287478552,0.00781103733789647,0.0305085955655781,0.0611278619301323,4.57760375998662e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40350,0.0312844429108789,0.00533467104197681,0.0208284876686043,0.0417403981531534,4.63651454680521e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42466,-0.0232551183447368,0.00396645729153702,-0.0310293746361493,-0.0154808620533242,4.65541865075133e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,42362,-0.0288673639994908,0.00492818352000754,-0.0385266036987056,-0.0192081243002761,4.80796408431076e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42229,-0.034671867257707,0.00592505662029012,-0.0462849782334756,-0.0230587562819383,4.98158148877408e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,42490,0.0193279602636706,0.00330413897736856,0.0128518478680283,0.025804072659313,5.0428303267685e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,40104,-0.0244260494977698,0.00417547313525628,-0.0326099768428721,-0.0162421221526675,5.06037828755789e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40187,-0.0223360885545356,0.00382011855540972,-0.0298235209231386,-0.0148486561859325,5.14877308744229e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,40411,-0.0434608890406516,0.00743678265242116,-0.0580369830393971,-0.0288847950419061,5.23660940978554e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,40362,-0.0560670219430092,0.00960270554606516,-0.0748883248132969,-0.0372457190727215,5.40847708198044e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40019,-0.0418044068904358,0.00717456310604997,-0.0558665505782937,-0.0277422632025779,5.81275083023055e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,40019,-0.0427237537747154,0.00733294346466395,-0.0570963229654567,-0.0283511845839741,5.82932177375419e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,42435,-0.0504535599391395,0.00867878106757702,-0.0674639708315905,-0.0334431490466886,6.2613147426964e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",40125,-0.0525248588696543,0.0090412220209635,-0.0702456540307428,-0.0348040637085659,6.44132164363749e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40428,-0.0506872454147866,0.00872648325306542,-0.0677911525907948,-0.0335833382387783,6.47683013966168e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40411,0.0194562764301197,0.00335635018518019,0.0128778300671665,0.0260347227930728,6.9391040531576e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,42518,-0.0405311282310673,0.00699942965865346,-0.0542500103620281,-0.0268122461001065,7.17031288969159e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40042,-0.0597379091158865,0.0103156488810906,-0.0799565809228241,-0.0395192373089489,7.1912038746217e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,40125,-0.018788653929934,0.00324595974393077,-0.0251507350280383,-0.0124265728318297,7.3049262697798e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,40352,-0.0254090002457353,0.00439225604841013,-0.0340178221006191,-0.0168001783908514,7.44815287647451e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42256,-0.0235194871039757,0.00406928158356972,-0.0314952790077724,-0.0155436952001791,7.6514111968734e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,42490,-0.0445405306583366,0.00772773457362334,-0.0596868904226383,-0.0293941708940348,8.41036954755579e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,42220,-0.0232294436292781,0.00403150144342518,-0.0311311864583915,-0.0153277008001648,8.50124372858032e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42496,-0.031525113268424,0.00547139638021757,-0.0422490501736505,-0.0208011763631976,8.50631351649533e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,42561,0.0169272485959051,0.00293929794410753,0.0111662246254543,0.0226882725663559,8.6504581371772e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42554,-0.0408959141354205,0.00710465485086025,-0.0548210376431066,-0.0269707906277345,8.79112931440151e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,42344,0.0368924680409835,0.00641357765660461,0.0243218558340385,0.0494630802479285,9.00270027285463e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42229,-0.039916561486641,0.00694568027541193,-0.0535300948264483,-0.0263030281468336,9.28947598518843e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40089,-0.0289771171114575,0.0050416434307915,-0.0388587382358088,-0.0190954959871062,9.29738967662828e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42466,-0.0238460830758846,0.00414963580771012,-0.0319793692589964,-0.0157127968927727,9.30849201804996e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40125,0.0125854546364429,0.00219415096612915,0.00828491874282979,0.016885990530056,9.95634317144794e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40350,-0.0313808095342453,0.00547894288519696,-0.0421195375892313,-0.0206420814792592,1.04537353657777e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,42475,-0.0210980862028406,0.00369199900185006,-0.0283344042464668,-0.0138617681592145,1.12362334848526e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,40372,-0.019366928473286,0.00339157007442227,-0.0260144058191536,-0.0127194511274183,1.15642932624063e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40385,0.0420182078369359,0.00736781884675848,0.0275772828972892,0.0564591327765825,1.20743643932564e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42229,-0.0439572402252545,0.00771757356298913,-0.0590836844087132,-0.0288307960417958,1.25497358320927e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42229,-0.0302054509666779,0.00530530917801551,-0.0406038569555883,-0.0198070449777675,1.27192377453167e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,42172,-0.0429523952610785,0.00755068760725894,-0.0577517429713061,-0.028153047550851,1.30896714195297e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,39987,-0.0330343197554369,0.00581598956985256,-0.0444336593123479,-0.0216349801985259,1.38247941057817e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,42191,-0.0362742216232848,0.00639460356118744,-0.0488076446032122,-0.0237407986433574,1.43620983335258e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,40206,-0.0441910189013955,0.00779749132178797,-0.0594741018920999,-0.0289079359106911,1.48676765626301e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40411,-0.0414199619340835,0.00731574995188887,-0.0557588318397857,-0.0270810920283813,1.53515814937416e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,40104,-0.0294968283332135,0.00521463943723986,-0.0397175216302036,-0.0192761350362234,1.5834074509211e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,39921,-0.0476822327502007,0.00843103613759911,-0.064207063579895,-0.0311574019205065,1.59313518186083e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,40187,-0.0732320728556689,0.0129579950912265,-0.0986297432344728,-0.047834402476865,1.6301549079135e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,40187,-0.0553403579427763,0.00979788422892387,-0.0745442110314671,-0.0361365048540855,1.66168210305288e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,42490,0.0145652698590773,0.00258022898106062,0.00950802105619844,0.0196225186619561,1.68605835285398e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,42518,0.0416306526026943,0.00738094634960482,0.0271639977574688,0.0560973074479197,1.73220567665945e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42561,0.0166773589663592,0.00296176596717999,0.0108722976706865,0.022482420262032,1.82900194747547e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40428,-0.035067590938267,0.00623063976680006,-0.0472796448811951,-0.0228555369953388,1.86410478315841e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,42518,-0.0247662438768509,0.00440578638943514,-0.0334015852001438,-0.016130902553558,1.93331097240797e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42623,-0.0308765082994466,0.00549458899536539,-0.0416459027303627,-0.0201071138685304,1.95388789918424e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42478,0.0104035581016019,0.0018533432754953,0.0067710052816311,0.0140361109215727,2.02361202771619e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42532,0.0289274927221,0.0051578807462597,0.0188180464594309,0.039036938984769,2.08255753113017e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40384,-0.0279112350665487,0.004985107253311,-0.0376820452830383,-0.0181404248500592,2.20770073789001e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42256,-0.0250883325744928,0.00450678072388413,-0.0339216227933057,-0.0162550423556799,2.64579386751853e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42191,-0.0642213239979217,0.0115784564526795,-0.0869150986451734,-0.04152754935067,2.96929683756537e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40125,-0.0305279101693582,0.00550403908174695,-0.0413158267695822,-0.0197399935691342,2.98297939975507e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,40019,-0.067545363034854,0.0121963909180177,-0.0914502892341687,-0.0436404368355392,3.12832522282824e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,40352,0.066787667372432,0.0120627963078715,0.0431445866090039,0.09043074813586,3.15258730915574e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,40185,0.0178736727864749,0.00322921617675483,0.0115444090800354,0.0242029364929143,3.18390349808514e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,42183,-0.0622993650171642,0.0112882286962061,-0.0844242932617281,-0.0401744367726002,3.4753315537981e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,40125,-0.0673173841501784,0.0122279849124168,-0.0912842345785153,-0.0433505337218414,3.77098745411983e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40385,-0.032773376953186,0.00595691515460662,-0.044448930656215,-0.021097823250157,3.84343352094399e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40350,0.0173939470259494,0.00316865897913598,0.0111833754268428,0.0236045186250559,4.12190915416421e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40352,-0.0536401485845894,0.009803667816763,-0.0728553375054449,-0.0344249596637339,4.56042050587847e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40352,-0.0315239505728449,0.0057628456715657,-0.0428191280891136,-0.0202287730565761,4.59212951850341e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,40206,-0.0423757758250582,0.00776024555347265,-0.0575858571098646,-0.0271656945402518,4.84769953003449e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,40042,-0.036426954722444,0.00667219047650443,-0.0495044480563927,-0.0233494613884953,4.87942178006546e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,42490,-0.0375172711163426,0.00688035170635019,-0.0510027604607889,-0.0240317817718962,5.04645703101858e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,40125,-0.0439086765777456,0.00805399969883891,-0.0596945159874698,-0.0281228371680213,5.0950760771033e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,40428,-0.0158198961148331,0.00290550400666865,-0.0215146839679037,-0.0101251082617625,5.29541669014658e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40385,-0.0129352528057119,0.00237801761607281,-0.0175961673332146,-0.00827433827820915,5.45513523534544e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,42229,-0.029320141004586,0.00539772870915461,-0.0398996892745291,-0.018740592734643,5.67449610067612e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,40104,-0.0282797462321485,0.00520627464225317,-0.0384840445309647,-0.0180754479333323,5.69677056030798e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40125,-0.0344945399681563,0.0063509825835251,-0.0469424658318655,-0.0220466141044471,5.7120905751504e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,42486,0.0333112508631832,0.00613891705995908,0.0212789734256634,0.045343528300703,5.85614810407062e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42631,-0.0155215380037162,0.00286379657660206,-0.0211345792938562,-0.00990849671357611,6.06558407046669e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42475,-0.0558808153833987,0.0103276366860612,-0.0761229832880788,-0.0356386474787187,6.38308198432206e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,42229,-0.0452385607778995,0.00836118620974467,-0.0616264857489991,-0.0288506358068,6.39442109448411e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40411,0.0208819446612649,0.00386271575880188,0.0133110217740132,0.0284528675485166,6.57587628321383e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,40012,0.0354806740754413,0.0065718093940507,0.0225999276631019,0.0483614204877806,6.84609810844711e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42568,-0.0178707330433596,0.00331690276821933,-0.0243718624690695,-0.0113696036176498,7.25428101483034e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,42490,-0.0675573533210314,0.0125454435087668,-0.0921464225982143,-0.0429682840438485,7.36720600324002e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2,Complement C2,42542,-0.0129174281356649,0.00239890535391187,-0.0176192826293322,-0.00821557364199767,7.37872502126394e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,42264,-0.0260029334201696,0.00483421164040927,-0.0354779882353718,-0.0165278786049675,7.62164226541093e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,42315,-0.0422793990480147,0.00787364675206674,-0.0577117466820655,-0.0268470514139639,8.01962610919925e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42191,-0.0408921233206825,0.00761800085191639,-0.0558234049904386,-0.0259608416509264,8.10596111781539e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42516,-0.0145199903924224,0.00270630619842561,-0.0198243505413366,-0.00921563024350824,8.21928117072996e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42590,-0.0286220511743489,0.00534301500945557,-0.0390943605928818,-0.018149741755816,8.6057173808892e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40411,-0.015821943241691,0.00295996994998647,-0.0216234843436645,-0.0100204021397175,9.20347159652035e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,42237,-0.029806851066386,0.00557850087284868,-0.0407407127771694,-0.0188729893556026,9.2873636879408e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42568,0.0328323940662427,0.00615625328609046,0.0207661376255054,0.04489865050698,9.80798159331479e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40384,-0.0222935984784159,0.00419732635711711,-0.0305203581383654,-0.0140668388184663,1.10883787048419e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40339,0.0151600058141322,0.00285543888819655,0.00956334559326695,0.0207566660349974,1.12243236910362e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42599,-0.019348346569639,0.00364473636554922,-0.0264920298461155,-0.0122046632931625,1.12249708378715e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,40125,-0.0289642198574992,0.00545716931466676,-0.039660271714246,-0.0182681680007523,1.13281259532899e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40206,-0.0379747960039853,0.00715866688874963,-0.0520057831059346,-0.023943808902036,1.15027866245759e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42475,-0.0450552034177741,0.00850293305265033,-0.0617209522009687,-0.0283894546345794,1.18440224228235e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42390,0.0186550436617695,0.00352581205225212,0.0117444520393553,0.0255656352841836,1.23600840053644e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,42229,-0.0365776920311714,0.0069137154352078,-0.0501285742841787,-0.0230268097781641,1.23890866254102e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,40385,-0.0158496114693298,0.00299741181599414,-0.0217245386286783,-0.00997468430998132,1.26152331368456e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42554,-0.0154164713742729,0.00291613115671408,-0.0211320884414325,-0.00970085430711327,1.26560815342662e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,42137,-0.0570211023523521,0.0107974360905106,-0.0781840770897528,-0.0358581276149514,1.30571544412383e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40352,-0.0239607579554607,0.00453691308849073,-0.0328531076089025,-0.0150684083020189,1.30689344073783e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40411,-0.0192155893397009,0.00363908620036803,-0.0263481982924222,-0.0120829803869795,1.31359467761835e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,40125,-0.0284537217100012,0.00539157097042505,-0.0390212008120343,-0.0178862426079681,1.335053056342e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFP,Properdin,40440,-0.0122410861822737,0.00232231169335353,-0.0167928171012466,-0.0076893552633008,1.38136363429639e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,42243,-0.0331666161758331,0.00629986888488781,-0.0455143591902132,-0.020818873161453,1.42683978440875e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42673,0.0174222772509714,0.00331052902598855,0.0109336403600339,0.023910914141909,1.44142504563276e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41838,-0.0241178286083487,0.00458480397995812,-0.0331040444090666,-0.0151316128076308,1.46102191021304e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,40432,-0.0442750447494094,0.00842550771837317,-0.0607890398774208,-0.027761049621398,1.50831987431511e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,42520,-0.0515552606796311,0.00982382437704918,-0.0708099564586475,-0.0323005649006147,1.56133356006218e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,40289,-0.024350125941363,0.00464355629428249,-0.0334514962781567,-0.0152487556045694,1.60150728489898e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40089,-0.0342088764348358,0.00653569755032975,-0.0470188436334821,-0.0213989092361895,1.68821440610568e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40411,-0.0155983343572057,0.00298493485651457,-0.0214488066759743,-0.00974786203843719,1.76624643621012e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40206,-0.0207918108764902,0.00398701388486245,-0.0286063580908206,-0.0129772636621598,1.87270007752629e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40329,-0.0224249264263874,0.0043168928614752,-0.0308860364348788,-0.0139638164178961,2.08683023824719e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,42229,-0.0353998977939542,0.00681547366822078,-0.0487582261836669,-0.0220415694042415,2.08871180090039e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42237,-0.047521910280757,0.00917772121828647,-0.0655102438685985,-0.0295335766929155,2.27658637102167e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40089,-0.0327669452888907,0.00634715154421522,-0.0452073623155525,-0.0203265282622288,2.48016057567615e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,40019,-0.0674837025011784,0.013074602038572,-0.0931099224967795,-0.0418574825055773,2.49409674318e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40125,-0.054746717326,0.010617846756775,-0.075557696969279,-0.0339357376827209,2.56550620658663e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42466,-0.0294114756206077,0.00571473618509334,-0.0406123585433906,-0.0182105926978247,2.69034656232826e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,42191,-0.0243734451938782,0.00475120643685284,-0.0336858098101097,-0.0150610805776466,2.93995425735886e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42516,-0.0193566952570928,0.0037741389155558,-0.0267540075315822,-0.0119593829826034,2.95733141663908e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,40125,-0.0163096357627919,0.0031805043530784,-0.0225434242948256,-0.0100758472307583,2.97844703224304e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40019,-0.0201130023297692,0.00392336562774834,-0.0278027989601559,-0.0124232056993825,3.00328435477261e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,40104,-0.0335543693099158,0.00654965219885766,-0.0463916876196768,-0.0207170510001548,3.05726725560871e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42377,-0.0574004534942529,0.0112140010566493,-0.0793798955652854,-0.0354210114232203,3.12076145460748e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,40245,-0.0172850950113312,0.00337659849555533,-0.0239032280626197,-0.0106669619600428,3.12184659352278e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,40019,-0.0413019622517397,0.00807198165769979,-0.0571230463008313,-0.0254808782026482,3.16245618286223e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42466,-0.0497149648300636,0.00972270970119859,-0.0687714758444129,-0.0306584538157144,3.21016577026502e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,40187,0.029196014686012,0.0057144323489978,0.0179957272819763,0.0403963020900477,3.2900402393103e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40385,0.0166879523921765,0.00327222980116366,0.0102743819818958,0.0231015228024573,3.45445607499092e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42599,0.0317355457135105,0.00622352648367139,0.0195374338055146,0.0439336576215064,3.455863979942e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42475,0.0260601611163815,0.00511285933084081,0.0160389568279335,0.0360813654048295,3.49851192057209e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,42590,-0.0695185812023244,0.0136774616994171,-0.096326406133182,-0.0427107562714669,3.77101222621797e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,40089,-0.0360236345358348,0.00708837188883654,-0.0499168434379544,-0.0221304256337152,3.79526479750958e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42256,-0.0349442590659343,0.00688266492775971,-0.0484342823243433,-0.0214542358075252,3.88431453099476e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40432,0.0310451385839775,0.00611556073664932,0.0190586395401448,0.0430316376278102,3.90774167198932e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,40019,-0.0321002640755237,0.00632463993758784,-0.0444965583531958,-0.0197039697978515,3.93042755013322e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42623,-0.0214220404436848,0.0042237788712819,-0.0297006470313973,-0.0131434338559723,3.9938478118044e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42599,-0.0324486465105411,0.00641067008521767,-0.0450135598775677,-0.0198837331435145,4.21125442192991e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42447,-0.0228981983577678,0.00452719068682176,-0.0317714921039384,-0.0140249046115971,4.29505445228815e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42460,-0.0359724616943697,0.00711498802214203,-0.0499178382177681,-0.0220270851709713,4.34143582201117e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42377,-0.0310274820986747,0.00614585907480261,-0.0430733658852879,-0.0189815983120616,4.51190725489105e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42191,-0.0331868561762964,0.00658329967538857,-0.046090123540058,-0.0202835888125348,4.6917288291432e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39987,-0.0189593192686072,0.00376131100505019,-0.0263314888385056,-0.0115871496987088,4.71564827510744e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40350,-0.0496866259282392,0.00987406745031505,-0.0690397981308567,-0.0303334537256217,4.92870315520533e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,40187,0.0145969317850587,0.00290398363256962,0.00890512386522221,0.0202887397048951,5.07326304702209e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42554,-0.0453184865767342,0.0090569020256741,-0.0630700145470555,-0.027566958606413,5.69403225756248e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,40380,-0.0134886203425031,0.00269978922254978,-0.0187802072187007,-0.00819703346630551,5.93624398013275e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,40187,-0.0577366143333043,0.0115585675969323,-0.0803914068232915,-0.035081821843317,5.96980825284694e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42490,-0.0126099024670834,0.00253139138793617,-0.0175714295874383,-0.0076483753467285,6.39149159512031e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,40432,-0.0124399862516502,0.00250160576841916,-0.0173431335577518,-0.00753683894554865,6.69675655791695e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,42518,-0.0182258368782478,0.00366673928407266,-0.0254126458750302,-0.0110390278814654,6.75810053442853e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,42554,-0.0185212223585116,0.00373115712070179,-0.0258342903150871,-0.0112081544019361,6.99307441741018e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,42237,-0.0256851607841499,0.00517712094817442,-0.0358323178425718,-0.0155380037257281,7.09119105272577e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40384,-0.0343054160964242,0.00692084569840498,-0.0478702736652979,-0.0207405585275504,7.27047326909601e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,42148,-0.0375687628516587,0.00758007823931713,-0.0524257162007203,-0.0227118095025971,7.2775309070211e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,40417,-0.0114663107552317,0.00231337348083644,-0.0160005227776711,-0.00693209873279226,7.28106213448613e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",40206,-0.0235253916740535,0.00475363841976928,-0.0328425229768012,-0.0142082603713057,7.57296318009274e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40206,-0.0391977065020821,0.00792388503484789,-0.054728521170384,-0.0236668918337802,7.6566455188896e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,42490,-0.0240551372905152,0.00486369950390299,-0.0335879883181651,-0.0145222862628654,7.67377048223039e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,40321,-0.0266849422701839,0.00539594154756865,-0.0372609877034185,-0.0161088968369494,7.71083050710831e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSG,Basigin,42623,-0.0112096032851505,0.00226836297388266,-0.0156555947139605,-0.00676361185634045,7.83719057077157e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42466,-0.0354891696538718,0.00718328121897303,-0.0495684008430589,-0.0214099384646846,7.88626420654627e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42237,-0.0476361522978103,0.00964873425949144,-0.0665476714464135,-0.0287246331492071,8.029970813905e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,42229,-0.0249649253111127,0.00506255777477678,-0.0348875385496752,-0.0150423120725502,8.26960463927152e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39987,-0.0216119058125063,0.00438221063201798,-0.0302010386512616,-0.0130227729737511,8.27164044961694e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,42469,-0.0447420104207738,0.00907910658861861,-0.0625370593344662,-0.0269469615070813,8.40697530860807e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,42237,-0.0228391921282652,0.0046366257388279,-0.0319269785763679,-0.0137514056801626,8.50364417859713e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,42518,-0.0191880875880151,0.00389865951157175,-0.0268294602306958,-0.0115467149453345,8.6815628461363e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40104,-0.0178832841210003,0.00363864723586479,-0.0250150327032953,-0.0107515355387054,9.0158045539436e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40385,-0.0538952048410285,0.0109723480238384,-0.0754010069677518,-0.0323894027143051,9.1468386131684e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42475,-0.0775422581549573,0.015791914255514,-0.108494410095765,-0.0465901062141499,9.20417609377727e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,40350,-0.0176532669204396,0.00359586842468602,-0.0247011690328242,-0.010605364808055,9.2687112301098e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42490,-0.0220661838413325,0.00450546686794585,-0.0308968989025063,-0.0132354687801586,9.81320897555936e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,42475,0.0222071726342124,0.00453614501917361,0.0133163283966321,0.0310980168717927,9.91560286092512e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40350,-0.0222479518216818,0.00454567376397166,-0.0311574723990662,-0.0133384312442974,1.0002996073226e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,42377,0.013161561216845,0.00269224561294589,0.00788475981547102,0.0184383626182189,1.02703509111862e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40350,-0.0594118373266886,0.0121961595314029,-0.0833163100082384,-0.0355073646451389,1.1235775407235e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40019,-0.027957189782786,0.00575174500695766,-0.039230609996423,-0.016683769569149,1.18647066689315e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,42191,-0.0184608725337562,0.00379969150908309,-0.0259082678915591,-0.0110134771759534,1.1964684244344e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,42256,-0.017724652934035,0.00364829777033091,-0.0248753165638836,-0.0105739893041864,1.19750791057511e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,42661,0.0231055178461669,0.00475818847603512,0.0137794684331381,0.0324315672591957,1.21157797384193e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,42172,-0.0451977389700261,0.00930942399580105,-0.0634442100017962,-0.0269512679382561,1.2175725787384e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42537,-0.0471277346127473,0.00971458031980997,-0.0661683120395749,-0.0280871571859198,1.24079568013043e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40385,-0.0237539600644831,0.00490737977380598,-0.0333724244211428,-0.0141354957078234,1.31272182788295e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,40104,-0.0206304794529605,0.00426367241823054,-0.0289872773926924,-0.0122736815132287,1.325041817275e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,40187,0.0161185704110535,0.00333661448156202,0.00957880602719192,0.0226583347949151,1.37810535870608e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40350,0.035502949365018,0.00735455269271741,0.0210880260872918,0.0499178726427441,1.40202220103824e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,42157,-0.037420409354687,0.0078063020198817,-0.0527207613136551,-0.0221200573957188,1.65621004671151e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40384,0.022423873450597,0.00468004234522849,0.0132509904539491,0.0315967564472448,1.67764157234973e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42229,-0.0233804969434216,0.00488070754935337,-0.0329466837401542,-0.013814310146689,1.68289994453582e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,42584,-0.0301875096244717,0.0063233093189529,-0.0425811958896194,-0.017793823359324,1.82508600634002e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40384,-0.0333318071764834,0.00699139060213766,-0.0470349327566732,-0.0196286815962936,1.88829645072468e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,40206,-0.0149995269685679,0.00314984408276038,-0.0211732213707783,-0.00882583256635758,1.9413711696403e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,40384,-0.0145360833981054,0.0030539758867957,-0.020521876136225,-0.00855029065998582,1.96285369398899e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42474,-0.0145450769201455,0.00305630922317719,-0.0205354429975728,-0.00855471084271825,1.96572515136348e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,40384,0.0177575936877674,0.00373202052412885,0.0104428334604749,0.02507235391506,1.97797997303504e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,40428,0.0162042715186304,0.00340604442305114,0.00952842444945012,0.0228801185878106,1.98441549624768e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,42240,-0.0284002826318702,0.00597046242604645,-0.0401023889869213,-0.0166981762768192,1.98794348145636e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,40411,-0.0315959554331092,0.00664922428818883,-0.0446284350379593,-0.0185634758282591,2.04090468466435e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42496,0.01889371185303,0.00397916705834708,0.0110945444186698,0.0266928792873903,2.0741897062916e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,42459,-0.0143466676224271,0.00302746917842215,-0.0202805072121345,-0.00841282803271964,2.17184684225143e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42568,-0.0228912171071069,0.0048339035189963,-0.0323656680043397,-0.0134167662098742,2.20698997479906e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42554,-0.0582353872671579,0.0123163336469172,-0.0823754012151157,-0.0340953733192001,2.28714540457222e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42657,-0.0117439920141642,0.00249743441295223,-0.0166389634635506,-0.00684902056477785,2.59644596584057e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,42673,0.0200872712988705,0.00427930802084505,0.0116998275780142,0.0284747150197268,2.70490315174352e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42377,-0.0148992429523044,0.00317547051685813,-0.0211231651653463,-0.00867532073926247,2.73293659812413e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40019,-0.0192298412235269,0.00409849015231044,-0.0272628819220554,-0.0111968005249984,2.73951186050483e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40231,-0.0272413036612109,0.00583217612739916,-0.0386723688709133,-0.0158102384515086,3.03476376932476e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,40440,-0.015267625471213,0.00326908242889708,-0.0216750270318513,-0.0088602239105747,3.04229965549173e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42341,-0.0145288203659499,0.00311177311611809,-0.0206278956735414,-0.00842974505835848,3.05685789578503e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,40352,-0.0400608190286555,0.00858160987771469,-0.0568807743889763,-0.0232408636683347,3.07365115561065e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,42191,-0.0180368697781857,0.00386853756923776,-0.0256192034138917,-0.0104545361424797,3.15573518048856e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40019,-0.0223149583582145,0.00479580380475596,-0.0317147338155362,-0.0129151829008928,3.30993311586376e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40187,-0.0303169460743752,0.00652008456758662,-0.043096311826845,-0.0175375803219054,3.36163575145219e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,42475,-0.0152212972831852,0.00327580187836421,-0.0216418689647791,-0.00880072560159138,3.40715481647193e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42568,0.0134809811606473,0.0029023446847188,0.00779238557859842,0.0191695767426961,3.43552032492351e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,40139,-0.0201974414907924,0.00434882210253297,-0.028721132811757,-0.0116737501698277,3.45126695700066e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42554,-0.0135797495537574,0.00293165022914961,-0.0193257840028906,-0.00783371510462415,3.65360213755434e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40428,-0.026616013082021,0.00574977954861261,-0.0378855809973017,-0.0153464451667403,3.71464126483568e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42191,-0.0203569743574958,0.00439877905801218,-0.0289785813111997,-0.011735367403792,3.73019381331157e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,40187,0.0448736970880852,0.00969829657729018,0.0258650357965964,0.063882358379574,3.75301429351917e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,42229,-0.035195607335297,0.00760786689371025,-0.0501070264469691,-0.0202841882236249,3.75999041417268e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,42012,-0.0163116837671385,0.00352940686627476,-0.023229321225037,-0.00939404630923996,3.84413026264538e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,40089,-0.0223157730555207,0.00483213366137764,-0.0317867550318209,-0.0128447910792206,3.91510119037932e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42590,-0.0221917636735139,0.00481716056126025,-0.031633398373584,-0.0127501289734438,4.1265372140275e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40385,-0.0186765067679964,0.0040540238904482,-0.0266223935932749,-0.0107306199427179,4.13217499275057e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42478,-0.023194199017979,0.00504544192871785,-0.033083265198266,-0.0133051328376921,4.32444842418383e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40384,-0.0475104500403689,0.0103366941970351,-0.0677703706665576,-0.0272505294141801,4.34786016976625e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,40019,-0.0288643362124063,0.00628349621726574,-0.0411799887982471,-0.0165486836265654,4.40425797117148e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42518,-0.0410731393026961,0.00895666912958976,-0.058628210796692,-0.0235180678087002,4.56455498230503e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42256,-0.034269663396827,0.00747843898960926,-0.0489274038164612,-0.0196119229771929,4.63789473933477e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40350,-0.0244343596044711,0.00533871340520186,-0.0348982378786668,-0.0139704813302755,4.77183709957116e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40352,-0.0179230192864224,0.00392009449658497,-0.0256064044997289,-0.0102396340731158,4.88080457673115e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40384,-0.0131158470196301,0.00287542745589414,-0.0187516848331826,-0.00748000920607759,5.13646042307395e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40350,-0.0194682269659547,0.00426994147707213,-0.0278373122610161,-0.0110991416708933,5.18542929082989e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,42172,-0.0316736143568476,0.00695371700082946,-0.0453028996784733,-0.0180443290352219,5.28832629624459e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,40089,-0.0290069410968973,0.0063809076131533,-0.0415135200186777,-0.0165003621751168,5.52915397277319e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,42236,-0.0423258041635658,0.00931166586767959,-0.0605766692642178,-0.0240749390629138,5.53083342211332e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40352,-0.0188416116553707,0.00415901428352756,-0.0269932796510847,-0.0106899436596567,5.95095349822106e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40352,-0.0230324448748981,0.00509235765637169,-0.0330134658813866,-0.0130514238684096,6.16148175677409e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,42631,-0.0365617619774937,0.00809908518020568,-0.0524359689306968,-0.0206875550242905,6.40638716805138e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42334,-0.010310212235651,0.00228888200356843,-0.0147964209626451,-0.00582400350865689,6.71106953587064e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,40104,-0.0254839922059408,0.00565845145138202,-0.0365745570506496,-0.0143934273612321,6.74723855787367e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42377,-0.0187911501051812,0.00417791518497537,-0.0269798638677329,-0.0106024363426295,6.92683273914732e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42237,-0.0292763868268405,0.00651472523670683,-0.0420452482907859,-0.0165075253628952,7.0539252262663e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42631,-0.0339893798550995,0.00756791323513286,-0.0488224897959599,-0.0191562699142391,7.13969390322581e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,42357,0.0153604525201438,0.00342332510874293,0.0086507353070077,0.02207016973328,7.28461256350361e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42237,-0.015756274253115,0.0035129616339126,-0.0226416790555837,-0.00887086945064629,7.34738357836217e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,40019,0.0164446283717145,0.00366629557789989,0.00925868903903074,0.0236305677043983,7.35432794974404e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42568,0.016860607659586,0.00376620199487133,0.00947885174963816,0.0242423635695338,7.63897483088495e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40384,-0.0585922209975243,0.0130968038203409,-0.0842619564853924,-0.0329224855096562,7.76068729508648e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42466,0.0310069606792692,0.00693146653898021,0.017421286262868,0.0445926350956704,7.76390073538102e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,42341,-0.0274048387513519,0.00613314092322885,-0.0394257949608804,-0.0153838825418233,7.94946532550001e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40187,-0.0328578677386779,0.00736739547740216,-0.0472979628743861,-0.0184177726029697,8.28105201076039e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,40219,-0.00626953892390569,0.00140710133586504,-0.00902745754220117,-0.00351162030561021,8.44673290035088e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42229,-0.0203618561701251,0.00457211296488167,-0.0293231975812932,-0.011400514758957,8.51886651702056e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40159,0.0225695197275347,0.00506805634954047,0.0126361292824354,0.032502910172634,8.54013419851877e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,40432,0.0116814750510931,0.00262461162363942,0.00653723626875989,0.0168257138334264,8.63972807134135e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,42515,0.012679714502316,0.00285243214112413,0.00708894750571267,0.0182704814989193,8.85077314821202e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,42466,-0.0195296505935432,0.00439558712165082,-0.0281450013519788,-0.0109142998351076,8.94259456505768e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40329,-0.0319703670116721,0.00719898200307146,-0.0460803717376921,-0.017860362285652,9.04229823859785e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,40104,-0.0289682104731792,0.00653068375247295,-0.0417683506280262,-0.0161680703183322,9.26685589588752e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40384,-0.0190851269137904,0.00430385384748485,-0.0275206804548607,-0.0106495733727201,9.31977226212903e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42673,-0.0106742659114932,0.00241256937225499,-0.0154029018811129,-0.00594562994187338,9.74516781287954e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42590,0.0131256850742299,0.00297752898970714,0.00728972825440392,0.0189616418940559,1.0502136803398e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42475,-0.0550964463672586,0.0125015842153737,-0.079599551429391,-0.0305933413051261,1.05557592974719e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42377,0.023968115938122,0.0054408516738069,0.0133040466574605,0.0346321852187835,1.06513064789728e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40125,-0.0222978740848964,0.00507342973319084,-0.0322417963619505,-0.0123539518078424,1.11802570552671e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,42490,0.0231739975560471,0.00527790174790087,0.0128293101301614,0.0335186849819328,1.13827697904755e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40385,-0.0215837152413649,0.00491574180637706,-0.0312185691818639,-0.0119488613008659,1.14005662339001e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40104,-0.0184991113960717,0.00421338218001547,-0.026757340468902,-0.0102408823232413,1.14123145299252e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42256,-0.0198452386110573,0.00452215197116816,-0.0287086564745469,-0.0109818207475677,1.15056935280525e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,40019,-0.023623318121007,0.00538486518724677,-0.0341776538880107,-0.0130689823540034,1.16020491435432e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42475,-0.0547589550184336,0.0124846589220704,-0.0792288865056915,-0.0302890235311757,1.16289986318142e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40104,-0.0177807057035486,0.00406353500348522,-0.0257452343103796,-0.00981617709671753,1.22182779152831e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI3,Elafin,42329,-0.0259988475549557,0.00595203807394363,-0.0376648421798852,-0.0143328529300262,1.2631691799665e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,42475,-0.028928465950703,0.00662679336818878,-0.041916980952353,-0.015939950949053,1.27862002551195e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,42590,-0.0293717813128226,0.00673041764017926,-0.0425633998875739,-0.0161801627380712,1.28640923387255e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42518,-0.028735306277725,0.00659571538174722,-0.0416629084259496,-0.0158077041295005,1.3304839249524e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42485,-0.049459160591874,0.01135740352715,-0.071719671505088,-0.02719864967866,1.3418876622654e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40352,-0.0267203350129214,0.00615177022374227,-0.0387778046514562,-0.0146628653743865,1.41456557872054e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42377,0.016509687213759,0.00380466976413765,0.00905253447604922,0.0239668399514688,1.43987097586402e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40125,-0.020717436822303,0.00477622683918829,-0.030078841427112,-0.011356032217494,1.45328819998015e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40385,-0.032079218117551,0.00739593261922566,-0.0465752460512333,-0.0175831901838687,1.45432194334124e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42485,-0.0432391977689767,0.00998994205162592,-0.0628194841901636,-0.0236589113477899,1.51382059556264e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39742,0.0511687568033979,0.0118258795101193,0.027990032963564,0.0743474806432318,1.52652854494993e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42466,-0.0381644158936032,0.00882637895097552,-0.0554641186375152,-0.0208647131496912,1.54410290279585e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,40385,-0.0436439938107284,0.0101589127340899,-0.0635554627695446,-0.0237325248519121,1.75274801597082e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42498,-0.0263556452305424,0.00613618163553166,-0.0383825612361845,-0.0143287292249004,1.75836387428854e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,42191,0.0150128866267633,0.00349927385963577,0.00815430986187723,0.0218714633916495,1.79733279213496e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,42590,-0.0127393403151141,0.00297264779261233,-0.0185657299886343,-0.00691295064159394,1.83586121612612e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,42490,0.0199681199925495,0.00468134648721427,0.0107926808776095,0.0291435591074894,2.00865280887916e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42424,-0.0126243689836877,0.00296102277778946,-0.018427973628155,-0.00682076433922034,2.02630460171124e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42518,0.0151158840005144,0.00356161332838832,0.00813512187687327,0.0220966461241555,2.2094647037179e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,40206,-0.0154518533110604,0.00364050631338989,-0.0225872456853046,-0.00831646093681623,2.20951371199792e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,42019,-0.0267828820475898,0.00634036711060542,-0.0392100015843765,-0.0143557625108032,2.41463487197219e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,42384,0.0213153756129837,0.00504922755997232,0.0114188895954379,0.0312118616305294,2.44294401383716e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,40411,-0.0424061411415573,0.0100830409142902,-0.0621689013335661,-0.0226433809495486,2.62309136367365e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,42229,-0.0239221342766281,0.00570309778184773,-0.0351002059290497,-0.0127440626242066,2.75178752796316e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40384,-0.0142903914865273,0.00340907763376196,-0.0209721836487008,-0.0076085993243539,2.78798782657072e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42599,-0.017395895419026,0.00415096036832847,-0.0255317777409498,-0.00926001309710219,2.79739357504515e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,40104,0.0114551842955833,0.00273680430063636,0.00609104786633608,0.0168193207248306,2.86636966153715e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42475,-0.0394264797072652,0.00945004879095159,-0.0579485753375303,-0.0209043840770001,3.03734483408407e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42490,-0.0167443303295019,0.00401408260831701,-0.0246119322418033,-0.00887672841720058,3.04660682475754e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,40385,-0.0169329401787464,0.00406262279869387,-0.0248956808641864,-0.00897019949330646,3.09619698423062e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42518,-0.0254123291633907,0.00610001050108764,-0.0373683497455225,-0.013456308581259,3.12015567750376e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42229,-0.0249895433411124,0.00601756429321916,-0.036783969355822,-0.0131951173264029,3.30570437099392e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42494,-0.0429106252808897,0.0103464433824055,-0.0631896543104045,-0.0226315962513749,3.38390849549458e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40350,-0.0419602863552538,0.0101184236736435,-0.0617923967555951,-0.0221281759549125,3.39473342038506e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,42639,-0.012353738387231,0.00298131048985295,-0.0181971069473428,-0.00651036982711927,3.43797492535701e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42475,-0.0152782717965003,0.0036939546804685,-0.0225184229702185,-0.00803812062278202,3.55555414607204e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40384,-0.0163951566766861,0.00397101335684097,-0.0241783428560944,-0.00861197049727781,3.67454094475126e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,42237,-0.0219695662022383,0.00532974786772564,-0.0324158720229806,-0.0115232603814961,3.77814315281819e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42234,-0.0236321386785625,0.00574734524465998,-0.0348969353580961,-0.012367341999029,3.94931703948228e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40385,0.0180576233408816,0.00440314569075804,0.00942745778699584,0.0266877888947674,4.14147173513087e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40432,0.028026225919443,0.00684632054565139,0.0146074376499663,0.0414450141889197,4.2766337327226e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,42237,-0.020324298293494,0.00497431550946842,-0.0300739566920521,-0.010574639894936,4.41787759845703e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42466,-0.0225252398049631,0.00553210529487113,-0.0333681661829105,-0.0116823134270157,4.69359590369802e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42466,-0.0150460296344208,0.00369583368748543,-0.0222898636618922,-0.00780219560694933,4.70672694994431e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,40019,-0.0171081204756014,0.00420577562727204,-0.0253514407050546,-0.00886480024614818,4.78020915125863e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,40042,-0.0321123252865689,0.00789824591587706,-0.0475928872816879,-0.0166317632914499,4.82155041456305e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,42475,-0.0173672220102638,0.00427246751466566,-0.0257412583390085,-0.00899318568151908,4.83265500728729e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42180,-0.0240737994005971,0.00592328865546282,-0.0356834451653042,-0.01246415363589,4.84683234550747e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,42229,-0.0202579064550583,0.004985071363463,-0.0300286463274457,-0.0104871665826708,4.85810909440515e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,40352,-0.0166185182222741,0.00409842395570133,-0.0246514291754487,-0.00858560726909945,5.05061253247918e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42602,-0.0355726992425369,0.00879267551488905,-0.0528063432517194,-0.0183390552333543,5.24549956667818e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42229,-0.0210367769287912,0.00520520885337117,-0.0312389862813987,-0.0108345675761837,5.34186243792533e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42568,-0.0136781968577418,0.00338587295710915,-0.0203145078536757,-0.00704188586180787,5.37992855795905e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40206,-0.0383133294762086,0.00948844762088548,-0.0569106868131442,-0.0197159721392731,5.42991042346547e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,40440,0.00967800009047286,0.00239895460705896,0.0049760490606373,0.0143799511203084,5.51374954266537e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42518,-0.0158450705481516,0.00392855420309188,-0.0235450367862117,-0.00814510431009153,5.53036110486395e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39987,-0.0155493094093587,0.00385788743214694,-0.0231107687763667,-0.0079878500423507,5.60347108559026e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,40173,-0.0246336319619198,0.00612676788385492,-0.0366420970142754,-0.0126251669095641,5.84241920400429e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,42545,0.0116697112160229,0.00290578456147812,0.00597437347552582,0.01736504895652,5.95112541239175e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,40187,0.0092700340102908,0.00231194554952921,0.00473862073321356,0.0138014472873681,6.12173066003872e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42561,0.0188137681451552,0.00469777836695214,0.00960612254592899,0.0280214137443814,6.23997917197395e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40019,-0.0280802152865987,0.00701515985810843,-0.0418299286084913,-0.0143305019647062,6.30172285398514e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,42338,-0.0172189671599796,0.00430229305328646,-0.0256514615444211,-0.00878647277553817,6.30801493318363e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40428,0.0165407790107597,0.0041333786974174,0.00843935676382161,0.0246422012576978,6.32773624267181e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42172,-0.0196843996547131,0.00491984979239548,-0.0293273052478082,-0.010041494061618,6.34211210537197e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40384,-0.0151249281824088,0.00378123095346523,-0.0225361408512007,-0.007713715513617,6.37497344982033e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,42466,-0.0321378691749265,0.00805399228663642,-0.0479236940567339,-0.0163520442931191,6.63435299208143e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,42475,-0.0211912735418343,0.00531172496207089,-0.0316022544674933,-0.0107802926161754,6.65602389269094e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42599,-0.0142910156365835,0.00358386369125608,-0.0213153884714454,-0.00726664280172155,6.70991751253867e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,40235,-0.0259693046640487,0.00653937172092376,-0.0387864732370592,-0.0131521360910381,7.19582511689928e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,42475,-0.0229584062107433,0.005781629840558,-0.034290400698237,-0.0116264117232496,7.19721596413861e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40019,0.0162296120873316,0.00409494684948589,0.00820351626233923,0.0242557079123239,7.43872945894804e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,40380,0.0197449269085321,0.00498891803405371,0.00996664756178686,0.0295232062552774,7.61245128182406e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,42466,-0.0117879647820523,0.00298015180578803,-0.0176290623213968,-0.00594686724270773,7.67744914223973e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,42454,-0.0215959904073434,0.00546920498842429,-0.032315632184655,-0.0108763486300318,7.89985148810122e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,40125,-0.0124188957290376,0.00315256116714317,-0.0185979156166382,-0.006239875841437,8.22264097018123e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40384,0.0185536780225921,0.00472351417670186,0.00929559023625648,0.0278117658089277,8.61912992691094e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,42554,0.0264623542516803,0.00674364646288016,0.0132448071844352,0.0396799013189254,8.75116408559175e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,40019,-0.018812454248122,0.00479487655095172,-0.0282104122879874,-0.00941449620825664,8.78298159038036e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42229,-0.0122951471619989,0.00313863740701726,-0.0184468764797527,-0.00614341784424509,8.99837627692749e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,42568,0.0123859562230802,0.0031652268575055,0.00618211158236946,0.018589800863791,9.15571717063167e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,40350,-0.0148331489340172,0.00379274393821646,-0.0222669270529215,-0.00739937081511295,9.24869708628963e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42462,-0.0134740349524337,0.00345061226141047,-0.0202372349847982,-0.0067108349200692,9.47607350051451e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,40089,0.0128929636153081,0.00331332799339601,0.00639884074825194,0.0193870864823643,0.000100325821895556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42473,-0.0244552918857687,0.00628964174449756,-0.0367829897049839,-0.0121275940665534,0.000101488231401214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40432,-0.0292288411576502,0.00752342973806914,-0.0439747634442657,-0.0144829188710347,0.000102899084934316
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40428,-0.0256350292235248,0.00660519882426207,-0.0385812189190785,-0.0126888395279712,0.000104606042380889
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,42471,-0.0227977409655003,0.00587621608943624,-0.0343151245007953,-0.0112803574302053,0.000105106171346547
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40384,-0.0309777370196291,0.00799061476164043,-0.0466393419524443,-0.0153161320868139,0.000106459385198778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40411,-0.0114849818414831,0.00296301714449036,-0.0172924954446842,-0.00567746823828195,0.000106744232948785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40104,-0.0149994053042201,0.00387196735417006,-0.0225884613183934,-0.00741034929004675,0.000107757325778331
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,42531,-0.0155432894456996,0.00401295394546916,-0.0234086791788192,-0.00767789971258008,0.000107893842285948
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,40104,-0.0498761746913734,0.012883419415104,-0.0751276767449772,-0.0246246726377696,0.000108867135782549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40352,-0.0116922339022941,0.00302037889649609,-0.0176121765394264,-0.00577229126516173,0.000108956198867533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42496,-0.0118833355620136,0.00307025121296196,-0.017901027939419,-0.00586564318460816,0.000109141624666511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42475,-0.0283670048662914,0.00733834106560181,-0.0427501533548709,-0.0139838563777118,0.000111349444834018
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,42191,-0.0350294165747364,0.00906477018549435,-0.0527963661383054,-0.0172624670111675,0.000111928138045482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42377,-0.0191579802155281,0.00496217554263902,-0.0288838442791006,-0.00943211615195561,0.00011355477236359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42525,-0.0198927196232473,0.00515480502722928,-0.0299961374766167,-0.00978930176987791,0.000114358875261088
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,42518,-0.0302672886483477,0.0078897230029082,-0.0457311457340477,-0.0148034315626476,0.000125481424158871
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42377,-0.0146128400202783,0.00380998598335281,-0.0220804125476498,-0.00714526749290678,0.000125941236979179
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,42237,-0.0465870596931808,0.01215235904579,-0.0704056834229292,-0.0227684359634323,0.000126884278616474
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,42317,-0.0137196033682949,0.00358063045783717,-0.0207376390656557,-0.006701567670934,0.00012789731969978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,42191,-0.0290480980243239,0.00758337264903836,-0.0439115084164391,-0.0141846876322087,0.000128485050710674
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,42426,-0.0130777601229375,0.00342774106484723,-0.0197961326100381,-0.00635938763583694,0.000136652447138446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40411,-0.0208786281355757,0.00547873103301471,-0.0316169409602845,-0.0101403153108669,0.000139229193074478
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,40230,0.00325052967955735,0.000855335137487753,0.00157407281008135,0.00492698654903334,0.000145298093558294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,40071,-0.0177533913047468,0.00467526775709562,-0.0269169161086542,-0.00858986650083938,0.000147076457706516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39987,-0.0223471692214375,0.00588501145252123,-0.0338817916683792,-0.0108125467744959,0.000147080752597487
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCT,Secretin,40089,-0.0198398696972744,0.00522554202436636,-0.0300819320650324,-0.00959780732951629,0.000147424399989426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42466,-0.0153245351510968,0.00403947486076978,-0.0232419058782056,-0.00740716442398802,0.000149080831620779
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40206,-0.0268573529507175,0.00707991898042113,-0.0407339941523429,-0.012980711749092,0.000149360487118347
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39987,-0.0259368905476193,0.00684442018074511,-0.0393519541018798,-0.0125218269933589,0.000151775123354315
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40089,-0.0153489936598618,0.00405364284424128,-0.0232941336345748,-0.00740385368514893,0.000153623612879022
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,42191,-0.019624664428128,0.00518881877740875,-0.0297947492318491,-0.0094545796244068,0.000156203684068053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,40089,-0.0131822993183071,0.00349251155073256,-0.0200276219577429,-0.00633697667887127,0.000161213976435066
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,42172,-0.0240066183747946,0.00637245025231632,-0.0364966208693346,-0.0115166158802546,0.000165784909433099
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,42342,-0.0223695966525906,0.00594664450264348,-0.0340250198777718,-0.0107141734274094,0.000169482952670424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40187,-0.0128035178264621,0.00340825479880436,-0.0194836972321187,-0.00612333842080559,0.000173113428314537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,42229,-0.0294009917747358,0.00783138987658846,-0.0447505159328492,-0.0140514676166224,0.00017461701616829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,42493,0.0258913401694739,0.00690339538367832,0.0123606852174644,0.0394219951214834,0.000177215110220102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40352,-0.017926112497075,0.00478632396088899,-0.0273073074604174,-0.00854491753373258,0.0001811009849181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,40411,-0.0203045583982026,0.00542874165307895,-0.0309448920382373,-0.00966422475816788,0.000184792353261671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39987,-0.0312902227011758,0.00837374851514369,-0.0477027697908575,-0.0148776756114942,0.000187409481514165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40440,-0.0125577555069973,0.0033631554176038,-0.0191495401255008,-0.00596597088849386,0.000189452321891092
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42475,-0.0318178809842071,0.00852405846791609,-0.0485250355813227,-0.0151107263870916,0.00019021735447368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,42560,-0.028506187513803,0.00764254334882261,-0.0434855724774953,-0.0135268025501107,0.000192321348690733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42498,-0.0362667234409435,0.00973585209491423,-0.0553489935469754,-0.0171844533349116,0.000196068757068078
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42518,-0.0113257303303979,0.00304279091711065,-0.0172896005279348,-0.00536186013286101,0.000198344957020079
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42172,-0.0168040583335201,0.00451728454540966,-0.025657936042523,-0.00795018062451717,0.000200104788783904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,42659,-0.0137831856752731,0.00370881969001391,-0.0210524722677003,-0.00651389908284579,0.000202958491758713
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,42561,-0.0172125188875329,0.00463735232469552,-0.0263017294439361,-0.00812330833112968,0.000206697277803299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42471,0.0190446441429285,0.00513147871825108,0.00898694585515641,0.0291023424307006,0.000207010031329114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,40019,0.0231737334896684,0.0062480243472285,0.0109276057691006,0.0354198612102363,0.000209144749335204
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,42237,-0.0215190988333017,0.00580425882849092,-0.0328954461371439,-0.0101427515294595,0.000210209695848545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,42256,-0.025699685831905,0.00693744330437684,-0.0392970747084836,-0.0121022969553264,0.000212690333789424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,42466,-0.0177105250141167,0.00478186411510137,-0.0270829786797154,-0.00833807134851798,0.000213350561495308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,40104,-0.0150075550349327,0.00405460084751961,-0.0229545726960711,-0.00706053737379423,0.000215498921638888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,40089,0.0121294284443589,0.00328514038235174,0.0056905532949495,0.0185683035937683,0.000223399428807245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42425,-0.0108371421690701,0.00294113814939578,-0.0166017729418858,-0.00507251139625432,0.00022990703101917
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,42237,-0.0300021530955255,0.00815142579359882,-0.0459789476509792,-0.0140253585400718,0.000233621876179117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40428,-0.0242856648150138,0.00660414408697863,-0.0372297872254919,-0.0113415424045356,0.000236780801286196
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,42485,-0.0155007664330981,0.00421831548901244,-0.0237686647915625,-0.00723286807463377,0.000239126749031889
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40440,0.00980589577037361,0.00267075421260863,0.00457121751366071,0.0150405740270865,0.000242169444334329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42191,-0.0147222726477639,0.00401047301684243,-0.0225827997607751,-0.00686174553475275,0.000242612100101155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,42237,-0.0261893853542578,0.0071376010006619,-0.0401790833155551,-0.0121996873929605,0.000244266613471747
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,42358,-0.0144796525147581,0.00394959222754624,-0.0222208532807487,-0.00673845174876747,0.000247233817956768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,42191,-0.0266182405333103,0.00726618797733939,-0.0408599689688955,-0.0123765120977251,0.000249974147806479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42229,-0.020015732278313,0.00546548257230634,-0.0307280781200334,-0.00930338643659258,0.000251040630481584
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",40019,-0.0237766919985059,0.00651040943233946,-0.0365370944858913,-0.0110162895111206,0.000261327640815716
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40352,-0.0209872360869732,0.00576926491403954,-0.0322949953184907,-0.00967947685545566,0.000276253257265089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40428,-0.019482896277514,0.00535932583309635,-0.0299871749103828,-0.00897861764464512,0.000278869784710309
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42590,-0.0109633878693897,0.00302365197383524,-0.0168897457381068,-0.00503703000067265,0.000289051522842692
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40428,-0.0154539769750212,0.00427730204025269,-0.0238374889739165,-0.00707046497612595,0.000303972912669166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,42599,-0.0093903977720146,0.00260022319634233,-0.0144868352368456,-0.00429396030718363,0.000305682530638243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,42144,0.0336198597302574,0.00937613171467134,0.0152426415695016,0.0519970778910132,0.000337431222873179
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,42557,-0.0162173643124374,0.00452308058599397,-0.0250826022609856,-0.00735212636388927,0.000337672994110797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40187,-0.0329588445991791,0.00921051638326016,-0.051011456710369,-0.0149062324879892,0.000347201539320161
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,40350,-0.0115693489974968,0.00324083805179356,-0.0179213915790122,-0.00521730641598146,0.000358668612819421
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40125,-0.0125206167782486,0.00351421970272836,-0.0194084873955962,-0.00563274616090103,0.000368420709329252
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,40187,-0.0134294514041335,0.00376982988459042,-0.0208183179779307,-0.00604058483033625,0.000369106076306707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,42191,-0.0192157627740952,0.00540953514869473,-0.0298184516655369,-0.00861307388265353,0.000383373693240494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,42237,-0.014485690322774,0.00408181700833229,-0.0224860516591053,-0.00648532898644268,0.000388301461899794
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40089,-0.020447766779616,0.00576763626066344,-0.0317523338505163,-0.00914319970871567,0.000393871740090431
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,42590,-0.0133056086622754,0.00375493535104744,-0.0206652819503284,-0.00594593537422245,0.000396199122819136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,42516,0.0126695717926044,0.00357920508513975,0.00565432982573051,0.0196848137594783,0.000401837297224892
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,42590,-0.0110487324059086,0.00312160580864549,-0.0171670797908538,-0.00493038502096349,0.000402337804356398
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42256,0.0146400326841431,0.00414732075027931,0.0065112840135957,0.0227687813546906,0.000416993336945439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40385,0.0221746104729231,0.00628474996542945,0.00985650054068136,0.0344927204051648,0.000419882966286295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42518,0.0104640219833137,0.00297150932904591,0.00463986369838371,0.0162881802682437,0.000430628168421102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,40187,-0.0288366332123752,0.00820639932267148,-0.0449211758848113,-0.0127520905399391,0.000443320522639673
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,42256,-0.0297025675182553,0.00845708219491989,-0.0462784486202983,-0.0131266864162123,0.000445992750436349
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42466,-0.0266869711000792,0.00761035234408424,-0.0416032616944844,-0.0117706805056741,0.000455255817453914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,42590,-0.0137247131546099,0.00392411670453591,-0.0214159818955003,-0.00603344441371951,0.000471111293227816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,40104,0.0111976184559353,0.00320497593073358,0.00491586563169753,0.0174793712801732,0.000478044797477261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,42431,-0.00895453702739774,0.00257105283413088,-0.0139938005822943,-0.00391527347250121,0.000497747616617858
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,40350,-0.0221296077629374,0.00635948054036692,-0.0345941896220566,-0.00966502590381827,0.000503738302783929
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39972,-0.0319758945805227,0.00920025709146473,-0.0500083984797935,-0.0139433906812518,0.000511825828922085
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,40104,-0.014938732497864,0.00430531374597345,-0.023377147439972,-0.00650031755575606,0.000522788919176263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42631,-0.0239014684042645,0.00689422792084737,-0.0374141551291253,-0.0103887816794036,0.000528181335586585
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40206,-0.0159832148018397,0.00461429952669016,-0.0250272418741524,-0.00693918772952703,0.000534540569698616
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,40352,0.0202026953557758,0.00584662101819907,0.00874331816010564,0.031662072551446,0.000551422984547439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40206,-0.0263357255727713,0.00763250308279375,-0.0412954316150471,-0.0113760195304956,0.000561709024515596
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,42367,-0.0370054572896986,0.0107545087572754,-0.0580842944539585,-0.0159266201254388,0.000581527558865798
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,40089,-0.0112202133622659,0.00326367912855394,-0.0176170244542317,-0.00482340227030022,0.000588428785362453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,40019,-0.0129036474818387,0.00376070077677586,-0.0202746210043194,-0.00553267395935799,0.000603203056014237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40104,-0.0107619923760989,0.00314109293584622,-0.0169185345303575,-0.0046054502218403,0.000614360576503632
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,40104,-0.0105806589581681,0.00309367772292857,-0.0166442672951081,-0.00451705062122811,0.000628294710456688
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39987,-0.0219532752091253,0.00642798519931991,-0.0345521261997923,-0.00935442421845829,0.000639545490973528
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,40104,-0.0176608447679514,0.00518180901312756,-0.0278171904336814,-0.0075044991022214,0.000656199153263433
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,40350,-0.0235080580799176,0.00690517049790565,-0.0370421922558126,-0.00997392390402248,0.000665396488569508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,40171,0.00747568021330075,0.00219609490091233,0.00317133420751258,0.0117800262190889,0.000666250375104477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42377,-0.0161193339084544,0.00474171852803653,-0.025413102223406,-0.00682556559350282,0.000677164082562288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42617,-0.0110765622702849,0.00325974119889675,-0.0174656550201225,-0.00468746952044723,0.000680805367269962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,42256,-0.0174978397712349,0.0051537945782164,-0.027599277144539,-0.00739640239793071,0.000687983519214741
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42475,0.0172468116267355,0.00508435188007706,0.00728148194178449,0.0272121413116866,0.00069552394663005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42357,-0.00943900310968991,0.00278625344387455,-0.014900059859684,-0.00397794635969578,0.000706866249627016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42237,0.012597805371197,0.00372138041359291,0.00530389976055484,0.0198917109818391,0.00071322950875709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42475,0.0204565284382629,0.00604766667126129,0.00860310176259073,0.032309955113935,0.000720238002135807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42617,-0.0150661062829334,0.00445429244990079,-0.0237965194847389,-0.00633569308112784,0.000720660771277376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42237,-0.0205970170963503,0.00609446887925268,-0.0325421760996856,-0.00865185809301505,0.000727975691374255
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,42414,-0.016111404617583,0.00477211117018829,-0.025464742511152,-0.00675806672401394,0.000737171888726194
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,42475,-0.0137507241938763,0.00407765592767261,-0.0217429298121147,-0.00575851857563802,0.000747795879836232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,42229,-0.0152576044112151,0.00454086387761641,-0.0241576976113433,-0.00635751121108694,0.000781473128465346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,40104,-0.0116478836656668,0.00346834575862412,-0.0184458413525701,-0.00484992597876355,0.000786804967770722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,42518,0.0136014148176414,0.00405470772778524,0.00565418767118229,0.0215486419641004,0.000797376276300413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40440,-0.00646853940281893,0.00192982569132552,-0.0102509977578169,-0.00268608104782092,0.000805300856363838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40428,-0.00813706559236346,0.00242791280693043,-0.0128957746939471,-0.00337835649077982,0.000806502333946516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,42172,-0.0128744194417746,0.00384339103459899,-0.0204074658695886,-0.00534137301396062,0.000811134375453444
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42500,-0.0261393146032025,0.00781567710188284,-0.0414580417228928,-0.0108205874835121,0.000826670536225912
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40373,-0.0240260081622729,0.00719676588640784,-0.0381316692996322,-0.00992034702491349,0.00084523896653141
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,40019,0.0153445219186351,0.00460110280474718,0.00632636042133062,0.0243626834159396,0.000855965091389374
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,42256,-0.0260928140735492,0.00782903761625738,-0.0414377278014136,-0.0107479003456847,0.000862077630239632
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40384,-0.0205840610184065,0.00619235665189261,-0.0327210800561161,-0.00844704198069702,0.000889868150937236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,40089,-0.0166701345257559,0.00502147104467977,-0.0265122177733283,-0.00682805127818355,0.000903870619691256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42475,0.0208797976155588,0.0062913739556877,0.00854870466241093,0.0332108905687067,0.000906490720108861
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40019,-0.0140143934316284,0.00423366879783727,-0.0223123842753894,-0.00571640258786733,0.000935259972024098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LXN,Latexin,42344,0.0234568249685255,0.00708724357089935,0.00956582756956282,0.0373478223674883,0.000936389280801002
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40206,-0.029854101918344,0.00904139266182,-0.0475752315355112,-0.0121329723011768,0.000963256289300722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,42377,-0.0193350009885845,0.00588085692419441,-0.0308614805600055,-0.00780852141716348,0.00101242736810979
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,42518,-0.0230786540149498,0.00702469395256324,-0.0368470541619738,-0.00931025386792589,0.00102114894382608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,40125,-0.0151168093018709,0.00460180676236868,-0.0241363505561135,-0.00609726804762831,0.0010231324633978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42631,0.00964264162445691,0.002940243650785,0.00387976406891831,0.0154055191799955,0.00104241618975918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,42256,-0.0101062741445667,0.00308222740955753,-0.0161474398672995,-0.00406510842183398,0.00104490053563482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42542,0.00959796780642604,0.00292785811740619,0.0038593658963099,0.0153365697165422,0.00104755800998763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,40104,0.015064248211509,0.00461126358263793,0.00602617158953871,0.0241023248334794,0.00109092096833885
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39845,-0.0362633976030333,0.011108437461163,-0.0580359350269129,-0.0144908601791538,0.00110006905119663
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40019,0.0163921996159996,0.00503272929902807,0.00652805018990461,0.0262563490420947,0.00112895698289308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40019,-0.03426794867779,0.0105290355610399,-0.0549048583774283,-0.0136310389781518,0.00113895145135869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,42229,-0.0121045691571275,0.00371961501847466,-0.0193950145933378,-0.00481412372091714,0.0011398063154619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,42516,-0.00837414600027439,0.00257339940056761,-0.0134180088253869,-0.00333028317516187,0.00114028501239783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40411,-0.0178248517490115,0.00548667665211797,-0.0285787379871627,-0.00707096551086028,0.00116253668984106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,40019,-0.021580734702128,0.00664867662247521,-0.0346121408821794,-0.0085493285220766,0.00117448600347064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40019,0.00705352771201814,0.00218049131601541,0.00277976473262794,0.0113272906914083,0.00122078817121401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,42117,0.023861453771549,0.00738207607452751,0.00939258466547509,0.0383303228776229,0.00123084396920197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,42191,-0.0144437553464878,0.00448346431894063,-0.0232313454116114,-0.00565616528136414,0.00127808103851349
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,40352,-0.0173893539553726,0.00540105934093979,-0.0279754302636146,-0.00680327764713062,0.00128728406779498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40125,0.0133481073280646,0.00415158797640735,0.0052109948943062,0.021485219761823,0.00130741175639719
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40330,-0.0289439187409071,0.00901615063321531,-0.0466155739820091,-0.0112722634998051,0.00133005004391001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,40104,-0.0191486394390976,0.00596563269957202,-0.0308412795302588,-0.00745599934793647,0.00133200057336433
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40350,-0.00722199543653784,0.00225212221094908,-0.011636154969998,-0.00280783590307763,0.00134621734903772
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42561,0.00926281472340085,0.00288922665994426,0.00359993046991011,0.0149256989768916,0.00134917972808042
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,42256,-0.0160745747227135,0.00501698217941773,-0.0259078597943722,-0.00624128965105473,0.00135842520146432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,42323,-0.00974984266072539,0.00304314512761487,-0.0157144071108505,-0.00378527821060025,0.00135917362918897
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,40089,-0.0216617156883294,0.0067626633141598,-0.0349165357840827,-0.00840689559257623,0.00136331796154732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,42357,-0.0234047745035951,0.0073082732656674,-0.0377289901043032,-0.00908055890288704,0.0013656246250671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40440,0.0052508829103768,0.00164017570061586,0.00203613853716973,0.00846562728358388,0.00137134775369126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42590,0.0156071148617307,0.00488084620282507,0.00604065630419358,0.0251735734192679,0.00138886482252692
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,40384,-0.0228007933461799,0.00713081598138504,-0.0367771926696946,-0.00882439402266526,0.00139009480466243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,42599,-0.0108443575337813,0.00340656695648745,-0.0175212287684967,-0.00416748629906586,0.0014590485914436
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42485,0.0100311646650832,0.00315411088303245,0.0038491073343396,0.0162132219958268,0.00147436951329687
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,42470,-0.00827521927628577,0.00260498262627192,-0.0133809852237787,-0.00316945332879282,0.00149307757720961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40385,-0.0161683505578848,0.00509898968573728,-0.0261623703419298,-0.00617433077383969,0.0015238109119345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,42599,0.0210871378039743,0.00665085746319709,0.008051457176108,0.0341228184318406,0.00152472490446514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42673,-0.00967861585558457,0.00305921986442729,-0.015674686789862,-0.00368254492130709,0.00156094853742475
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,40042,0.013957196929308,0.00441339819454822,0.00530693646799349,0.0226074573906225,0.00156873155254733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,40417,-0.00484095119846982,0.00153305559937336,-0.0078457401732416,-0.00183616222369805,0.00159432677469653
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,42631,0.0131249126355206,0.00415885554881106,0.00497355575985095,0.0212762695111903,0.00160359518472232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40352,-0.0171412450706919,0.00544530952867185,-0.0278140517468887,-0.00646843839449508,0.0016488575067679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40019,-0.0202136109508411,0.0064394487733782,-0.0328349305466623,-0.00759229135501979,0.0016996466293077
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40352,-0.0134784776692864,0.00429563904679241,-0.0218979302009995,-0.00505902513757328,0.00170715358732207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,40352,-0.0229436525280487,0.00732942659383419,-0.0373093286519637,-0.00857797640413369,0.00175050155002408
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,40042,0.0157163400035615,0.00504123041045689,0.00583552839906602,0.025597151608057,0.00182831406471209
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,42553,-0.0199974213259201,0.00641785363875706,-0.0325764144578839,-0.00741842819395621,0.00183769970528633
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42661,-0.0192581553360747,0.00621058639056253,-0.0314309046615773,-0.00708540601057216,0.00193358285017036
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40428,-0.0151924556848586,0.00490102526943578,-0.0247984652129527,-0.00558644615676446,0.00194095716603884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,40125,0.0175325305450708,0.00566039033584546,0.0064381654868137,0.0286268956033279,0.00195716521261103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',40019,-0.014049403377237,0.00454276760184643,-0.022953227876856,-0.00514557887761805,0.00198851240884055
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42307,0.0555857498090828,0.0180269424019424,0.0202529427012756,0.09091855691689,0.00205018574075532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42466,-0.00809433566597724,0.00262600041571882,-0.0132412964807861,-0.00294737485116836,0.00205772221982364
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42514,-0.0210577343209174,0.00684520652473854,-0.0344743391094049,-0.00764112953242981,0.00210029742306567
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,40019,0.0162666633470143,0.00529011729785269,0.00589803344322297,0.0266352932508055,0.00211086763586914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40384,-0.00643847901374978,0.00209417945340819,-0.0105430707424298,-0.00233388728506973,0.00211389173998914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40352,-0.0194262137712683,0.00631859848293225,-0.0318106667978155,-0.00704176074472111,0.0021140058413797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,40030,-0.0316892283457896,0.01034212034491,-0.0519597842218132,-0.0114186724697659,0.00218866676712004
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,42631,-0.0139699551824024,0.00456001400333916,-0.0229075826289472,-0.0050323277358577,0.00219140671822621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,42599,-0.00703715352338736,0.00229881452317683,-0.0115428299888139,-0.00253147705796077,0.0022088076580949
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,42256,-0.01810034519224,0.00591316947511085,-0.0296901573634572,-0.00651053302102272,0.00221030298378263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42489,0.00713257935706281,0.00233524839140264,0.00255549250991363,0.011709666204212,0.00226022983868479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,40089,-0.0166357713685504,0.00544732049458713,-0.0273125195379412,-0.00595902319915967,0.00226404973981099
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40385,-0.0172273607665963,0.00565335253942391,-0.0283079317438671,-0.00614678978932539,0.00231459081953876
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42517,0.0119852075995385,0.00394333434150695,0.00425627229018485,0.0197141429088921,0.00237542154526684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,40125,-0.0221625969587516,0.00730186201748428,-0.0364742465130208,-0.00785094740448236,0.0024094323077403
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40089,-0.0241552062100141,0.00796801693879844,-0.039772519410059,-0.00853789300996913,0.00243897134226281
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42673,0.00720707138240126,0.00238331403427916,0.0025357758752141,0.0118783668895884,0.00249950170411834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40350,-0.0256818155604539,0.00850206728552509,-0.0423458674400831,-0.00901776368082475,0.00252799411993068
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42377,-0.0190874095918159,0.00632018646722908,-0.0314749750675849,-0.00669984411604686,0.00253199640881162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40390,-0.00709069835967301,0.00235186478641485,-0.0117003533410461,-0.0024810433782999,0.00257617927519936
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,42460,-0.0347263158310442,0.0115208962323516,-0.0573072724464534,-0.0121453592156349,0.00258142451840257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,40187,-0.0110050136874836,0.00365357338436602,-0.018166017520841,-0.00384400985412619,0.00260017228538879
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40352,-0.0132134500693414,0.00439462924317668,-0.0218269233859677,-0.00459997675271513,0.00264664761970665
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42372,-0.0316934516228505,0.0105721041662861,-0.0524147757887712,-0.0109721274569298,0.00272409469395572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,42467,-0.022325898746679,0.00746577322694833,-0.0369588142714978,-0.00769298322186032,0.00279092801413389
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40104,-0.00763319608953144,0.00255397158757054,-0.0126389804011697,-0.00262741177789319,0.00280740353719346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,42475,0.0185545476123966,0.00622259767228678,0.00635825617471449,0.0307508390500787,0.00287078122324496
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42490,0.00740650755897953,0.00248789498406306,0.00253023339021593,0.0122827817277431,0.00291591521702951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42490,0.0107112580614741,0.00360891536390701,0.00363778394821637,0.0177847321747318,0.00300279138852104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,40352,-0.0164384286283935,0.00554515559818763,-0.0273069336008412,-0.0055699236559457,0.00303849166697947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40187,-0.0116609731772996,0.00394325315694126,-0.0193897493649045,-0.00393219698969473,0.00311110781750071
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40042,0.00898433322381828,0.003043005671867,0.00302004210695897,0.0149486243406776,0.00315934876648592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,40019,0.00978553341996474,0.00331820912368859,0.0032818435375351,0.0162892233023944,0.00319443666378458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42466,-0.0140182726615036,0.00475817887994194,-0.0233443032661898,-0.00469224205681736,0.00322323284006636
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,40432,-0.00826699594348248,0.00281482217781865,-0.013784047412007,-0.00274994447495792,0.00332128557724047
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,42599,-0.014909535519968,0.00507800679283927,-0.024862428833933,-0.00495664220600303,0.00332931912810763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,40428,0.00782711122865465,0.00266848123725674,0.00259688800363144,0.0130573344536779,0.00336197083228029
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42475,-0.0149569030270663,0.00511146069606887,-0.0249753659913613,-0.00493844006277131,0.00343766233811968
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42475,-0.0265465484654174,0.00908972155803866,-0.0443624027191731,-0.00873069421166159,0.00350055949838254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39987,-0.00884743395444205,0.00303362892055688,-0.0147933466387335,-0.00290152127015057,0.00354766036337792
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42475,-0.0100688735736549,0.00346198905486538,-0.0168543721211911,-0.00328337502611879,0.00363876967515915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,42142,-0.00934441039856574,0.00322624165524713,-0.0156678440428501,-0.00302097675428136,0.00378131195524285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42229,-0.0143484863820513,0.00498672211905269,-0.0241224617353946,-0.00457451102870806,0.0040169655438067
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42496,-0.0893358512272674,0.0311301491536205,-0.150350943568364,-0.0283207588861713,0.00411439367540844
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,40104,0.0130463714148466,0.0045580469528276,0.00411259938730451,0.0219801434423887,0.00421415989470591
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,42504,0.0198107159641854,0.00692740544673273,0.00623300128858924,0.0333884306397815,0.00424621218253693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,42256,-0.0166863834892547,0.00584158082950786,-0.0281358819150901,-0.00523688506341929,0.00429037263910703
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,42256,0.0153665238482441,0.00538413304798209,0.00481362307419921,0.025919424622289,0.00432351873843758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42229,-0.0157747981442816,0.00554704527719867,-0.026647006887591,-0.00490258940097218,0.00446455906401345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,38956,-0.0326822633322484,0.0115598214210906,-0.055339513317586,-0.0100250133469109,0.00470482524608538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42518,-0.0145305654131398,0.00514324075797894,-0.0246113172987785,-0.00444981352750105,0.00473247516578405
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40352,-0.00990768970021187,0.00350884642558419,-0.0167850286943569,-0.00303035070606687,0.0047567051640336
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,40271,-0.0193107323236963,0.00684197826368334,-0.0327210097205156,-0.00590045492687692,0.00477520778489426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42561,0.00742187345104437,0.00263803646538884,0.00225132197888223,0.0125924249232065,0.00490909252009074
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40428,0.00963170655735234,0.0034311439396149,0.00290666443570715,0.0163567486789975,0.00500693943612453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,42369,-0.0152018348286642,0.00542217768310094,-0.025829303087542,-0.00457436656978631,0.0050603163882439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42560,-0.00882119039961301,0.00314743773918069,-0.0149901683684072,-0.00265221243081887,0.00507564064273546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,42496,0.0107128919764095,0.00382710754125418,0.0032117611955513,0.0182140227572677,0.00513009918186307
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FST,Follistatin,42532,0.0143989863914808,0.00514434532422582,0.00431606955599824,0.0244819032269634,0.00513358583591125
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42490,-0.0107690485328354,0.00384782546415926,-0.0183107864425876,-0.00322731062308327,0.00513768986900892
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,42490,0.00591857580893602,0.00211573310186569,0.00177173892927927,0.0100654126885928,0.00515879488892879
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,42475,0.0180097438582972,0.00645920794775088,0.00534969628070546,0.0306697914358889,0.00530726130357628
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,40350,-0.0127782870468205,0.00458521096424343,-0.0217653005367376,-0.00379127355690337,0.00533133511453772
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,40019,-0.0158941104394602,0.00570527844260036,-0.0270764561869569,-0.00471176469196349,0.00534786910333481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42673,0.0046361369619143,0.0016693763483139,0.00136415931921907,0.00790811460460954,0.0054910732595995
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40089,0.0183755236281331,0.00664595581776829,0.00534945022530726,0.0314015970309589,0.00570328541843834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,40187,-0.0090045799370029,0.00326058862269235,-0.0153953336374799,-0.00261382623652589,0.00576068854397229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42438,0.00625279215749725,0.00226594464727803,0.00181154064883231,0.0106940436661622,0.00579758425669678
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40352,-0.00993402989366609,0.00359992800676703,-0.0169898887869295,-0.0028781710004027,0.00579828852724325
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40089,0.0104658875855673,0.00380832220330525,0.00300157606708901,0.0179301991040456,0.00600289517584516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40384,-0.013656700990974,0.00497952147029825,-0.0234165630727586,-0.00389683890918945,0.00610568601789391
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,42475,-0.0190661902083286,0.00695465778706868,-0.0326973194709832,-0.00543506094567401,0.00612413095670844
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,40019,0.0115542712283831,0.00421630617542961,0.00329031112454109,0.0198182313322252,0.00614692334886671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40359,-0.0108645235977161,0.0039650166921831,-0.018635956314395,-0.00309309088103725,0.00615189636595223
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40019,-0.0128691303344999,0.00469831417678163,-0.0220778261209919,-0.00366043454800788,0.00617093420706305
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40350,-0.0322984902082482,0.0117982979408459,-0.0554231541723062,-0.00917382624419017,0.00619958579386295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40042,0.00932175922453256,0.00340563957553063,0.00264670565649252,0.0159968127925726,0.00620742724610081
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,42599,-0.00851652497319244,0.00313547516832391,-0.0146620563031073,-0.00237099364327757,0.00661240447270879
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,42256,-0.0160250507156983,0.0059060639288672,-0.027600936016278,-0.00444916541511855,0.00666997565914969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,42490,-0.0125831739494787,0.00463951363803323,-0.0216766206800238,-0.00348972721893353,0.00669292052194139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,42490,0.00955031729502909,0.00352226357125878,0.00264668069536189,0.0164539538946963,0.00670828407224648
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42406,-0.0123037554761576,0.00454189706370308,-0.0212058737210156,-0.00340163723129956,0.00675842311330527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,42391,0.0367693373278981,0.0135990096037684,0.0101152785045121,0.0634233961512841,0.00686342839750923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42631,0.00722626194100253,0.00267617182276724,0.00198096516837874,0.0124715587136263,0.00693797031157236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,42673,-0.00711721540229784,0.00264109981493615,-0.0122937710395727,-0.00194065976502299,0.00705198293811415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42553,-0.0202408262812798,0.00751797930710557,-0.0349760657232067,-0.00550558683935289,0.00710447085331311
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,42532,0.00907708531130644,0.00338231122938129,0.00244775530171913,0.0157064153208938,0.00729037861135745
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42256,-0.0121480263453657,0.00452954982582093,-0.0210259440039747,-0.00327010868675667,0.00732864277391217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40019,0.0115435584267014,0.00431484086618967,0.00308647032896961,0.0200006465244331,0.00747713552670297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42466,0.00948933030781145,0.00355256430979322,0.00252630426061673,0.0164523563550062,0.00756905267103234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42191,-0.00786470410633323,0.00294913037131972,-0.0136449996341199,-0.00208440857854657,0.00766749011416616
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42466,-0.00607197226771399,0.00227747973757416,-0.0105358325533593,-0.00160811198206862,0.00768314863315882
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42599,0.0168149557678882,0.00631903339943129,0.00442965030500283,0.0292002612307735,0.00780014853469993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,42446,-0.0180913020417281,0.00680504756282063,-0.0314291952648565,-0.00475340881859965,0.00785807758536362
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,40042,0.0255412728969277,0.00962113690704612,0.00668384455911728,0.0443987012347381,0.00794938515668095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40042,0.0171182060824612,0.00645240076553308,0.00447150058201637,0.029764911582906,0.00798965522593641
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42516,-0.00966512095520659,0.0036508157351047,-0.0168207197960118,-0.00250952211440137,0.00812120152039572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,40104,-0.0057492798199533,0.00217168291990256,-0.0100057783429623,-0.00149278129694429,0.00812336401247932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,42229,-0.00874371606197477,0.00330341133997885,-0.0152184022883333,-0.00226902983561622,0.00813370939718174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,42518,-0.0234760040012914,0.00889411748223591,-0.0409084742664738,-0.00604353373610901,0.00831256239584966
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40384,0.0140631429090442,0.00532918442107273,0.00361794144374164,0.0245083443743468,0.00832926672214244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,40350,-0.0309812147245805,0.0117446142603914,-0.0540006586749475,-0.00796177077421343,0.00835349120256437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40125,-0.0102403118673499,0.00388224987308687,-0.0178495216186002,-0.00263110211609963,0.00835821408991093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40042,0.0216429915621467,0.00820957232467739,0.00555222980577905,0.0377337533185144,0.00839320555434418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,40104,-0.0220762982261823,0.00841023675248531,-0.0385603622610535,-0.00559223419131113,0.008678714917435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42495,-0.0130036940208128,0.00496191511737383,-0.0227290476508656,-0.00327834039076014,0.00878490539702778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,42568,0.00845694579727174,0.00322891465421748,0.00212827307500548,0.014785618519538,0.00882539324032285
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,40104,-0.00732669900873983,0.00280972278043918,-0.0128337556584006,-0.00181964235907904,0.00912973436069905
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42256,-0.00893897519231753,0.00343119073159808,-0.0156641090262498,-0.00221384135838528,0.00919218317626641
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40019,0.0131941604685115,0.00506836598042915,0.00326016314687037,0.0231281577901526,0.00924739367329468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40385,-0.0103266876571848,0.00397137201094434,-0.0181105767986357,-0.00254279851573388,0.00932695685549106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40104,-0.00965533228504486,0.00371331388111855,-0.0169334274920372,-0.00237723707805251,0.00932969717139827
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40350,-0.023776623800096,0.00915195366853773,-0.04171445299043,-0.00583879460976207,0.00938962673110592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,42483,-0.00825043486911853,0.00318135828609077,-0.0144858971098564,-0.00201497262838063,0.00951450272139638
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40042,0.0175274193655599,0.00676302203417677,0.0042718961785734,0.0307829425525463,0.00956435068620687
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,40019,0.0110088316099882,0.00426308693494801,0.00265318121749014,0.0193644820024863,0.00982568248280964
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,42561,-0.00592198432210224,0.00229793558873101,-0.010425938076015,-0.00141803056818946,0.00997425085681855
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,42599,0.0163622645331702,0.00635821580922461,0.00390016154708992,0.0288243675192504,0.0100809760993672
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40019,-0.0225795168235161,0.00878372376927736,-0.0397956154112997,-0.00536341823573247,0.0101652380872153
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,40384,-0.00693565816542058,0.00269850251113453,-0.0122247230872442,-0.0016465932435969,0.0101771586722504
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40385,-0.0076001151944213,0.00296042016740207,-0.0134025387225294,-0.00179769166631324,0.010263976193777
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40104,-0.0223183967252369,0.00870396398365186,-0.0393781661331945,-0.00525862731727922,0.0103557137463201
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40432,-0.0108949269512704,0.00425067336344795,-0.0192262467436284,-0.00256360715891238,0.0103869330199951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,39987,0.0127458468099316,0.00497897534155712,0.00298705514047966,0.0225046384793836,0.010482708722993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40352,-0.0100157333070846,0.0039153226199496,-0.0176897656421858,-0.00234170097198339,0.0105380856743726
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,40187,-0.00661366437616131,0.0025905805435928,-0.0116912022416032,-0.00153612651071942,0.0106943762292685
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,40019,-0.0103240031550875,0.00404642506932822,-0.0182549962909708,-0.00239301001920418,0.0107430866256727
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40350,-0.00730359289468337,0.00286318954759748,-0.0129154444079744,-0.0016917413813923,0.0107590116916222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,40089,-0.0147452132233081,0.0057949959770867,-0.026103405338398,-0.00338702110821817,0.0109579428523942
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,40019,-0.00991093241462709,0.00390043246529399,-0.0175557800466033,-0.00226608478265087,0.0110679687193136
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,40385,-0.00813511618838841,0.00320198823888443,-0.0144110131366019,-0.00185921924017492,0.0110782044046199
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,40019,0.0152019755517639,0.00598570865588398,0.0034699865862313,0.0269339645172965,0.0111082450361582
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,40104,-0.00843609048472862,0.00332276537484449,-0.0149487106194238,-0.00192347035003342,0.0111346839371178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,42191,-0.0147720565145409,0.00581938741589941,-0.0261780558497037,-0.00336605717937806,0.0111469551520158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40385,-0.00899201632495723,0.00354817840335257,-0.0159464459955283,-0.00203758665438619,0.0112819379284465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42559,-0.0139742378334273,0.0055259123846307,-0.0248050261073035,-0.00314344955955115,0.0114548972822202
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,40350,-0.0158640635718171,0.00627480614435812,-0.028162683614759,-0.00356544352887521,0.0114780678387346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42568,-0.0114047398750982,0.00452530160608712,-0.0202743310230289,-0.00253514872716743,0.0117398091808435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40440,0.00519285808759046,0.00206322371537719,0.00114893960545118,0.00923677656972974,0.0118541709842006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42256,-0.0159465605343132,0.00634090546895573,-0.0283747352534664,-0.00351838581515995,0.0119194971125729
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,40042,-0.0116560957445235,0.00463688334550857,-0.0207443871017203,-0.00256780438732672,0.0119589196593619
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40384,0.0107613237112546,0.00428154237447535,0.00236950065728292,0.0191531467652263,0.0119705452122491
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40089,-0.0134901688402202,0.0053691713721566,-0.0240137447296471,-0.00296659295079327,0.0120014413157816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40432,0.00694411134617215,0.00276624909790895,0.00152226311427061,0.0123659595780737,0.0120768430786026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42357,0.00897190907350085,0.00359043713543886,0.00193465228804069,0.016009165858961,0.0124723299924611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40089,0.0098685617834204,0.00395146449001136,0.00212369138299814,0.0176134321838427,0.0125238535918027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,40384,-0.00822482661423222,0.00329656707907278,-0.0146860980892149,-0.00176355513924956,0.0126111783548849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42490,0.00926178889574272,0.00372416494603432,0.00196242560151546,0.01656115218997,0.0128967454031949
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42568,-0.0178539642552936,0.00718057268360168,-0.0319278867151528,-0.00378004179543426,0.0129154396517111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42631,-0.0124326690146389,0.00501963866856843,-0.0222711608050331,-0.00259417722424482,0.0132686220759568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40104,-0.0112112675849364,0.00453528325854666,-0.0201004227716879,-0.00232211239818496,0.013450700484928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,42191,-0.0118609507457383,0.00480701770592061,-0.0212827054493427,-0.00243919604213392,0.0136217012366043
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40432,-0.0135206038030651,0.00548341202782411,-0.0242680913776004,-0.00277311622852989,0.0136883298880098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,42516,-0.00763288781925819,0.00309825944737962,-0.0137054763361222,-0.00156029930239413,0.0137672984581229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,40042,0.00909447632481462,0.00369155188271183,0.00185903463469944,0.0163299180149298,0.0137706771755811
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42465,0.0156251410769612,0.00634592520223801,0.0031871276805747,0.0280631544733477,0.0138201405445342
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42490,0.0162464614276403,0.00659951721453361,0.00331140768715445,0.0291815151681262,0.0138381153432542
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,39916,-0.0100709550407778,0.00409895142466835,-0.0181048998331278,-0.00203701024842783,0.0140275988810908
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42256,-0.0148344070792338,0.00606699806959545,-0.0267257232956409,-0.00294309086282671,0.0144943793697177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40089,0.00950490554533983,0.00389137174378413,0.00187781692752294,0.0171319941631567,0.0145993187151021
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42466,-0.00815722611309752,0.00334203965556185,-0.0147076238379987,-0.00160682838819628,0.0146680452091701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40350,0.00904404924816283,0.00370634811752254,0.00177960693781865,0.016308491558507,0.0146965800509086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERVV_1,,40019,0.0111562482080928,0.00457900556902476,0.0021813972928043,0.0201310991233814,0.0148506479024738
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,40440,0.00798523319171866,0.0032878732022529,0.00154100171530298,0.0144294646681343,0.0151689439795066
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,42339,-0.0111922342414629,0.00461254417298068,-0.020232820820505,-0.00215164766242075,0.0152595569290309
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,41903,-0.00713213797275813,0.00294648411872976,-0.0129072468454685,-0.00135702910004779,0.0155105971118363
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RETN,Resistin,42481,-0.0109178422173813,0.00452215790645582,-0.0197812717140347,-0.00205441272072792,0.0157789359655078
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40042,0.00764975256954514,0.00316912785747135,0.00143826196890129,0.013861243170189,0.0158020525300302
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,42041,-0.00943629115109307,0.00391190322543472,-0.0171036214729451,-0.00176896082924102,0.0158705242201208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,42296,0.0105350708230983,0.00437633478800911,0.00195745463860049,0.0191126870075962,0.0160855047016317
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40411,0.00918701082307552,0.00381971218246988,0.00170037494543456,0.0166736467007165,0.0161815725365385
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39987,-0.0146358302605431,0.00608974114069048,-0.0265717228962964,-0.00269993762478972,0.0162620217751893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,42213,-0.018717005508433,0.00781623927328427,-0.0340368344840702,-0.00339717653279582,0.0166511699037833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42237,0.00795645112865775,0.00332526562362802,0.00143893050634684,0.0144739717509687,0.0167377620763306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,42256,0.0156880339986214,0.00655747288720885,0.00283538713969203,0.0285406808575507,0.016753079609714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,40089,-0.0189879178861353,0.00795309177054297,-0.0345759777563995,-0.00339985801587105,0.0169808604496416
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,42518,0.00895200302762306,0.00375266261528832,0.00159678430165796,0.0163072217535882,0.017069484886092
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42340,-0.00861800301763226,0.0036246639938919,-0.0157223444456604,-0.00151366158960412,0.0174399082742961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40089,-0.0266767196464163,0.0112370195846304,-0.0487012780322919,-0.00465216126054061,0.017613631439578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40042,0.00844377694114587,0.00356183476296906,0.0014625808057265,0.0154249730765652,0.0177753825998375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,42356,0.00710912399866402,0.00300804858047822,0.00121334878092671,0.0130048992164013,0.0181241550562431
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40384,0.00892700556958772,0.00377917299474125,0.00151982649989488,0.0163341846392806,0.018185894530468
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40350,-0.0123202924119111,0.00522533492061782,-0.022561948856322,-0.00207863596750013,0.0184007802186412
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,42490,-0.00952403688025824,0.0040395090357918,-0.0174414745904102,-0.00160659917010631,0.0184018899353394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40125,-0.00985990391091878,0.00418815182056131,-0.018068681479219,-0.00165112634261862,0.0185783433443836
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,40385,0.00917800276794928,0.00390318059987398,0.00152776879219628,0.0168282367437023,0.0187193363928673
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,40019,-0.0227501566581306,0.0096827775661894,-0.0417284006878618,-0.00377191262839935,0.0188140557740609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,40019,-0.0174091967601697,0.0074903608836005,-0.0320903040920267,-0.00272808942831275,0.0201324733413763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,40019,0.00879663893161945,0.00381082107842668,0.00132742961790315,0.0162658482453357,0.0209994494454139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40350,-0.0104592999748084,0.00453724538328546,-0.0193523009260479,-0.00156629902356886,0.0211731187290444
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,42256,0.0118500229998895,0.00516035320823504,0.00173573071174883,0.0219643152880302,0.0216711225898846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42191,-0.0203239535526636,0.00885357013804805,-0.0376769510232378,-0.00297095608208944,0.0217165618011769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,42466,0.00367001307444482,0.00159884913895142,0.000536268762100044,0.0068037573867896,0.0217252035733464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40352,-0.00954985092385477,0.00417590994977252,-0.0177346344254089,-0.00136506742230063,0.0222208243839269
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,40042,-0.0113334475500177,0.00495851417675514,-0.0210521353364578,-0.00161475976357764,0.0222937089238911
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40352,-0.0115365057627389,0.00507798112817298,-0.0214893487739579,-0.00158366275151984,0.0231134000413944
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,40104,-0.0112561281129144,0.00496100866536224,-0.0209797050970244,-0.00153255112880443,0.0232926803139519
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,40125,0.00948957488946216,0.00418624933627671,0.00128452619035982,0.0176946235885645,0.0234191975697224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,40440,-0.00349970203731435,0.00155388122546796,-0.00654530923923156,-0.000454094835397143,0.0243267788993394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,42631,-0.0115345623024506,0.00513378237822909,-0.0215967757637797,-0.00147234884112162,0.0246692268366101
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,40089,-0.00838191123618279,0.00373191128325322,-0.0156964573513591,-0.00106736512100648,0.0247233028661479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,40104,-0.00508339133445495,0.00226611529476046,-0.00952497731218544,-0.00064180535672445,0.0249027267811442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,40440,-0.00486498351933221,0.00217175881363345,-0.00912163079405377,-0.000608336244610646,0.0251030897446149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,40125,-0.0221678145947266,0.00990275568706171,-0.0415772157413675,-0.00275841344808561,0.0252052516751778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,42016,-0.00585585831652206,0.00261934361337616,-0.0109897717987393,-0.000721944834304779,0.0253937818795456
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,40042,0.0127484753545529,0.005704620887969,0.00156741841413363,0.0239295322949721,0.025453196034017
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,42588,0.0104022996703178,0.00465846333480804,0.00127171153409405,0.0195328878065416,0.0255660924937616
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40104,-0.00726983689629044,0.00325619656937878,-0.0136519821722729,-0.000887691620308032,0.0255944810975296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42229,-0.0088574790377663,0.0039756985484447,-0.0166498481927179,-0.00106510988281468,0.0259038421616077
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40352,-0.0123344988127668,0.00554026219646663,-0.0231934127178414,-0.00147558490769225,0.02601140837749
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,42673,0.00405525777039975,0.00182202642261334,0.000484085982077607,0.00762642955872189,0.0260517306067577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40350,-0.0132784579012997,0.00596932042935404,-0.0249783259428337,-0.0015785898597658,0.026138079887143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40042,0.0137894435472838,0.00620615774720753,0.00162537436275701,0.0259535127318105,0.0263108154447019
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42229,-0.0110882738736002,0.00500247830358022,-0.0208931313486174,-0.00128341639858297,0.0266706354164549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42191,0.0130929370000138,0.00591900905748467,0.0014916792473438,0.0246941947526837,0.0269829523043008
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,42452,0.00662004643170984,0.00299296977432444,0.00075382567403394,0.0124862671893857,0.0269929505938754
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,42496,-0.00564657752502099,0.00255636715230778,-0.0106570571435442,-0.000636097906497744,0.027203530321734
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,42357,-0.00935213094100093,0.00424744493596424,-0.0176771230154908,-0.00102713886651103,0.0276949470644995
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,40104,-0.0146588191298642,0.00669022334265865,-0.0277716568814752,-0.00154598137825329,0.0284670288489234
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42590,-0.00690475005432426,0.00315223952027062,-0.0130831395140547,-0.000726360594593848,0.0285104694076899
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,42673,-0.00715370202737588,0.00327817336811613,-0.0135789218288835,-0.000728482225868272,0.0291103579081518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,40352,-0.0104923478038474,0.00480863359842199,-0.0199172696567545,-0.00106742595094027,0.0291317141380406
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,42191,-0.0147059868356165,0.00681781411255636,-0.028068902496227,-0.00134307117500608,0.0310243762687353
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,42377,0.00765030863896189,0.00354744424590058,0.000697317916996759,0.014603299360927,0.0310572789123127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,40042,0.0214646055589713,0.00996852998118234,0.0019262867958539,0.0410029243220887,0.0313220454516655
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,42649,-0.0134437026277829,0.00624458024429481,-0.0256830799066008,-0.00120432534896509,0.0313474591912048
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42538,-0.0119072211990618,0.00553957543372246,-0.0227647890491579,-0.00104965334896583,0.0316140851610037
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42451,-0.0194349793295114,0.00906366504043431,-0.0371997628087627,-0.00167019585026018,0.032029083979948
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42673,-0.00705961021331375,0.00329555612234722,-0.0135189002131143,-0.000600320213513199,0.0321984309037981
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42229,0.00860242979271167,0.0040213241484417,0.000720634461765943,0.0164842251236574,0.0324377306550227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,40042,0.00630010398271874,0.00294628559068648,0.000525384224973239,0.0120748237404642,0.0325129831938384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40104,-0.0130866622787401,0.00612174273530307,-0.0250852780399341,-0.00108804651754607,0.0325604349722263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42562,-0.00609743790256652,0.00285737129851723,-0.0116978856476603,-0.000496990157472742,0.0328664406553795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40385,-0.0530593394825031,0.0250640243553649,-0.102184827219018,-0.00393385174598793,0.0342859159763631
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,42377,-0.00789551143885548,0.00373768889372457,-0.0152213816705556,-0.000569641207155322,0.0346705087577346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42440,-0.00777014632654267,0.00368193312055086,-0.0149867352428224,-0.000553557410262991,0.034847413410702
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,39987,-0.0160327929925972,0.00761496730767382,-0.0309581289156379,-0.00110745706955646,0.035276797305528
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40125,-0.00622117144884392,0.00296354601737738,-0.0120297216429036,-0.000412621254784243,0.0358193034936557
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42475,0.0105379559402435,0.00502085483530119,0.000697080463053137,0.0203788314174338,0.0358501033487923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40384,-0.00644062022677317,0.00308719741274653,-0.0124915271557564,-0.000389713297789966,0.0369799020786884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,42191,0.011637378950567,0.00559035661073037,0.000680279993535466,0.0225944779075985,0.0373904868213645
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40104,-0.00618223977847854,0.00297107631720924,-0.0120055493602087,-0.00035893019674842,0.0374747426287263
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40104,-0.00969211236299122,0.00466749576016134,-0.0188404040529074,-0.000543820673074997,0.0378699479190667
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,40104,-0.00721011888993579,0.0034874348056133,-0.0140454911089379,-0.000374746670933723,0.0387147069466236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40042,0.0111252147356601,0.00539225244323794,0.000556399946913744,0.0216940295244065,0.0391187875969429
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,42256,0.0135403650461221,0.00656443983446882,0.000674062970563225,0.026406667121681,0.0391623839400767
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42059,-0.0144171971036379,0.00699892340733648,-0.0281350869820174,-0.000699307225258402,0.0394266029064994
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40042,0.0090316984818026,0.00439707162864929,0.000413438089649993,0.0176499588739552,0.0399971077977419
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40352,-0.0141472540396361,0.00689809143649893,-0.027667513255174,-0.00062699482409816,0.0403005783033401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39987,0.0111975708320543,0.0055239068348328,0.00037071343578202,0.0220244282283266,0.0426756191514441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40019,0.0127231334558454,0.00629235074397799,0.000390125997648516,0.0250561409140422,0.043200897075493
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,40206,-0.00945514058158162,0.00468331182111612,-0.0186344317509692,-0.000275849412194022,0.0435217492854748
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40191,0.0106169747398467,0.00526395224061214,0.00029962834824694,0.0209343211314465,0.0437280345152945
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,42469,-0.00636043498817726,0.00317071782837933,-0.0125750419318007,-0.00014582804455378,0.0448773390770715
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42599,0.00559697221270515,0.00279016893601126,0.000128241098123078,0.0110657033272872,0.0448803818732345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40019,0.0107247075093918,0.00534818137010105,0.000242272023993736,0.0212071429947898,0.044955843003976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42172,-0.0101728309647278,0.00508475700445019,-0.0201389546934502,-0.000206707236005445,0.0454506618499259
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,42172,0.0118199766535921,0.00591528200039859,0.000226023932810878,0.0234139293743734,0.0457147071331078
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42377,0.0122445770114668,0.00613118669841845,0.000227451082566679,0.024261702940367,0.0458351231285924
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40432,0.0303657671940952,0.0152115139917277,0.000551199770308992,0.0601803346178814,0.0459323596246595
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42466,0.0183803552595835,0.00921078345903984,0.000327219679865428,0.0364334908393016,0.0460059766465551
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42475,-0.00503844070397252,0.00252502280084067,-0.00998748539362023,-8.93960143248029e-05,0.0460192226938344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,42256,-0.0177265999204937,0.00888861936741758,-0.0351482938806322,-0.000304905960355258,0.0461397059049244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,40089,0.00821565058066239,0.00412140837380734,0.000137690167999997,0.0162936109933248,0.0462416240122297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40125,-0.0190253901232974,0.00955698429296963,-0.0377570793375179,-0.000293700909076957,0.0465352650060009
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,40019,-0.00919882915796808,0.00462809501896051,-0.0182698953951307,-0.000127762920805477,0.0468804422239842
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42584,-0.00612295041232155,0.00309091970351588,-0.0121811530312127,-6.47477934304242e-05,0.0476175608623103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,40285,-0.00649872522588575,0.0032932468540298,-0.0129534890597841,-4.39613919873474e-05,0.048480605503967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40019,-0.00808318271015959,0.00409863651327734,-0.0161165102761832,-4.98551441360049e-05,0.0486163215581067
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,40042,0.0108154679041127,0.00548476499007316,6.53285235693423e-05,0.0215656072846561,0.0486451433942373
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42554,-0.00585170615845621,0.002969360178202,-0.0116716521077321,-3.17602091802907e-05,0.0487792733227824
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,40104,-0.00581184998315552,0.00295616657767948,-0.0116059364754073,-1.77634909037322e-05,0.0493228941282963
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42447,-0.0079547764206268,0.00405051673834135,-0.0158937892277758,-1.57636134777636e-05,0.0495635174054207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42673,0.00846552771850764,0.00431596351789851,6.23922342656187e-06,0.0169248162135887,0.0498476166781556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42229,-0.00925640857665731,0.00472712167368265,-0.0185215670570753,8.74990376067974e-06,0.0502338299288686
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42554,0.00870399101066281,0.0044450314934703,-8.27071653897865e-06,0.0174162527378646,0.050234445722443
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,41667,0.010278583490986,0.00525083781616908,-1.30586287053983e-05,0.0205702256106774,0.0503094474055415
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,42561,0.00763889167358928,0.00390407783016939,-1.31008735427237e-05,0.0152908842207213,0.0504100908688402
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40384,-0.00661414649735294,0.00338927696290848,-0.0132571293446536,2.88363499476897e-05,0.0510234751589361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,42229,-0.0065046357117337,0.00333422400836867,-0.0130397147681363,3.04433446688835e-05,0.0510939758347298
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42237,0.00628207198636439,0.0032212153912533,-3.15101804920824e-05,0.0125956541532209,0.051171542757715
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,42601,-0.00439572333852954,0.00225699884305552,-0.00881944107091836,2.79943938592715e-05,0.0514840928330928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,40042,-0.017322841506217,0.00890454802698029,-0.0347757556390983,0.000130072626664417,0.0517535472996847
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42466,0.00434585633199605,0.00223489549190347,-3.45388321347532e-05,0.00872625149612685,0.0518507819816928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,42419,-0.0119413232208896,0.00615334273363781,-0.0240018749788197,0.00011922853704052,0.0523251510783603
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,42466,-0.0390656231305713,0.020136162827179,-0.0785325022718421,0.000401256010699451,0.0523919902551465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40042,-0.00657535027832745,0.00339672810055334,-0.013232937355412,8.22367987570929e-05,0.0529194485959609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40428,-0.00593147477375409,0.00306625137561172,-0.0119413274699531,7.83779224448828e-05,0.0530843128030284
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,40206,0.00829440015614332,0.00429418037036681,-0.000122193369775633,0.0167109936820623,0.0534413895526763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,40042,0.015559723373051,0.00808021153199181,-0.000277491229652963,0.0313969379757549,0.0541732077747479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42590,-0.00468633588693824,0.00243985377769978,-0.0094684492912298,9.57775173533286e-05,0.0547851200310507
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,42599,-0.00598113418278439,0.0031139777113042,-0.0120845304969406,0.000122262131371838,0.0547859802701215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40019,0.00872156085865021,0.00455208069949413,-0.000200517312358281,0.0176436390296587,0.0553977191472514
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42229,0.00613277938999273,0.00320560954005935,-0.000150215308523606,0.0124157740885091,0.0557520346038818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40019,0.00650011133174875,0.00340544357010512,-0.000174558065657295,0.0131747807291548,0.0563218702628085
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40206,0.0139662913057539,0.00732318131113322,-0.000387144064067162,0.0283197266755751,0.0565291732978887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41998,0.00976974018830548,0.00512695545361575,-0.000279092500781385,0.0198185728773923,0.0567292107019678
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,40019,0.0102462165341111,0.00538970396677928,-0.000317603240776251,0.0208100363089985,0.0573190838829011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40411,-0.00543110138378783,0.00285813509368716,-0.0110330461674147,0.000170843399839015,0.0574291403048227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,39987,0.0157612073736334,0.00830277104350308,-0.000512223871632644,0.0320346386188994,0.0576823189626682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39987,0.00838708576280937,0.00442453549679155,-0.000285003810902077,0.0170591753365208,0.058041553189269
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,42256,-0.0130503262568531,0.0069002405397214,-0.026574797714707,0.000474145201000867,0.058608321352874
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40350,0.00921060735902061,0.00487001088857681,-0.000334613982589929,0.0187558287006312,0.0586114018772604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,42229,-0.0109559238458675,0.00579321451293671,-0.0223106242912234,0.000398776599488478,0.0586244894830768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42490,-0.00743095811117438,0.00394670876282723,-0.0151665072863158,0.000304591063966994,0.0597460321512378
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,40089,-0.00457219530128448,0.00242943362795738,-0.00933388521208095,0.000189494609511983,0.0598625797244552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40206,0.0145489259648028,0.00775220316250132,-0.00064539223369975,0.0297432441633054,0.0605791640623262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,40042,0.00979603012810241,0.00522463725287239,-0.000444258887527482,0.0200363191437323,0.0608239056057783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40089,-0.0107069833258461,0.00571529096212142,-0.0219089536116041,0.000494986959911851,0.0610409527292295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,42084,0.00534392656387461,0.00285785004625855,-0.000257459526792156,0.0109453126545414,0.0615187634622544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42191,0.0120583096458373,0.00645647803762659,-0.000596387307910768,0.0247130065995855,0.0618362034955443
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40352,0.0103172087754406,0.00552490416344336,-0.000511603384908372,0.0211460209357896,0.0618718793364301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,39987,0.0231027045004161,0.012385061921242,-0.00117201686521813,0.0473774258660504,0.0621568803310329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,40104,-0.00605460906147619,0.003247542605762,-0.0124197925687697,0.000310574445817328,0.0622971137653817
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,42518,-0.00791061336518641,0.00425813073224864,-0.0162565496003938,0.000435322870020937,0.0632241996492625
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40206,-0.0105559990984462,0.00568245500784689,-0.0216936109138261,0.000581612716933725,0.0632457432265919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40411,-0.00612881106212722,0.00332512937336606,-0.0126460646339247,0.000388442509670261,0.0653291395276785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42554,0.00422656071529311,0.00229340892110398,-0.000268520770070693,0.00872164220065692,0.0653633695872237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,42237,0.0273732931103794,0.0148569582518726,-0.00174634506329089,0.0564929312840496,0.0654311472495502
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,40104,-0.00858384121632779,0.00467108316360603,-0.0177391642169956,0.000571481784340029,0.0661403760585817
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40411,-0.014321421973297,0.00779842101840219,-0.0296063271693653,0.000963483222771323,0.0663173563041852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,40104,0.010862061378115,0.0059162671296873,-0.000733822196072088,0.0224579449523021,0.0663899808663189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,40352,-0.00688835429453734,0.00375647409050995,-0.0142510435119368,0.000474334922862162,0.0667208981813822
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40019,-0.00753586714941889,0.00411218557490871,-0.01559575087624,0.000524016577402181,0.0668940237261881
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40206,-0.010990281025695,0.00599791635382459,-0.0227461970791912,0.000765635027801165,0.0669263065678304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,40104,-0.00627443156742589,0.00342887491580333,-0.0129950264024004,0.000446163267548635,0.0672950717953665
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,40019,0.00523490050267147,0.00286198904585462,-0.000374598027203583,0.0108443990325465,0.0674102222528152
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,40104,-0.0116680552077946,0.00638744225216263,-0.0241874420220333,0.000851331606444197,0.0677695023367941
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,42554,-0.0082731804282313,0.00453047961578914,-0.017152920475178,0.000606559618715414,0.0678551272389831
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42377,0.013170412199556,0.00722472465958208,-0.000990048133224905,0.0273308725323369,0.0683314971234566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40411,0.00531974974833549,0.00291997610470925,-0.000403403416894633,0.0110429029135656,0.0685048199349459
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40125,-0.00488453694107865,0.00268363305245245,-0.0101444577238855,0.000375383841728152,0.0687679112165341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40384,-0.00941359717778618,0.00517407375407237,-0.019554781735768,0.000727587380195675,0.0688804553026273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,42237,0.00669654564773605,0.00368219074878545,-0.000520548219883433,0.0139136395153555,0.0689906927547924
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42123,-0.00765503049240251,0.00422076725392632,-0.0159277343100981,0.000617673325293073,0.0697534883558312
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,40042,0.00914082002554728,0.00505603860654077,-0.000769015643272619,0.0190506556943672,0.0706495093203569
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42518,0.00546690806216623,0.0030241452165167,-0.000460416562206508,0.011394232686539,0.070667468557787
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40352,-0.0088443614488919,0.00489947245105022,-0.0184473274529503,0.000758604555166523,0.0710756433571746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42452,-0.0346482118390402,0.0192152844652869,-0.0723101693910024,0.00301374571292209,0.0713859534517608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,40019,0.0094144114322756,0.00522450416842003,-0.000825616737827665,0.0196544396023789,0.0715775844021103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,42590,0.00603367465216131,0.00335101559132318,-0.000534315906832121,0.0126016652111547,0.0717961549821888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,40019,0.0113652256078789,0.00633696303682059,-0.00105522194428948,0.0237856731600472,0.0729238777660827
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42237,-0.00521078693870831,0.0029087112854745,-0.0109118610582383,0.000490287180821719,0.0732456041787911
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42466,-0.00856349441056205,0.00478073764652208,-0.0179337401977453,0.000806751376621236,0.0732760269337976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40352,-0.00938497343829337,0.00524154954793219,-0.0196584105522405,0.000888463675653721,0.0734013122244673
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,40125,0.00340740944418536,0.00190675561528888,-0.000329831561780839,0.00714465045015155,0.0739620385827191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42237,0.00581732518169606,0.00325615112102424,-0.00056473101551144,0.0121993813789036,0.074031063358484
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,40104,-0.0189142869795577,0.0106204760054605,-0.0397304199502603,0.00190184599114485,0.0749522773705932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40352,-0.00999295885780177,0.00563136505541508,-0.0210304343664153,0.00104451665081179,0.0760047618936071
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40019,0.00760808428341503,0.00429016558071962,-0.000800640254795423,0.0160168088216255,0.0761942399444919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42490,0.00744274612130704,0.00420272747282598,-0.000794599725431883,0.015680091968046,0.0765948546816885
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,42475,-0.00664394817799051,0.00375241497174968,-0.0139986815226199,0.000710785166638857,0.0766536255376754
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39987,-0.00681187988190859,0.00385939457115747,-0.0143762932413772,0.000752533477560058,0.077589930992242
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,39987,-0.0135040763698631,0.00766854110700388,-0.0285344169395907,0.0015262641998645,0.078271672852236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42618,-0.00965803639940919,0.0054928486768151,-0.0204240198059668,0.00110794700714841,0.0787204835948135
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,40104,0.00718080906934563,0.004092130323428,-0.000839766364573243,0.0152013845032645,0.0793241513646506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,40089,-0.00757184441557501,0.00431899699978249,-0.0160370785351487,0.000893389703998671,0.0796045897890714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,42191,-0.0157293843738646,0.00900604959691769,-0.0333812415838233,0.0019224728360941,0.0807415851610596
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39987,-0.0169063290504763,0.00969356466164941,-0.0359057157873092,0.00209305768635655,0.0811740265341267
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,42256,-0.00858116035109311,0.00493295863038721,-0.018249759266652,0.00108743856446582,0.0819604748468197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_A,,40384,0.00604249158528785,0.00347415073822647,-0.000766843861636019,0.0128518270322117,0.0820145051297214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40125,0.00429108621198575,0.00246962832865755,-0.000549385312183055,0.00913155773615455,0.08231947843617
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42229,-0.00720749466205652,0.00414925327815834,-0.0153400310872469,0.000925041763133821,0.0824005103785708
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,40104,-0.00477886296898987,0.00275123328770316,-0.0101712802128881,0.000613554274908324,0.0824172708298064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,40125,-0.00411035853286145,0.00236850147319791,-0.00875262142032936,0.000531904354606461,0.0826935979079775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,40385,0.00770083717016921,0.00443745211344461,-0.000996568972182226,0.0163982433125206,0.0826942058441542
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40428,0.00667649095731387,0.00385846745167738,-0.000886105247973785,0.0142390871626015,0.0835956029864722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,40104,-0.00864619661030826,0.00501352298865256,-0.0184727016680673,0.00118030844745077,0.0846324085861652
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,40042,-0.0087073632110136,0.00505919553721409,-0.0186233864639532,0.00120866004192602,0.0852618458544376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,40019,-0.00727635182155022,0.00423218529911264,-0.015571435007811,0.00101873136471055,0.0855902550770891
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,42533,-0.0197895042509147,0.0115115473843644,-0.042352137124269,0.00277312862243959,0.0856193158128393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",42237,-0.0152291270329516,0.0088716855076986,-0.0326176306280408,0.0021593765621377,0.0860761967639854
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42603,-0.00509832338352872,0.00297155770556826,-0.0109225764864425,0.00072592971938508,0.0862387200080889
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42191,-0.00952703920338988,0.00555661571393172,-0.0204180060026961,0.00136392759591629,0.0864534604999854
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42377,-0.0110751815854306,0.00646899693740091,-0.0237544155827364,0.00160405241187522,0.0869128140725742
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,40440,-0.00908505425112845,0.00532196755899079,-0.0195161106667504,0.0013460021644935,0.087833745040749
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40385,-0.00969668870049906,0.0056929709102259,-0.0208549116845418,0.00146153428354369,0.0885445905612931
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42256,-0.00660581614881986,0.00388622224081816,-0.0142228117408234,0.00101117944318373,0.0891916055276861
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39987,0.00844694152257361,0.00498365129213943,-0.00132101501001968,0.0182148980551669,0.0901174924624633
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40125,-0.011476316806205,0.00677118420092994,-0.0247478378400277,0.0017952042276177,0.0901274510151121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,40440,-0.00456977970878569,0.00270501054664329,-0.00987160038020655,0.000732040962635166,0.0911751298364467
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,42256,-0.0103379288342654,0.00612756706924015,-0.0223479602899761,0.00167210262144526,0.0916045375541283
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,42233,-0.00762989149556411,0.00452270971898447,-0.0164944025447737,0.00123461955364545,0.0916238621597819
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,40019,0.00845601426223015,0.00501248007457258,-0.0013684466839321,0.0182804752083924,0.0916336842424059
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40019,-0.00867953464904057,0.00515506402424008,-0.0187834601365511,0.00142439083846999,0.0922702437192955
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,40154,-0.0150345260433713,0.00893510199144197,-0.0325473259465975,0.00247827385985497,0.0924740236234618
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42631,-0.0106955521659827,0.00637639907914291,-0.0231932943611028,0.00180219002913743,0.0934942793937211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,42516,-0.00595584828490922,0.00355222818356957,-0.0129182155247056,0.00100651895488713,0.093634135771104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40206,0.00508679186618323,0.00303470550413944,-0.000861230921930069,0.0110348146542965,0.0937262171882244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,42432,-0.0104773483921063,0.00625971402891301,-0.0227463878887758,0.0017916911045632,0.094198592141151
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,40244,-0.00754219610917556,0.00451086316239889,-0.0163834879074774,0.00129909568912626,0.0945511961569849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40350,-0.00448548480599675,0.00268343215424813,-0.00974501182832309,0.000774042216329592,0.0946415939504444
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,42524,-0.00975413267603249,0.00584073436867483,-0.0212019720386352,0.00169370668657018,0.0949392421739382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40089,0.00891021752588443,0.00533698296159118,-0.00155026907883427,0.0193707041306031,0.0950424410147018
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,40019,0.00856454358892835,0.00515140695368606,-0.00153221404029633,0.018661301218153,0.0964287000547563
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39987,-0.0102643769659279,0.00619402836736758,-0.0224046725659684,0.00187591863411254,0.0975200817247576
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40089,-0.00693932789888589,0.00419316933391949,-0.0151579397933681,0.00127928399559631,0.0979710730730182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,40019,0.00677597721953268,0.00409579402154402,-0.0012517790626936,0.014803733501759,0.0980804346869216
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40104,-0.00925196501095323,0.00560921958899533,-0.0202460354053841,0.00174210538347763,0.099090188829985
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,42206,-0.0148058684929915,0.00900090601772259,-0.0324476442877278,0.00283590730174478,0.100008215436826
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40125,-0.00752608670422474,0.00457693747423238,-0.0164968841537202,0.00144471074527072,0.100132702167005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,40042,0.0162350847076417,0.00988462380094603,-0.0031387779422125,0.0356089473574959,0.100523996994978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40206,-0.00901698719598187,0.0054924003343763,-0.0197820918513594,0.00174811745939567,0.100676459827838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39987,0.0137954130101238,0.00841393057400112,-0.00269589091491839,0.030286716935166,0.1011191772828
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42490,0.0101135425669338,0.006177625919683,-0.00199460423564486,0.0222216893695125,0.101628129730063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40104,-0.0110038938369857,0.0067480706497123,-0.0242301123104218,0.00222232463645036,0.102988288763332
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39987,-0.011095328667894,0.00682622006039594,-0.02447471998627,0.00228406265048208,0.104106846691144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,42191,0.00839360290692166,0.00518959674916678,-0.00177800672144522,0.0185652125352885,0.105818347943102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,39835,0.0118401335314524,0.00732043857707289,-0.00250792607961041,0.0261881931425153,0.105819950653984
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,42561,0.00532710984112466,0.00329840839653321,-0.00113777061608043,0.0117919902983298,0.106322460455075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,42475,-0.0157111890557569,0.00974667544779327,-0.0348146729334317,0.00339229482191795,0.106995787791081
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40019,0.00657155821579768,0.00408451828958254,-0.0014340976317841,0.0145772140633795,0.107668615635242
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,42490,-0.00901606576660388,0.00560599120591522,-0.0200038085301977,0.00197167699698995,0.107795181492641
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,40153,0.00551560925207591,0.00344648432703036,-0.00123950002890359,0.0122707185330554,0.109547980184169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,40042,0.00855591145043223,0.00536165706207046,-0.00195293639122587,0.0190647592920903,0.11057178399371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40089,0.00767710947969037,0.00483090077814297,-0.00179145604546985,0.0171456750048506,0.112051645957883
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40384,-0.01522540447682,0.00958087814439782,-0.0340039256398398,0.00355311668619969,0.112055914184043
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42465,-0.00696521964075265,0.00439880050511725,-0.0155868686307825,0.00165642934927716,0.113345922277006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,42568,-0.00794372889664021,0.00501871337933169,-0.0177804071201303,0.0018929493268499,0.11348573423053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,40206,-0.00735804421564177,0.00466392324948431,-0.016499333784631,0.00178324535334748,0.114674481723389
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,40187,0.00871261262715649,0.00555726593638524,-0.00217962860815859,0.0196048538624716,0.1169594919443
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,42237,0.0086767229594773,0.00553641969925438,-0.00217465965106128,0.0195281055700159,0.117090267633085
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40042,0.00518716068225284,0.00332087641945846,-0.00132175709988575,0.0116960784643914,0.118320584292162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,40059,-0.011278477254548,0.00722309058695877,-0.0254357348049872,0.00287878029589118,0.118447309735937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42455,0.0055902870262199,0.00358622467298672,-0.00143871333283407,0.0126192873852739,0.119062305603006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,39987,0.00856357047521961,0.00549660952315301,-0.00220978419016028,0.0193369251405995,0.11926891489226
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42532,-0.0143841237184682,0.00925710820371214,-0.032528055797744,0.00375980836080761,0.120244799377201
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42191,-0.00824321492425349,0.00530588757084664,-0.0186427545631129,0.00215632471460592,0.12030474777352
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C5,Complement C5,40440,-0.00243797562068979,0.00157240556375263,-0.00551989052564494,0.000643939284265362,0.121055672622395
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42191,-0.00485456452987023,0.00315987387574815,-0.0110479173263366,0.00133878826659614,0.124485259861194
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,40206,-0.00655755267561731,0.00429303157711172,-0.0149718945667563,0.00185678921552166,0.12666851895741
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,40171,0.00483717189162807,0.00317001973150626,-0.00137606678212421,0.0110504105653803,0.127060533675997
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42229,-0.00657724555490381,0.00431793681833289,-0.0150404017188363,0.00188591060902865,0.127723424362777
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42673,0.00438526123973532,0.00288595762982097,-0.00127121571471378,0.0100417381941844,0.128655905384315
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,39987,0.00546381674396672,0.0035990266432214,-0.00159027547674722,0.0125179089646807,0.129009068451613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,40042,0.00953924737175477,0.00632810056685426,-0.00286382973927958,0.0219423244827891,0.131726406448916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,40104,-0.00472646550658787,0.00313980215825898,-0.0108804777367755,0.00142754672359973,0.13226598544262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39987,0.0108744915586066,0.00723594969042888,-0.00330796983463405,0.0250569529518472,0.132908962063516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,40089,0.00457547489644671,0.00304555362099875,-0.00139381020071085,0.0105447599936043,0.133036790708458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42631,-0.00561299391602875,0.00373948666046012,-0.0129423877705306,0.00171639993847308,0.133377367761014
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42191,-0.0235146670883104,0.0156878828254953,-0.0542629174262812,0.00723358324966048,0.133922217789241
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40411,-0.005210257474148,0.00348626497050806,-0.0120433368163438,0.00162282186804781,0.135070528773939
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40104,-0.00972622211942856,0.00651220333880326,-0.0224901406634829,0.00303769642462582,0.135325374718684
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,40089,0.010922117476755,0.00731900158170979,-0.00342312562339615,0.0252673605769062,0.135650494617398
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,42191,-0.00609338143327857,0.0040842533759465,-0.0140985180501337,0.00191175518357656,0.135744252582446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42673,-0.00427145777366376,0.00286327434416882,-0.00988347548823464,0.00134055994090712,0.135772687215497
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40042,0.0115745671093989,0.00779163801611463,-0.00369704340218582,0.0268461776209835,0.137437463966423
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42229,-0.0120476122666188,0.008117551096821,-0.027958012416388,0.00386278788315037,0.137794983149846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,42202,0.00451016125289267,0.00303962374451131,-0.0014475012863495,0.0104678237921348,0.137889049556018
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,42422,0.00774515283194126,0.00525320589615409,-0.00255113072452076,0.0180414363884033,0.140406632137134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,39987,0.014604961851141,0.00992274528594463,-0.00484361890931043,0.0340535426115925,0.141085939023679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,40089,-0.0075872076835203,0.00515631406098956,-0.0176935832430598,0.00251916787601924,0.141200996200045
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,40104,0.00889275961713869,0.00604366252658625,-0.00295281893497036,0.0207383381692477,0.141206691688304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,40384,-0.00963124236798959,0.00654934697700153,-0.0224679624429126,0.00320547770693341,0.14143683244301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,42256,0.00438789054829504,0.00298838172976692,-0.00146933764204812,0.0102451187386382,0.142042319451191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,40428,0.0150304558666149,0.0102497711576392,-0.00505909560235795,0.0351200073355878,0.14256225142527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,42237,-0.00510895629244051,0.00348665903328786,-0.0119428079976847,0.00172489541280369,0.142866725346088
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,40104,-0.0135576582891394,0.00926620487433163,-0.0317194198428294,0.00460410326455059,0.143460737336638
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39986,0.0134814531011722,0.00922927030493716,-0.00460791669650462,0.031570822898849,0.144119226891858
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,40428,-0.00672566829245409,0.00460514563834081,-0.0157517537436021,0.0023004171586939,0.144189434166024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,42256,-0.00746458716542364,0.00511574179061273,-0.0174914410750246,0.0025622667441773,0.144550426878453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,40104,0.00683779687756422,0.0047136918430294,-0.0024010391347734,0.0160766328899018,0.146913197911627
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40384,-0.00412746557907692,0.00284579013642124,-0.00970521424646255,0.00145028308830871,0.146981737662781
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42561,-0.0148010548855429,0.010218851162853,-0.0348300031647347,0.00522789339364901,0.147526732119534
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,42556,0.00634490544383248,0.00438348133429754,-0.00224671797139071,0.0149365288590557,0.147792131448254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40206,-0.00791077291724885,0.00551307415526615,-0.0187163982615705,0.00289485242707281,0.151340747803752
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",42599,-0.0109701711468069,0.00765211309658651,-0.0259683128161165,0.00402797052250266,0.15170596798086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40350,-0.00444303069810211,0.00310522675126299,-0.0105292751305776,0.00164321373437335,0.152508881060003
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,40350,-0.0397986285210462,0.0278559512168732,-0.0943962929061175,0.0147990358640252,0.153109896837607
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,40019,-0.00995490717189485,0.00696844075504857,-0.0236130510517901,0.00370323670800035,0.153156641224018
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39987,0.00459587456391136,0.00322216412994089,-0.00171956713077279,0.0109113162585955,0.153801567098705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40104,0.0135283061981951,0.0095113961791507,-0.00511403031294026,0.0321706427093305,0.154960219510359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,40409,0.00534887668650546,0.00377628160535903,-0.00205263525999823,0.0127503886330092,0.156674464973636
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,42518,-0.00697421117287551,0.00492776110237667,-0.0166326229335338,0.00268420058778276,0.157006847772947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42495,-0.00481588766967976,0.0034053953178283,-0.0114904624926232,0.00185868715326371,0.157328523849555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42554,-0.0049090417740854,0.0034727874943422,-0.0117157052629961,0.00189762171482531,0.157510347349705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,40019,0.0110140804994865,0.00781245002814067,-0.0042983215556692,0.0263264825546422,0.15862413209465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42490,-0.00649905618182912,0.00461240409509122,-0.0155393682082079,0.00254125584454967,0.158847090978498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,40125,0.0108155469825733,0.00768644340816679,-0.00424988209743362,0.0258809760625802,0.159428003582261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42237,0.00881023064921645,0.00629122842783454,-0.00352057706933926,0.0211410383677722,0.161417625998926
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,40019,0.00505810349341187,0.00361487600209098,-0.00202705347068645,0.0121432604575102,0.161767655076796
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40050,-0.00561837109883636,0.00401762301992692,-0.0134929122178931,0.0022561700202204,0.162012056075735
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,40411,-0.00391246274288432,0.00280394737870932,-0.00940819960515459,0.00158327411938595,0.162940656460309
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,42599,0.00651355975074267,0.00467378085131335,-0.00264705071783149,0.0156741702193168,0.163449976594448
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40019,0.0104957105083871,0.00753300990483479,-0.00426898890508907,0.0252604099218633,0.163558989836426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40042,0.00484366207457957,0.00349042655331081,-0.00199757396990962,0.0116848981190688,0.165257167690438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,42599,0.00665842603819101,0.00481585234243248,-0.00278064455297666,0.0160974966293587,0.166808760065338
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,40104,-0.00485451578600202,0.00351799393375356,-0.011749783896159,0.00204075232415496,0.1676425663051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,42191,0.00584817752662839,0.00424413710327896,-0.00247033119579837,0.0141666862490552,0.168244718197193
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42599,-0.00592093637239911,0.00430315790982141,-0.0143551258756491,0.00251325313085085,0.168859651202483
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,40089,0.00970805293590673,0.0070701704747337,-0.00414948119457132,0.0235655870663848,0.169749437431098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40089,-0.0121057678967846,0.00881924485935454,-0.0293914878211195,0.00517995202755029,0.169888325341424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42496,0.00368602546153472,0.00269544608650983,-0.00159704886802455,0.00896909979109398,0.171491400256177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40206,-0.00773330141742338,0.00566786832703119,-0.0188423233384045,0.00337572050355774,0.172466155596976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39987,-0.0123763419742108,0.00907700017834875,-0.0301672623237743,0.00541457837535276,0.172758550344795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42466,0.00560426919855015,0.00411165498949835,-0.00245457458086662,0.0136631129779669,0.172899237806288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,42532,-0.00443229787800702,0.00325218397924059,-0.0108065784773186,0.00194198272130454,0.172947084267409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40206,-0.00526665366325485,0.00388541266871004,-0.0128820624939265,0.00234875516741682,0.175288010037314
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42229,-0.0180339427484542,0.0133068080284611,-0.044115286484238,0.00804740098732962,0.175364007445117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,40089,-0.00393168369021039,0.00290232394268643,-0.0096202386178758,0.00175687123745501,0.175551632419296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,40104,-0.00245331413438968,0.00181182142685315,-0.00600448413102185,0.00109785586224248,0.175745420663812
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40042,0.0103978998321688,0.00769888414475761,-0.00469191309155616,0.0254877127558937,0.176860644507032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,40284,-0.00424235558329187,0.00314400701906482,-0.0104046093406589,0.00191989817407518,0.177253169119254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40352,0.00634541732330497,0.0047099736935288,-0.00288613111601147,0.0155769657626214,0.177933563106262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40352,0.0059153357562842,0.00439161182682856,-0.00269222342429978,0.0145228949368682,0.17801971616917
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,40089,-0.00571990177865642,0.00425812320669661,-0.0140658232637818,0.00262601970646894,0.17920550097434
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42561,0.0112978126094387,0.00841420073278487,-0.00519402082681961,0.0277896460456971,0.179389421305256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40083,-0.00535420427235491,0.00398792819247007,-0.0131705435295962,0.00246213498488643,0.179428552520588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,40384,-0.00509028201872988,0.00381621744032593,-0.0125700682017687,0.00238950416430894,0.182278416706749
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,42256,-0.0072328623800882,0.00542972875347168,-0.0178751307368927,0.0034094059767163,0.182855369428171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40352,-0.006190745640793,0.00465447252879762,-0.0153135117972363,0.00293202051565033,0.183524421438289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40384,-0.0159941335754083,0.0120662676712005,-0.0396440182109613,0.0076557510601447,0.185024305221809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40125,-0.00686955662042011,0.00518347737823934,-0.0170291722817692,0.00329005904092898,0.185106144733273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,42229,-0.0102412678961574,0.00775474181148822,-0.0254405618466743,0.00495802605435955,0.186642649876508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42256,-0.00505895774670583,0.00384249448676476,-0.0125902469407648,0.00247233144735311,0.188001991594235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,42518,-0.00415390190086718,0.00316098325501807,-0.0103494290807026,0.00204162527896824,0.188829449678883
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40384,0.00614387554575115,0.00468670833183185,-0.00304207278463927,0.0153298238761416,0.189913434963203
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,40089,-0.00714623779345327,0.0054591251570047,-0.0178461231011825,0.00355364751427594,0.190546883684776
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,40384,-0.00656991282017829,0.00501888813236941,-0.0164069335596223,0.00326710791926576,0.190548525653093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40352,-0.00789611685411697,0.00604614069366207,-0.0197465526136946,0.00395431890546068,0.191587517348765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40415,-0.0149920510929282,0.011489339173512,-0.0375111558730117,0.00752705368715528,0.191965149053763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40372,-0.00558401592828489,0.00428976076121148,-0.0139919470202594,0.00282391516368962,0.193043046896768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42191,-0.00896295004140284,0.00688691721983843,-0.0224613077922862,0.00453540770948048,0.193128946377725
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,42518,-0.0160419743753355,0.0123740113658214,-0.0402950366523455,0.00821108790167456,0.194851648635737
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42322,0.00812303882572371,0.00626773049857771,-0.00416171295148861,0.020407790602936,0.19499496529799
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,40206,0.00477827007496002,0.0036939377971651,-0.00246184800748358,0.0120183881574036,0.195850201908488
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,42469,0.00979855748924728,0.00761804899895459,-0.00513281854870371,0.0247299335271983,0.198385496233133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,42256,-0.00567499835407391,0.00441339180043084,-0.0143252462829184,0.00297524957477053,0.198515164998265
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42475,0.00560249319174915,0.00435979664289182,-0.00294270822831882,0.0141476946118171,0.198802310189963
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40042,0.010482974407308,0.00817621203557324,-0.00554240118241554,0.0265083499970316,0.199824116417376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39987,-0.0036091194284288,0.00281548298751621,-0.00912746608396058,0.00190922722710297,0.199911271123944
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,40089,-0.00814882721450792,0.00635716235128215,-0.0206088654230209,0.0043112109940051,0.199928140797229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,40206,0.0051345845028739,0.00400710881041551,-0.00271934876554051,0.0129885177712883,0.200091112858607
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,40206,0.00410157831024328,0.00320689477246875,-0.00218393544379547,0.010387092064282,0.200928410504567
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42578,0.00294534082279838,0.00231055417141046,-0.00158334535316613,0.00747402699876288,0.202425712257866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,40089,0.0065442886056232,0.00514055351262892,-0.00353119627912948,0.0166197734903759,0.203020080444997
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40104,-0.00387547341038805,0.00305321598031164,-0.00985977673179887,0.00210882991102276,0.204358083732539
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42490,-0.00716803429441297,0.00566384491320024,-0.0182691703242854,0.0039331017354595,0.205686586923319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42518,0.00337858947498755,0.00267774484946563,-0.00186979042996508,0.00862696937994018,0.207068251465222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42673,0.00361997049438877,0.00287308804706769,-0.00201128207786391,0.00925122306664145,0.207706299293707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,42229,0.0103782507732562,0.00826018677436332,-0.00581171530449585,0.0265682168510083,0.208986824516788
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40019,0.0047743097260498,0.00380656254047663,-0.00268655285328439,0.012235172305384,0.209785043344062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,40019,0.00941734587476983,0.00750996351155925,-0.0053021826078863,0.024136874357426,0.209876264923949
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42561,-0.00494448946027874,0.00394438527925429,-0.0126754846076171,0.00278650568705966,0.210027050754777
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,40089,-0.0089856946345156,0.00716995702816232,-0.0230388104097137,0.00506742114068254,0.210144373513947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,40188,0.00701801436682193,0.00560537330476496,-0.00396851731051738,0.0180045460441613,0.210590844210413
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40042,0.00836352125341666,0.00669701659628044,-0.004762631275293,0.0214896737821263,0.211749508620802
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40206,-0.00850273067903661,0.00681651322070146,-0.0218630965916115,0.00485763523353826,0.212287496379708
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,40385,0.0102011534683649,0.00818033824875808,-0.00583230949920089,0.0262346164359308,0.212411418257077
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42405,-0.00754178731751237,0.0060570264154999,-0.0194135590918922,0.00432998445686743,0.213105930757094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42577,-0.00852853224134048,0.00686055749292848,-0.0219752249274803,0.00491816044479934,0.213843460545197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40385,0.00533864705558702,0.00429814678404924,-0.00308572064114949,0.0137630147523235,0.214232655026893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,42191,0.00872328992093976,0.00704200165200049,-0.0050790333169812,0.0225256131588607,0.215459921304851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,42442,-0.00470790510361984,0.00380811267712989,-0.0121718059507944,0.00275599574355474,0.216375292187049
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40089,-0.00995031748436296,0.00807320978152467,-0.0257738086561513,0.00587317368742539,0.217784965692423
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,42256,0.0179995756088688,0.0146065965261115,-0.0106293535823096,0.0466285048000473,0.217862628131355
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,40206,-0.009090190725754,0.00740386670324898,-0.023601769464122,0.005421388012614,0.219562337457776
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,40428,-0.0125644832347749,0.010250740962994,-0.0326559355222432,0.00752696905269337,0.220331774773074
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40385,-0.00368332053458845,0.00300705612550777,-0.00957715054058367,0.00221050947140677,0.220641502824479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,39987,-0.00757861098203771,0.00620645686410659,-0.0197432664356866,0.00458604447161121,0.22208053607818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39987,0.0107950578302818,0.00885986567557119,-0.00657027889383775,0.0281603945544013,0.223090170858762
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,40206,-0.00693441977092368,0.00571424378891271,-0.0181343375971926,0.00426549805534523,0.224952376281395
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,40104,-0.00363955851968695,0.00300849856096361,-0.00953621569917561,0.00225709865980172,0.226397555547901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,40089,0.00751441060423664,0.00621214311164138,-0.00466138989458046,0.0196902111030537,0.226446162741388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,40042,0.00729691172411079,0.00603794821979628,-0.00453746678668991,0.0191312902349115,0.226878071711865
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,40187,-0.00507167922135902,0.00423353134598607,-0.0133694006594917,0.00322604221677368,0.230951243558717
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40385,0.00470773641045813,0.003942298023099,-0.0030191677148159,0.0124346405357322,0.232440518261221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,40239,0.0042683273185068,0.0035863417896803,-0.00276090258926658,0.0112975572262802,0.234008349660568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40019,0.0066498396455342,0.00561090891049805,-0.00434754181904198,0.0176472211101104,0.23597916321219
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,39972,-0.00444619927847733,0.00375196755205619,-0.0118000556805075,0.00290765712355281,0.236031169061461
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,40042,0.0046324242432212,0.00390933608333772,-0.00302987448012073,0.0122947229665631,0.236057465425106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40104,-0.0049717321759119,0.00419898705883136,-0.0132017468112214,0.00325828245939757,0.23642646177898
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40384,0.0044457206063035,0.00375876529175991,-0.00292145936554593,0.0118129005781529,0.236929051375289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40042,0.00937923890708043,0.00793590301269199,-0.00617513099779586,0.0249336088119567,0.237281532958187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,40042,0.0042528281575792,0.00360320237126463,-0.00280944849009949,0.0113151048052579,0.237910285007218
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,42651,-0.00381279605059943,0.0032313432463166,-0.01014622881338,0.00252063671218111,0.238044333814537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40417,0.00225352521931849,0.0019128095015012,-0.00149558140362387,0.00600263184226085,0.238772480469284
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42490,-0.00428496018168887,0.00364278943017284,-0.0114248274648276,0.0028549071014499,0.23950189007307
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42325,0.00377881709733715,0.00321446313724007,-0.00252153065165339,0.0100791648463277,0.239789224429547
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,40206,0.00344868457797404,0.00294452933789813,-0.0023225929243063,0.00921996208025438,0.241536665290853
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40042,0.00763715540357679,0.00656475339861691,-0.00522976125771235,0.0205040720648659,0.24471005500031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39749,0.00628811394277898,0.00541108862089639,-0.00431761975417795,0.0168938476397359,0.245229540485075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40019,-0.00735236919494488,0.00634274244949696,-0.0197841443959589,0.00507940600606916,0.246409097552646
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,42127,0.00811706529743963,0.00701735503653735,-0.00563695057417358,0.0218710811690528,0.247411030496951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39987,-0.00413270735879901,0.00358574974821826,-0.0111607768653068,0.00289536214770879,0.249126218054236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,40352,-0.00486604132912623,0.00422547677181241,-0.0131479758018786,0.00341589314362609,0.249511880210798
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,40104,-0.0104675126686509,0.0090956449936625,-0.0282949768562294,0.00735995151892764,0.249828689462584
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40206,-0.00850148264325937,0.00739975244812828,-0.0230049974415908,0.00600203215507206,0.250627351320985
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,40019,0.00645987823490632,0.00566145555487712,-0.00463657465265284,0.0175563311224655,0.253883591896238
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,42191,-0.00698135794062184,0.00611974368387328,-0.0189760555610135,0.00501333967976978,0.25397728573343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39987,-0.00928409167760181,0.00815958460090519,-0.025276877495376,0.00670869414017237,0.255223308333011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40019,0.00574992842700085,0.00505917543725096,-0.00416605543001102,0.0156659122840127,0.255758011424298
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,42543,-0.00510572142735271,0.00450009258101344,-0.013925902886139,0.00371446003143364,0.256571114648171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,40089,-0.00723244780535541,0.00637559817618131,-0.0197286202306708,0.00526372461995995,0.256653780238424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,42256,0.00564302559392236,0.0049763990912951,-0.00411071662501603,0.0153967678128608,0.256833142572075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,42358,-0.00397686216813067,0.00350762227023983,-0.0108518018178007,0.00289807748153941,0.256908662447924
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,40042,0.0108111288154676,0.00955596279376354,-0.00791855826030891,0.0295408158912442,0.257933243461753
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,42590,0.00277185686613125,0.00245283280041914,-0.00203569542269025,0.00757940915495276,0.258469693513612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,40019,-0.00395119652937697,0.00351165509773935,-0.0108340405209461,0.00293164746219216,0.26054345010074
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40352,-0.00738359247566058,0.00656274893791773,-0.0202465803939793,0.00547939544265818,0.260580956417835
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40089,0.00435958843527726,0.00389219266230896,-0.00326910918284831,0.0119882860534028,0.262702033643869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40019,0.0129318450827185,0.0115650994758774,-0.00973574989000125,0.0355994400554382,0.263515597182856
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,40089,0.00590357705137169,0.00530669559360786,-0.00449754631209971,0.0163047004148431,0.265957638644615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,40089,0.00499893415943769,0.00449595091859826,-0.00381312964101491,0.0138109979598903,0.266216554441231
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39987,0.00493840159974266,0.00444651880929937,-0.0037767752664841,0.0136535784659694,0.266755831997456
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,40352,-0.00504573261173574,0.0045648603729508,-0.0139928589427193,0.00390139371924784,0.269035190131637
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40384,-0.0083670129180027,0.00756966802255387,-0.0232035622422083,0.00646953640620289,0.26903857016184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,42229,0.00975919996134801,0.00883549671382038,-0.00755837359773993,0.027076773520436,0.269377366750901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",42191,-0.00629096945001851,0.0057010004714419,-0.0174649303740446,0.0048829914740076,0.269836960525988
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42229,0.00368584584831076,0.0033430771880411,-0.0028665854402498,0.0102382771368713,0.270251294672569
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40206,0.0093387511748753,0.0084886845439112,-0.00729907053119066,0.0259765728809413,0.27129467564947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,40175,0.00468889076801269,0.00427509753478044,-0.00369030040015698,0.0130680819361824,0.272756584772236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40352,-0.0110651333093645,0.0101273384644934,-0.0309147166997716,0.00878445008104266,0.274592908595527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,42180,-0.00650077837091396,0.00595590297405459,-0.0181743482000609,0.00517279145823303,0.275079807315156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40019,-0.00457598350340064,0.00419847825606339,-0.0128050008852849,0.00365303387848361,0.275774946688086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40352,-0.00509241983268555,0.00467285604168283,-0.0142512176743839,0.00406637800901281,0.275830321707166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,39987,-0.00527280207487749,0.00484699106907941,-0.0147729045702731,0.00422730042051815,0.276685365170761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,42256,-0.00441950054222742,0.00406509336975961,-0.0123870835469563,0.00354808246250141,0.276975988331838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40420,-0.00224543580809491,0.00207054010543346,-0.00630369441474449,0.00181282279855468,0.27818035426742
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,42256,-0.0038658226526953,0.0035731727522685,-0.0108692412471416,0.00313759594175097,0.279316060596488
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,42468,-0.00887577489084166,0.00823601759365442,-0.0250183693744043,0.007266819592721,0.28119706779515
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,42229,-0.00544289964050733,0.0050559946093041,-0.0153526490747434,0.0044668497937287,0.281712887896254
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,40102,0.00783163692475994,0.00728924004978494,-0.00645527357281854,0.0221185474223384,0.282662450044162
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,42091,0.00776980916189462,0.0072488458953919,-0.00643792879307351,0.0219775471168627,0.283799182830799
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,42229,0.0187347739479343,0.0174941867860184,-0.0155538321526617,0.0530233800485302,0.284227815323487
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,40089,-0.00593429370158717,0.00554662311180682,-0.0168056750007285,0.00493708759755421,0.28469113871214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40089,-0.00336879409917779,0.00315074866647059,-0.00954426148546014,0.00280667328710456,0.285001298305917
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39987,-0.0159978785279832,0.0150335085193341,-0.0454635552258779,0.0134677981699116,0.287285450807989
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,40206,0.00626286057438064,0.00590505106830633,-0.00531103951949978,0.017836760668261,0.28889780036628
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40089,-0.00748759461237551,0.00707823974167119,-0.021360944506051,0.00638575528130003,0.290155100677877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,42215,-0.00650979129149129,0.00615794756798173,-0.0185793685247355,0.00555978594175291,0.290468895797165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40089,0.0055108774937828,0.00523894507261157,-0.00475745484853588,0.0157792098361015,0.292866031391371
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40019,0.00675736566184135,0.00643372666670281,-0.00585273860489616,0.0193674699285788,0.293602041348769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40421,-0.00277683076596248,0.00264759602427301,-0.00796611897353757,0.00241245744161262,0.294287180666421
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,40172,-0.00408915997439564,0.00390782374588821,-0.0117484945163365,0.00357017456754525,0.295397871580693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42377,0.00317047311981862,0.0030324474568393,-0.00277312389558641,0.00911407013522365,0.295803599808427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",40042,-0.00936946947525153,0.00896674428093903,-0.026944288265892,0.00820534931538898,0.296086370656515
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40089,0.00861905372469956,0.00824873942688984,-0.00754847555200453,0.0247865830014036,0.296095403630377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42543,0.00538488151279134,0.00516622239222693,-0.00474091437597346,0.0155106774015561,0.297280013083409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42673,0.00375579098181462,0.0036251713568038,-0.00334954487752083,0.0108611268411501,0.300206127905242
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39987,-0.00602660606799879,0.00582275365117951,-0.0174392032243106,0.00538599108831304,0.300687605833899
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,42512,0.0200959260559665,0.0194520150593819,-0.018030023460422,0.058221875572355,0.301574676847774
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,40206,-0.00662184067875933,0.00642909119433539,-0.0192228594196567,0.00597917806213804,0.303041626365033
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40428,-0.00272149144409352,0.00264571555957244,-0.00790709394085549,0.00246411105266845,0.303670560204428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40019,0.00279527632277706,0.00271744623008107,-0.00253091828818183,0.00812147093373595,0.303671436460296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,42237,0.0114819654087637,0.0111636591944045,-0.010398806612269,0.0333627374297965,0.303727786194524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,40089,-0.00390981185024744,0.00380215404294771,-0.0113620337744249,0.00354241007393006,0.303824528612275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,40206,-0.00932386640123394,0.00907050474488989,-0.0271020557012181,0.00845432289875024,0.304004169431612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,39987,-0.00568135425310429,0.00556371279406361,-0.016586231329469,0.00522352282326037,0.307208909796337
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,40089,-0.0091919457178843,0.00903877925770077,-0.0269079530629778,0.00852406162720922,0.309201947654771
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,42518,0.00844981996702102,0.00831379981609363,-0.00784522767252249,0.0247448676065645,0.309476075407449
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40104,0.00520151311228867,0.00514161213333947,-0.0048760466690567,0.015279072893634,0.311727753847764
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,40104,-0.00585243556781489,0.00581382247488588,-0.0172475276185912,0.00554265648296144,0.314129360095912
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39987,0.00687029681204199,0.00692745213540743,-0.00670750937335657,0.0204481029974405,0.321341997451221
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,40019,0.00472399990193219,0.00476736764454286,-0.00462004068137181,0.0140680404852362,0.321754993004108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42256,-0.00375109709184076,0.00378834778626572,-0.0111762587529216,0.00367406456924006,0.322110824102506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,42256,0.00674359803247617,0.00686276296196834,-0.00670741737298178,0.0201946134379341,0.325804813570604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42490,0.00343074255847191,0.00349290125593236,-0.00341534390315551,0.0102768290200993,0.326017091889335
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,39987,-0.00630816404282605,0.00642686661978557,-0.0189048226176058,0.00628849453195366,0.326353322243081
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40089,0.00811395959386435,0.00826749032260555,-0.00809032143844253,0.0243182406261712,0.326402735510801
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40019,0.0102754876749108,0.0104934491544426,-0.0102916726677966,0.0308426480176183,0.32748882250945
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42518,0.00179267296065199,0.0018316055983556,-0.001797274012125,0.00538261993342897,0.327724263688273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42191,-0.00494709457027696,0.0050883512936555,-0.0149202631058417,0.00502607396528783,0.330949658581986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,40089,0.00608290038746217,0.00625718837359018,-0.00618118882477459,0.0183469895996989,0.330999523127769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42617,0.0035286249832391,0.00363619779999538,-0.00359832270475183,0.01065557267123,0.331856599052043
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41995,0.00382155915202684,0.00394499729088129,-0.00391063553810049,0.0115537538421542,0.332708099028682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42054,0.00872702393771483,0.00902289836831931,-0.00895785686419102,0.0264119047396207,0.333458005841973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42229,-0.00571578200511491,0.00592391261477255,-0.0173266507300691,0.00589508671983928,0.334629821218219
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40173,-0.00640768856274649,0.00664348498415507,-0.0194289191316904,0.00661354200619745,0.334812984428057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42518,-0.00463364750527434,0.00480559053718474,-0.0140526049581564,0.00478530994760774,0.334953034607075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40019,0.0067968839605053,0.00706519505595752,-0.00705089834917143,0.020644666270182,0.336059267547084
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42256,-0.00451347660849146,0.00472244996289327,-0.0137694785357623,0.00474252531877935,0.339216771480887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40042,-0.00606088976218775,0.00635545343609006,-0.0185175784969243,0.00639579897254876,0.340281162527286
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40206,-0.00381367229084799,0.00399914943395775,-0.0116520051814052,0.0040246605997092,0.340296528424183
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,40104,-0.00634309567630979,0.00671466064741908,-0.0195038305452512,0.0068176391926316,0.344851552160697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,42590,-0.00280532828151473,0.00297969640345797,-0.00864553323229234,0.00303487666926288,0.346475272786561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40019,0.00684867636499004,0.00729719585723068,-0.0074538275151821,0.0211511802451622,0.347990292177599
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,39943,-0.00342900069930263,0.00366459099373283,-0.010611599047019,0.00375359764841372,0.349442661492764
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCN,Decorin,42237,0.00234791951864663,0.00251916364391032,-0.0025896412234176,0.00728548026071087,0.35134167281258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,39987,0.00410737877425635,0.00442892427978058,-0.00457331281411358,0.0127880703626263,0.353740285016332
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,40104,-0.00711312519772581,0.00770365790217066,-0.0222122946859803,0.00798604429052869,0.355848459430001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,42191,-0.00371865139739067,0.00403064011029834,-0.0116187060135754,0.00418140321879407,0.35623504232026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,40089,0.00685076179808866,0.00744582702442356,-0.00774305916978151,0.0214445827659588,0.357550955786965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42599,0.00326587338251703,0.00355676018932946,-0.00370537658856871,0.0102371233536028,0.358522421868772
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42428,-0.00391641499381802,0.00427677954963946,-0.0122989029111114,0.00446607292347532,0.35982034700166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42237,-0.00467290822383617,0.00511018207338831,-0.0146888650876773,0.00534304864000492,0.360507392653034
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39987,-0.00398963922505756,0.00436676527511514,-0.0125484991642832,0.00456922071416812,0.360927918198951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,40206,0.00567256807050772,0.00621215222615702,-0.00650325029276003,0.0178483864337755,0.361188619654482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,40042,-0.0105607618657662,0.0115841076908297,-0.0332656129397925,0.0121440892082601,0.361968246163108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40206,0.00670720265533708,0.00740260419346124,-0.00780190156384696,0.0212163068745211,0.364923984018838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42556,-0.00543132938255692,0.00602406617898813,-0.0172384990933737,0.00637584032825983,0.367282879275149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,40206,0.0162907038462415,0.0181170619960988,-0.0192187376661121,0.0518001453585951,0.368570454965568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,40042,0.00573503047969994,0.00638913198515489,-0.00678766821120364,0.0182577291706035,0.369406605438464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,42256,-0.0056996829642761,0.00635642555446011,-0.0181582770510179,0.00675891112246573,0.369905944171801
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,40125,-0.00806657938594463,0.00901310341117124,-0.0257322620718403,0.009599103299951,0.370815582061674
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40019,0.00305891683419424,0.0034197302159058,-0.00364375438898112,0.0097615880573696,0.371079297102028
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,40384,0.00448243221561417,0.00502429509243977,-0.00536518616556777,0.0143300505967961,0.372330937891786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39987,0.00235334697685496,0.00264223544982571,-0.00282543450480343,0.00753212845851336,0.373128701064543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,40206,0.00330681074199901,0.00371626238322355,-0.00397706352911914,0.0105906850131172,0.373581095568393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,40411,0.00279904183197682,0.00315800577257501,-0.0033906494822702,0.00898873314622384,0.375457607233545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,40187,-0.00270260150904691,0.00305168297687197,-0.00868390014371596,0.00327869712562215,0.375846995474809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40019,0.00450741840508518,0.00511219358011933,-0.0055124810119487,0.0145273178221191,0.377958920647246
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,39967,-0.00406636288409223,0.00463419911103112,-0.0131493931417132,0.00501666737352877,0.380251889077532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,40440,0.00662378439394801,0.00758771786863755,-0.0082481426285816,0.0214957114164776,0.38270278604852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39987,-0.00578280482154812,0.00662768142555125,-0.0187730604156286,0.00720745077253233,0.382942508296401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,40385,-0.00206435842359652,0.00236782595112589,-0.00670529728780327,0.00257658044061023,0.383315975427191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,40042,0.00664897451304758,0.00763514499542018,-0.00831590967797598,0.0216138587040711,0.383861875630856
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,40350,-0.010333313035311,0.0118853846137859,-0.0336286668783313,0.0129620408077093,0.38463974304973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,40206,-0.00645998587476937,0.0074320657225176,-0.0210268346909039,0.00810686294136512,0.384754164053617
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40440,-0.00169428371766786,0.0019574009760404,-0.00553078963070704,0.00214222219537132,0.386739949880098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39987,0.00236722498836779,0.00274072701385545,-0.0030045999587889,0.00773904993552447,0.3877600652165
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42469,-0.00213016587432839,0.00247060575624728,-0.00697255315657306,0.00271222140791627,0.388590908401284
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42577,-0.00373399490726935,0.00433170420216482,-0.0122241351435124,0.0047561453289737,0.388694593232064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42341,-0.00374712391922316,0.00435103688108931,-0.0122751562061582,0.00478090836771189,0.389142219331119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40019,-0.00299109805360522,0.00350359894791064,-0.00985815199151007,0.00387595588429963,0.393278161108577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,40384,0.0142741738615621,0.0167338616663846,-0.0185241950045516,0.0470725427276759,0.393671269983292
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40125,-0.00298886503175346,0.00350429566155325,-0.00985728452839783,0.00387955446489091,0.393725336740191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,40019,-0.00353715641646803,0.00416485943977431,-0.0117002809184257,0.00462596808548963,0.395741003505556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40089,-0.00747498157900372,0.00881733036496756,-0.0247569490943401,0.0098069859363327,0.396590166626039
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,42474,0.0117038853142738,0.0138206370626523,-0.0153845633285248,0.0387923339570723,0.39709888280707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40384,-0.00638115421467586,0.00756327925652983,-0.0212051815574743,0.0084428731281226,0.398853956758103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40411,-0.00258944839113553,0.00309463164623031,-0.00865492641774693,0.00347602963547587,0.402748142600056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39987,0.00267929472050864,0.00321262729331889,-0.00361745477439638,0.00897604421541366,0.404305833066379
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40206,-0.00585289071981488,0.00702337499421461,-0.0196187057084755,0.00791292426884576,0.404668556513851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,40019,-0.00434545952028143,0.00522892286939194,-0.0145941483442896,0.00590322930372677,0.405967692221773
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40089,0.00355396443807542,0.00428228733158707,-0.00483931873183523,0.0119472476079861,0.406601073135396
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,40385,0.0022593714042608,0.00273571056990422,-0.00310262131275148,0.00762136412127308,0.408889200604615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,39987,0.00355185286237969,0.00430076264773067,-0.00487764192717242,0.0119813476519318,0.408898467298763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,40104,0.0025583422179605,0.00309942168311745,-0.00351652428094971,0.00863320871687072,0.409148014423982
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,42256,0.00255456789002188,0.0031104130856977,-0.00354184175794562,0.00865097753798939,0.411493029312547
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,40019,0.00442900648272991,0.00542658954909091,-0.00620710903348827,0.0150651219989481,0.414422253038782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,40089,-0.00778537087188374,0.00954502292856336,-0.0264936158118679,0.0109228740681004,0.414719797535249
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,42256,-0.00273562049623103,0.00336255429901109,-0.00932622692229276,0.0038549859298307,0.415915158823383
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,40042,0.00531466215342111,0.00653351346871407,-0.00749102424525846,0.0181203485521007,0.415980093915991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40089,0.00606768506422325,0.00748303114298676,-0.0085990559760308,0.0207344261044773,0.417464212847446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42237,-0.00657489430353517,0.00814256029509281,-0.0225343124819171,0.00938452387484673,0.419408981354454
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,42466,-0.0016368073661985,0.00202796544479018,-0.00561161963798724,0.00233800490559025,0.419612979833653
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,40428,0.00366299851783321,0.00454016447598909,-0.0052357238551054,0.0125617208907718,0.419799583502557
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40042,0.00455624690296176,0.00565901651686346,-0.00653542547009062,0.0156479192760141,0.420762012237895
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,40440,0.00176448227446859,0.0021926774085924,-0.00253316544637252,0.0060621299953097,0.421000679879067
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,40206,0.00295333786951589,0.00368190456497855,-0.00426319507784206,0.0101698708168738,0.42249950827142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,40428,-0.00778066357709778,0.00971406037111173,-0.0268202219044768,0.0112588947502812,0.423166391531689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,40089,0.00407842010166408,0.00509357843221019,-0.0059049936254679,0.0140618338287961,0.423323728653529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40185,0.00455254136238045,0.00571056559471899,-0.00664016720326877,0.0157452499280297,0.425344128091217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,42451,-0.00371240628549815,0.00465746363815931,-0.0128410350162904,0.0054162224452941,0.425414460960958
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,42614,-0.00287255293412421,0.00360754117196844,-0.00994333363118236,0.00419822776293394,0.425893049624537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,42161,0.00406944090098007,0.00511106813299062,-0.00594825263968154,0.0140871344416417,0.425929412244396
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,40104,0.00388253796945113,0.00491072040769048,-0.00574247402962221,0.0135075499685245,0.429180081013147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,40187,-0.00676792785444375,0.00871190797630865,-0.0238432674880087,0.0103074117791212,0.437258425435401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,40428,-0.00388268565807834,0.00500999398266473,-0.0137022738641012,0.00593690254794453,0.438363010013442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,42538,-0.00257149024907079,0.00332073098704922,-0.00908012298368726,0.00393714248554568,0.438722927178385
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,40089,-0.00833717526802994,0.0107962352804435,-0.0294977964176992,0.0128234458816394,0.43999504895734
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42631,0.0029461987390772,0.00382474872375489,-0.00455030875948238,0.0104427062376368,0.441136305585704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40384,-0.0027681431507785,0.00359394378056787,-0.00981227296069154,0.00427598665913453,0.441183059261031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42397,0.00334163695194364,0.00437065086564106,-0.00522483874471283,0.0119081126486001,0.444545607256892
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,40042,-0.00626188174835738,0.00821729621895751,-0.0223677823375141,0.00984401884079933,0.44605463481105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40019,0.0039241179320823,0.00519996289253534,-0.00626780933728697,0.0141160452014516,0.450479362768762
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40385,-0.00315393064248772,0.00418742441998964,-0.0113612825056674,0.00505342122069197,0.451350954364678
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,40385,-0.00642005411495351,0.00855074130836955,-0.0231795070793578,0.0103393988494508,0.452777726292875
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42590,-0.00559402906207173,0.00747297725657499,-0.0202410644849587,0.00905300636081525,0.454130975635524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40019,0.00381030788595461,0.00510473771450845,-0.00619497803448195,0.0138155938063912,0.455426454104626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,39987,0.00322687240729333,0.00433180422262375,-0.00526346386904922,0.0117172086836359,0.456332841746701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39987,0.0045752692229927,0.00616265965920824,-0.00750354370905545,0.0166540821550408,0.457850296954908
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39972,0.0040463878572934,0.00546490047262133,-0.00666481706904442,0.0147575927836312,0.459053962506361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,40089,-0.00475268927102742,0.0064333778515733,-0.0173621098601111,0.00785673131805624,0.460071769451428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40042,0.00549780476212234,0.00746855935568329,-0.0091405715750169,0.0201361810992616,0.461669609106968
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40104,-0.00364016497117284,0.00494762622828593,-0.0133375123786133,0.00605718243626758,0.461904949224789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40042,-0.00930244434098004,0.0126527262202878,-0.0341017877327442,0.0154968990507841,0.462225891633446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,40042,-0.00340414960067072,0.0046602416199209,-0.0125382231757157,0.00572992397437425,0.465120960459942
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,40019,0.00561289645843244,0.00771884326656629,-0.00951603634403749,0.0207418292609024,0.467138721278893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40411,0.00299950171252585,0.0041341826742365,-0.00510349632897769,0.0111024997540294,0.468137906843365
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,42256,0.00383422284182971,0.00530547452524314,-0.00656450722764684,0.0142329529113063,0.46988220424142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,40019,-0.00356965131858751,0.00497356978191354,-0.013317848091138,0.00617854545396304,0.472942855887576
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40042,0.00683662941972436,0.00952592173621131,-0.0118341771832498,0.0255074360226985,0.472965804916439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,40440,-0.0014486041599722,0.00202205556772917,-0.00541183307272137,0.00251462475277697,0.473758186933661
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39987,0.00194305690491374,0.00273972371903178,-0.00342680158438854,0.00731291539421603,0.478205537166241
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,40428,-0.00664754511714567,0.00943252738234001,-0.0251352987865321,0.0118402085522408,0.480982323602986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42599,0.0044928976948932,0.00638479869096772,-0.00802130773940354,0.0170071031291899,0.481640149149743
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40042,0.00369958511799317,0.00528094951600737,-0.00665107593338127,0.0140502461693676,0.483597032294401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,42336,0.00182290499185899,0.00260312964185743,-0.00327922910618158,0.00692503908989956,0.48376836576343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,40206,0.00270151668458497,0.00386667487614597,-0.00487716607266113,0.0102801994418311,0.4847751506829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,42191,0.00389528662361225,0.00559698628172517,-0.00707480648856907,0.0148653797357936,0.486465423904642
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSND,Barttin,39987,-0.00248796505495015,0.00358293325372501,-0.00951051423225117,0.00453458412235088,0.487450503975952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,40104,-0.00533199624122686,0.00768265788544496,-0.020390005696699,0.00972601321424525,0.487678075266223
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40187,0.00192472635821926,0.0027964147153985,-0.00355624648396179,0.00740569920040032,0.491288737354345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42256,0.00280015117121181,0.00411194401774435,-0.00525925910356711,0.0108595614459907,0.495896288851294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,40432,-0.00410537642165451,0.00608023142698356,-0.0160226300185423,0.00781187717523326,0.49956216334059
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,42191,-0.00316403205681582,0.00472493189974547,-0.0124248985803169,0.0060968344666853,0.503095336944167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,42466,0.002295025181203,0.0034673616101898,-0.00450100357476902,0.00909105393717501,0.508050771818406
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,40019,-0.00774262563672808,0.011717350817184,-0.0307086332384086,0.0152233819649525,0.508765580332155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,42237,-0.00337354879693736,0.00511549663561186,-0.0133999222027366,0.00665282460886189,0.509601603209473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42461,-0.00234885362424441,0.00356982356065783,-0.00934570780313376,0.00464800055464494,0.510565797913653
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42639,-0.00314326561536636,0.00478846728338544,-0.0125286614908018,0.00624213026006911,0.511562483580438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTN,Titin,40019,0.00449703254249909,0.00688885749919425,-0.00900512815592163,0.0179991932409198,0.513900362425375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,40104,0.00282504115681835,0.00434456504780705,-0.00569030633688346,0.0113403886505202,0.51554626374384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40350,-0.0119141682676131,0.0183281495903467,-0.0478373414646926,0.0240090049294664,0.515674909098539
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,39987,0.00304872148997945,0.00469396697348659,-0.00615145377805427,0.0122488967580132,0.516030452776621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,42142,0.00314548050978106,0.00485918105851175,-0.00637851436490196,0.0126694753844641,0.517431618625122
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39987,-0.00432183232493096,0.00671234584284389,-0.017478030176905,0.00883436552704307,0.519677842458004
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,42256,-0.00221102316075798,0.00346143889138963,-0.00899544338788166,0.00457339706636571,0.522991315701989
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,40104,-0.00390346424467034,0.0061601534709405,-0.0159773650477137,0.00817043655837303,0.526313751245469
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40384,0.00157490809538878,0.00248634866252576,-0.0032983352831617,0.00644815147393927,0.52647100750986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40352,0.00505650544966415,0.00802403419464005,-0.0106706015718303,0.0207836124711586,0.528596284141236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,40019,-0.00296285169380842,0.00471146503721282,-0.0121973231667455,0.00627161977912871,0.529454013446368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,42518,0.00171921494155195,0.00275048776815598,-0.00367174108403377,0.00711017096713767,0.531943563125693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40352,0.00357448124951303,0.00574647831519922,-0.00768861624827745,0.0148375787473035,0.533934926413822
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,40104,0.00299724829967916,0.00483459917875815,-0.00647856609068681,0.0124730626900451,0.535298405336212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40206,-0.00307476775446753,0.00496918338200384,-0.0128143671831951,0.00666483167425999,0.536082523117665
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40015,-0.00221144388810276,0.00360186659563513,-0.00927110241554762,0.00484821463934209,0.539246984428505
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,40019,0.00247930037507415,0.00403983219173313,-0.00543877072072279,0.0103973714708711,0.539417427195282
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39987,0.00372011223995545,0.00608767284510551,-0.00821172653645135,0.0156519510163623,0.541153277697876
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40042,-0.00449215690383119,0.00736306594709678,-0.0189237661601409,0.0099394523524785,0.541812811041318
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,42191,-0.00185344561466388,0.0030687533637665,-0.00786820220764622,0.00416131097831845,0.545871822810942
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,40190,-0.00648705410874106,0.0107478588218166,-0.0275528573995016,0.0145787491820195,0.546143933741529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42256,-0.00359365371539661,0.00596457416797801,-0.0152842190846335,0.0080969116538403,0.546852070035566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,42191,-0.00365967732477134,0.00613693708930947,-0.0156880740198179,0.00836871937027522,0.550961083732724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40384,0.0046757072652122,0.00785319065847278,-0.0107165464253944,0.0200679609558188,0.551595182527697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42191,0.00255687552591331,0.00430533403707037,-0.00588157918674462,0.0109953302385712,0.55259902306059
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40089,-0.00265718639742115,0.00449191348177865,-0.0114613368217073,0.00614696402686501,0.554164986289605
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,39987,0.00409327645950713,0.00695599011420477,-0.00954046416433421,0.0177270170833485,0.556240276229813
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,39987,0.00352333491565169,0.00602841456926624,-0.00829235764011013,0.0153390274714135,0.55892668506098
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39987,0.0058846340075444,0.010098838904929,-0.0139090902461164,0.0256783582612052,0.56010474108111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40019,-0.00428195415584385,0.0073531695045875,-0.0186941663848353,0.0101302580731477,0.560358110762733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40089,0.00338573678861959,0.00581846958075457,-0.00801846358965936,0.0147899371668985,0.560649629828787
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42475,0.0021773510457941,0.00376082021177692,-0.00519385656928867,0.00954855866087687,0.562628390606335
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40352,-0.00256807291094374,0.00446809192624022,-0.0113255330863746,0.00618938726448709,0.565466361661918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42673,-0.00158581905440846,0.00275976306182562,-0.00699495465558668,0.00382331654676976,0.565556931310473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40206,0.00217540008783455,0.00384998663694473,-0.00537057372057712,0.00972137389624622,0.572057425110579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,40335,-0.00352414121951839,0.00625643404909131,-0.0157867519557374,0.00873846951670059,0.573253715505379
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40352,-0.00375114784058895,0.00668758066354239,-0.016858805941132,0.00935651025995413,0.574868425826562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,42552,0.00222680596660649,0.00397326347925734,-0.00556079045273789,0.0100144023859509,0.575183573470024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,40019,-0.00285496284696485,0.00510724381291466,-0.0128651607202776,0.00715523502634789,0.576171472520428
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42475,0.0032950193627725,0.00594992703506703,-0.00836683762595888,0.0149568763515039,0.579730829656516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,42367,0.00205476888197199,0.00371110365181639,-0.00521899427558813,0.00932853203953211,0.579806338148739
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39987,0.00275397349461218,0.00497613929692568,-0.00699925952736215,0.0125072065165865,0.579976513196341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,40104,0.00605067861386594,0.0109676995707896,-0.0154460125448816,0.0275473697726135,0.581177782251233
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40042,0.0029711315316232,0.00542056545831431,-0.00765317676667286,0.0135954398299192,0.5836193693901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,40206,0.00353484800713058,0.0064565188216968,-0.00911992888339514,0.0161896248976563,0.584056583392661
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40019,0.00217182083296959,0.00396709970420875,-0.00560369458727957,0.00994733625321874,0.584075341337244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40104,-0.00235045265685489,0.00430241496353675,-0.0107831859853869,0.00608228067167714,0.584863980822931
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40089,0.00410297667845699,0.00751662547926189,-0.0106296092608963,0.0188355626178103,0.585177787946349
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40328,0.00157899550379704,0.00290379353655783,-0.00411243982785629,0.00727043083545038,0.586610715967537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,40352,-0.00194229706848125,0.00357872815727227,-0.0089566042567349,0.00507201011977241,0.587323874154313
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,40125,-0.00225190324006383,0.00415520186933359,-0.0103960989039577,0.00589229242383001,0.587865392320597
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40042,0.0023018258139727,0.00425286105817565,-0.00603378186005158,0.010637433487997,0.588352102438572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,40206,0.00252203394486245,0.00467562217359466,-0.00664218551538307,0.011686253405108,0.589621293206207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,42256,-0.00248065450543389,0.00460205061372489,-0.0115006737083347,0.00653936469746689,0.589873667544812
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40384,-0.00425136248042433,0.00790984243897583,-0.019754653660817,0.0112519286999683,0.590948498213921
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39987,0.00239978223890017,0.00447982849400559,-0.0063806816093508,0.0111802460871511,0.592186490603761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,40104,-0.00488512583638626,0.00915710926553888,-0.0228330599968425,0.01306280832407,0.59371288581605
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,42229,-0.00479321148136406,0.00898589290636834,-0.022405561577846,0.0128191386151179,0.5937553218952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,40089,0.0023334295192258,0.00438775754210927,-0.00626657526330838,0.01093343430176,0.594872199289797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40042,0.00299130533913811,0.00562627185427284,-0.00803618749523666,0.0140187981735129,0.594967259907053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40104,-0.0015689199099996,0.00296596543181974,-0.0073822121563663,0.0042443723363671,0.59683394091207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,40125,0.00236707695489929,0.00447615054175802,-0.00640617810694643,0.011140332016745,0.596941210475236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40019,0.00261978439802654,0.00504287341707057,-0.00726424749943177,0.0125038162954848,0.603421122893916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,40042,0.00451433142905855,0.00882501417154322,-0.0127826963471662,0.0218113592052833,0.60898469322436
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,40089,0.00224572405711211,0.00440139034675383,-0.0063810010225254,0.0108724491367496,0.60990024992535
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39987,0.00275654795743447,0.00540473659705843,-0.00783673577280006,0.013349831687669,0.610044742754248
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42229,-0.00423952509587297,0.00844538324367176,-0.0207924762534696,0.0123134260617237,0.61568077193869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40042,-0.00304518097350526,0.00609184182161462,-0.0149851909438699,0.00889482899685939,0.617170745345492
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39987,-0.00460525595529099,0.00921382755618906,-0.0226643579654215,0.0134538460548396,0.617211965077704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,42377,-0.0022759054255192,0.00458587162330089,-0.0112642138071889,0.00671240295615053,0.619700679600307
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40428,0.00144974612497105,0.00292410243633254,-0.00428149465024073,0.00718098690018283,0.620050981884332
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,40385,-0.00271591117954237,0.00547811237043306,-0.0134530114255912,0.00802118906650643,0.620062898239361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,42673,-0.002729261211942,0.00556097902103266,-0.013628780093166,0.00817025766928201,0.623584459204057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42191,-0.00261771940078444,0.00534459946712274,-0.013093134356345,0.00785769555477613,0.624292359651736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,42567,-0.00230340279612221,0.00473027708681742,-0.0115747458862844,0.00696794029403994,0.626302589064887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,40104,0.00214225426317701,0.00441468032995455,-0.00651051918353391,0.0107950277098879,0.627503840484442
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,40384,0.0011206090839274,0.00232631330952181,-0.00343896500273535,0.00568018317059014,0.630021177974654
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40089,0.00159850075347641,0.00332450089582577,-0.0049175210023421,0.00811452250929492,0.630651046586395
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42554,0.00143140158959654,0.00303908299227084,-0.0045252010752543,0.00738800425444738,0.637649952261878
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39987,0.00155173640812854,0.00330246750998464,-0.00492109991144135,0.00802457272769844,0.638456094120582
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,42561,0.00169878023686121,0.00361624836206091,-0.00538906655277818,0.00878662702650059,0.638531904680975
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40206,-0.0031028994265916,0.00667140694487987,-0.0161788570385561,0.00997305818537295,0.641866031214978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39987,0.0016829709366547,0.00363154429051354,-0.00543485587275184,0.00880079774606125,0.643064662457076
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42553,0.00169255019643558,0.00365848459488661,-0.00547807960954217,0.00886318000241333,0.643632145685896
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,40104,0.00180798234225135,0.00390800693100099,-0.00585171124251059,0.00946767592701329,0.643634957855137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,40019,-0.00211136009177077,0.00456821636972084,-0.0110650641764236,0.00684234399288206,0.64395810339109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,42357,-0.00223961704050082,0.004877916653526,-0.0118003336814118,0.00732109960041014,0.646145574466543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,40104,0.00140575784291428,0.00307421875342691,-0.00461971091380246,0.00743122659963102,0.647483796154082
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40042,0.0025856258987268,0.0056669927218724,-0.00852167983614311,0.0136929316335967,0.648211676111701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40385,0.00129791605122384,0.0028480337678145,-0.00428423013369258,0.00688006223614025,0.648597629291729
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,40042,-0.00294086785543485,0.00646001095924912,-0.0156024893355631,0.00972075362469343,0.648944309101493
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40019,0.00248243136296189,0.0054605792464733,-0.00822030396012578,0.0131851666860496,0.649399293474561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39987,0.0023839863829516,0.00529090713987029,-0.00798619161119417,0.0127541643770974,0.652300048145755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40042,0.00202723797638735,0.00453826227138166,-0.0068677560755207,0.0109222320282954,0.655101200472116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,42256,-0.00144000739040626,0.00327379965515878,-0.00785665471451747,0.00497663993370495,0.66004714098855
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40206,-0.00201119025123118,0.00457710854662202,-0.0109823230026103,0.00695994250014798,0.660378962731447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42673,-0.00149154395659736,0.00339654787160672,-0.00814877778494653,0.00516568987175181,0.660570565549739
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40104,0.00133124849052097,0.00307551811851155,-0.00469676702176167,0.00735926400280362,0.665129828604361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,40019,0.00383727030343066,0.00888333415949566,-0.0135740646491808,0.0212486052560421,0.66577702061617
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40019,-0.00267690271302676,0.00622023560313942,-0.01486856449518,0.00951475906912651,0.666946784406149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,40384,-0.00205290271534643,0.00477938880679081,-0.0114205047766564,0.00731469934596356,0.667544034027363
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40125,-0.00114981173858459,0.00267707425942495,-0.00639687728705749,0.00409725380988831,0.667565591488816
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,42475,-0.00244422075527725,0.00578880819733292,-0.0137902848220498,0.00890184331149528,0.672862434081008
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,40019,0.00231119932868756,0.00547560432646908,-0.00842098515119183,0.013043383808567,0.672967509414613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40042,0.00247968830821861,0.00590096638553874,-0.00908620580743731,0.0140455824238745,0.674335022610357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,40019,0.00148207979364017,0.00354118529930467,-0.00545864339299699,0.00842280298027732,0.675570538207542
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40042,0.00239119704425964,0.00576616239517799,-0.00891048125028921,0.0136928753388085,0.678373605404063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,42229,0.00234347182656701,0.00565400815410407,-0.00873838415547697,0.013425327808611,0.678529622420362
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40019,0.00163079415719011,0.00396229326670071,-0.00613530064554328,0.0093968889599235,0.680656645410276
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,40352,-0.00472289861259374,0.0115268819413996,-0.027315587217737,0.0178697899925495,0.682012568759509
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40019,0.00204651523692725,0.00500387674531895,-0.00776108318389789,0.0118541136577524,0.682558069951624
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,40089,0.00147201876045696,0.00362041375910677,-0.00562399220739232,0.00856802972830623,0.684318198683438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40019,0.00375609356045358,0.00924742120946988,-0.0143688520101074,0.0218810391310145,0.684620282796147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40104,-0.00205704967347783,0.00506638651357501,-0.0119871672400849,0.00787306789312919,0.684736532150927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,40206,0.00230519499294072,0.00569537927643031,-0.00885774838886269,0.0134681383747441,0.685670407595671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,42191,0.00137087964411918,0.00340130325042431,-0.00529567472671248,0.00803743401495083,0.686921452422155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,39987,0.00314897655266378,0.00783885221780565,-0.0122151737942353,0.0185131268995628,0.687902485842983
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,40411,-0.00159757635890573,0.00402880112395699,-0.00949402656186144,0.00629887384404997,0.691715061333927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,42590,0.00308800699970755,0.00785689497579504,-0.0123115071528507,0.0184875211522658,0.694302490665954
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,40190,-0.00404151373429742,0.0104097389248746,-0.0244446020270516,0.0163615745584568,0.697843342121805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40350,0.00227513482029039,0.00586912698901808,-0.00922835407818505,0.0137786237187658,0.69828652531423
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,42191,0.00144495467487555,0.003737012838915,-0.00587959048939784,0.00876949983914895,0.699014006892805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,40104,-0.00143528235077004,0.00372117341182735,-0.00872878223795164,0.00585821753641156,0.699721254522948
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42490,-0.00145205810579882,0.00381753421170704,-0.00893442516074462,0.00603030894914697,0.703680236123316
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40019,-0.00209091855615511,0.00549793450390048,-0.0128668701838001,0.00868503307148984,0.703722898640011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,40206,-0.00316171555478681,0.00837647826823617,-0.0195796129605297,0.0132561818509561,0.705845262363301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42590,0.00187484884275567,0.00497412295627051,-0.00787443215153453,0.0116241298370459,0.706238666870961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,40385,0.00405864112360536,0.0108099507272792,-0.0171288623018619,0.0252461445490726,0.707329837258889
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,40206,-0.00212021900506017,0.00569863019804045,-0.0132895341932194,0.0090490961830991,0.709857080127532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,40206,0.00155811526899528,0.00419097079575746,-0.00665618749068935,0.00977241802867991,0.71006449364836
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40089,0.00140836218215196,0.00380593011931424,-0.00605126085170395,0.00886798521600788,0.711356786289148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,42229,-0.00536935674636493,0.0146404045248882,-0.0340645496151458,0.023325836122416,0.713812051449566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,40363,0.000907006500389254,0.00250776009773322,-0.00400820329116785,0.00582221629194635,0.717598067340087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40089,-0.00195585386606215,0.00543242494649154,-0.0126034067611856,0.00869169902906128,0.718829211982621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39987,-0.0016830744245896,0.0047490768742265,-0.0109912650980735,0.00762511624889435,0.723045808886058
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,40352,-0.00168216804121362,0.00476936276630202,-0.0110301190631656,0.00766578298073834,0.724317852948778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39538,-0.0020077823317014,0.00572699786612082,-0.0132326981492982,0.00921713348589541,0.725909105758034
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,40125,0.00227723037259299,0.0065677043916911,-0.0105954702351216,0.0151499309803076,0.728799674162786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,40042,0.00182267027947374,0.00526823920014096,-0.00850307855280255,0.01214841911175,0.729369464439445
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40042,0.00137209037717738,0.00397389376316994,-0.0064167413986357,0.00916092215299047,0.729893537926501
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,42673,0.00258192753606912,0.00753175469472015,-0.0121803116655824,0.0173441667377206,0.731750073524741
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,42229,-0.0016559073417715,0.00483565367739928,-0.0111337885494741,0.00782197386593109,0.732027475080743
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,42256,0.00160256567759101,0.00469278989558782,-0.00759530251776111,0.0108004338729431,0.732736238304289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,40019,-0.00163765562427459,0.0048124864745917,-0.0110701291144743,0.00779481786592514,0.733642465410089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,39987,-0.0013546470714911,0.00398832416657271,-0.00917176243797361,0.00646246829499141,0.734124317394173
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,42532,-0.0028944884219453,0.00867193698905549,-0.0198914849204941,0.0141025080766035,0.738553495724508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39987,0.00191514120634733,0.00582495571431143,-0.00950177199370307,0.0133320544063977,0.742326768189926
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,39987,0.00106640619948254,0.00329539476848951,-0.0053925675467569,0.00752537994572198,0.746243377593897
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40019,-0.00127454228704144,0.00396797474568619,-0.00905177278858637,0.00650268821450348,0.748059533567567
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,39987,-0.00104318798265809,0.00327203343775022,-0.00745637352064852,0.00536999755533235,0.749869578919322
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,40206,-0.000782624071201835,0.00245526842488221,-0.00559495018397096,0.00402970204156729,0.749919898915775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40352,0.00121467575185812,0.0038256459045388,-0.00628359022103792,0.00871294172475416,0.750863601193482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,40104,-0.00235110835947894,0.00745761334829137,-0.01696803052213,0.0122658138031721,0.752568126896927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_DRA,,42430,-0.00121697074624708,0.00387565356890609,-0.00881325174130302,0.00637931024880886,0.753522944847482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,42172,0.0011403600992106,0.00364891819892204,-0.0060115195706766,0.00829223976909781,0.754650348843484
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,40125,0.00182658795592831,0.00584711874138727,-0.00963376477719075,0.0132869406890474,0.754749259138491
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40206,0.0020165337221211,0.00659741886928912,-0.0109144072616856,0.0149474747059278,0.759873156288679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,40206,-0.00138468227856447,0.00453700058739376,-0.0102772034298562,0.00750783887272731,0.760221329689422
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40125,0.00243290152280691,0.00798373149141753,-0.0132152122003715,0.0180810152459853,0.76057578524344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40384,0.00118258122473089,0.00388844094844244,-0.00643876303421629,0.00880392548367807,0.76103652909789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,40104,-0.00309110600964644,0.010230658167085,-0.0231431960171329,0.0169609839978401,0.762549986284095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,40089,-0.00104471916144194,0.00350919655549919,-0.00792274441022035,0.00583330608733647,0.765931001460229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42518,-0.00146515409003658,0.0049260586625571,-0.0111202290686485,0.00818992088857534,0.766143427910237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,39972,0.00128382628137365,0.00431891911074577,-0.00718125517568807,0.00974890773843536,0.766276505923584
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,40042,0.00303538421189288,0.0102131706476438,-0.016982430257489,0.0230531986812747,0.76631727785105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,42529,-0.00109424642449217,0.00368382234871472,-0.00831453822797302,0.00612604537898868,0.766439802973831
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,42237,-0.00190390536361238,0.00645777029824305,-0.0145611351481688,0.010753324420944,0.768133060128426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,42237,-0.000836309166297617,0.00290020530463109,-0.00652071156337455,0.00484809323077931,0.773074191257562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,40042,-0.00222821195305175,0.00784025563973155,-0.0175951130069256,0.0131386891008221,0.776261435308851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42191,0.00117093948583845,0.00415849624914589,-0.00697971316248749,0.00932159213416439,0.77827188387427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,40104,-0.00162851329914241,0.00578976352361827,-0.0129764498054342,0.0097194232071494,0.778505140567155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40350,-0.00298724678177037,0.0106421471766952,-0.023845855248093,0.0178713616845523,0.778945997258115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40042,0.00147076490651548,0.00524553428455582,-0.00881048229121393,0.0117520121042449,0.779188108242363
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40411,-0.00142025025045268,0.0051184487902663,-0.0114524098793746,0.00861190937846926,0.78141921224592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,40104,-0.000639044538822038,0.00230390892782431,-0.00515470603735769,0.00387661695971361,0.781498164390217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42237,0.000958028668090832,0.00349391760838083,-0.0058900498443356,0.00780610718051726,0.783936049041411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,40104,0.000750960905729772,0.00278190380065734,-0.0047015705435586,0.00620349235501815,0.78720770444345
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,42256,-0.000911029031945745,0.00343153775621908,-0.00763684303413515,0.00581478497024366,0.79063843034494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40411,-0.0019417250350557,0.00750760709121184,-0.0166566349338309,0.0127731848637195,0.795922127396364
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,40352,0.000706091499036328,0.00275784737930626,-0.00469928936440393,0.00611147236247659,0.797932438596783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40432,0.000721986622490523,0.00282052093287902,-0.00480623440595236,0.0062502076509334,0.797973792637659
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,42341,-0.00179145899305116,0.00700033918203663,-0.015512123789843,0.0119292058037406,0.798024094639026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,40384,0.00101467426234264,0.00402684230831218,-0.00687793666194924,0.00890728518663452,0.801062966712841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40206,-0.00106201432811839,0.00424707055736427,-0.00938627262055237,0.00726224396431559,0.802547094725369
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40019,-0.00145683257050799,0.00593022032838688,-0.0130800644141463,0.0101663992731303,0.805948184236895
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,40042,0.00117516358411937,0.00479941741639256,-0.00823169455201006,0.0105820217202488,0.806572977056372
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40206,-0.00160663020739602,0.00661442347804328,-0.0145709002243609,0.0113576398095688,0.808088942003811
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,40042,-0.00145261124600449,0.00598494050540659,-0.0131830946366014,0.0102778721445924,0.808233828630524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,40104,0.000795382954581796,0.00335176149569852,-0.00577406957698731,0.0073648354861509,0.812426214606517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,42237,-0.00152023031129702,0.00641776972396134,-0.0140990589702612,0.0110585983476672,0.81275493362902
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42673,0.00173753270359644,0.00736166812973146,-0.0126913368306772,0.0161664022378701,0.813417385831825
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42191,0.00113075558748252,0.00479969750772313,-0.00827665152765482,0.0105381627026199,0.813755378221266
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39987,0.00120649388216106,0.00512427480981344,-0.00883708474507328,0.0112500725093954,0.813866466645919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40330,0.000965673617260737,0.00412363272706467,-0.00711664652778601,0.00904799376230749,0.814849300348377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,42191,0.00084575952613847,0.00361817343603802,-0.00624586040849606,0.007937379460773,0.815180285445919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,40206,0.00099932783704773,0.00430283980735462,-0.00743423818536732,0.00943289385946278,0.816349371519682
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,42237,-0.00174262183929286,0.00751343834838406,-0.0164689610021256,0.0129837173235399,0.816592911862886
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42256,-0.000722281180298821,0.00312316728600929,-0.00684368906087703,0.00539912670027939,0.817112085930205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40432,0.00070354018454822,0.00305888964074613,-0.0052918835113142,0.00669896388041064,0.818097081910835
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,40089,-0.00130065960536797,0.0057269149943477,-0.0125254129942895,0.00992409378355353,0.820339762055873
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40352,0.00213938665494684,0.00949300323670547,-0.0164668996889959,0.0207456729988896,0.821699793872916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42191,0.00182884925577901,0.0081323341940394,-0.0141105257645382,0.0177682242760962,0.822071386308698
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,42444,0.000842912044477052,0.00375080144709906,-0.0065086587918371,0.0081944828807912,0.822193944462197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,40104,0.00130570074479882,0.00587194356894587,-0.0102033086503351,0.0128147101399327,0.824035772178124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",40019,-0.000921266705586532,0.00417806061181757,-0.00911026550474896,0.0072677320935759,0.825485121668671
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,39987,-0.00142071643494624,0.00648024521338738,-0.0141219970531855,0.011280564183293,0.826468749168153
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40385,-0.000596672460275184,0.00273423245692541,-0.00595576807584899,0.00476242315529862,0.827259329970634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,40206,-0.00164105576563848,0.0078662943819929,-0.0170589927543446,0.0137768812230676,0.83474980368642
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,40187,0.000968356866395618,0.00468832436976777,-0.00822075889834921,0.0101574726311404,0.836367891673575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39966,0.000563399672564315,0.00277784550655279,-0.00488117752027915,0.00600797686540778,0.839280386582615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42256,0.00242306600149691,0.0119505876483961,-0.0210000857893595,0.0258462177923533,0.839328080899346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,42673,-0.000411261675916291,0.00205611868410924,-0.0044412542967704,0.00361873094493782,0.841469167694116
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,40330,-0.00111478756021477,0.00559132958651267,-0.0120737935497796,0.00984421842935006,0.841970785573257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42229,-0.00120467056799059,0.00604757317097912,-0.0130579139831097,0.0106485728471285,0.842110183427589
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,40432,0.000464872156458278,0.00233934102551019,-0.00412023625354169,0.00504998056645824,0.842485938918228
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,40042,-0.00074262517010907,0.00375681197911604,-0.00810597664917651,0.00662072630895837,0.84330360395351
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40019,-0.00123142680015792,0.00628524059153767,-0.0135504983595717,0.0110876447592559,0.844673662996356
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,42216,-0.00103287223976144,0.00531056637830571,-0.0114415823412406,0.00937583786171776,0.845792283226721
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,40384,-0.00073787814398846,0.00381543946802511,-0.00821613950131768,0.00674038321334076,0.846654941368168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,40352,0.00156108338219294,0.00812778524897402,-0.0143693757057961,0.017491542470182,0.847692828375326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40019,0.00191707202646061,0.0100527426410277,-0.0177863035499538,0.021620447602875,0.848763123324646
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,42256,0.00150693099951735,0.00791496944505408,-0.0140064091127886,0.0170202711118233,0.849006495195782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42466,0.00045925203231565,0.0024599103941039,-0.00436217234012799,0.00528067640475929,0.85190292934083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,42229,-0.000758007095042402,0.00409598367827037,-0.00878613510445233,0.00727012091436753,0.853184020150026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42229,0.000701871391086627,0.00379844670031418,-0.00674308414152917,0.00814682692370242,0.853405624417611
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,42191,0.00094441902360872,0.00518344375053858,-0.00921513072744689,0.0111039687746643,0.855429284871252
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,42191,0.000908047216594876,0.00499606580037824,-0.00888424175214647,0.0107003361853362,0.855779833956184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,42256,-0.000882391582353898,0.0049010287483863,-0.010488407929191,0.00872362476448324,0.85712229816795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40125,-0.00159056959366766,0.00888528793670752,-0.0190057339496144,0.0158245947622791,0.85793191247689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",42237,0.000791864145081121,0.0045985216168666,-0.00822123822397742,0.00980496651413966,0.863283187918149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40019,-0.00069191988802702,0.00414043841399459,-0.00880717917945641,0.00742333940340237,0.867284486172348
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,40042,0.0012970804898868,0.00778238392402285,-0.013956392001198,0.0165505529809716,0.867633772526435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,40089,0.000724326117299715,0.00440668620115901,-0.00791277883697194,0.00936143107157137,0.869443087661589
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,40089,-0.00107228913326187,0.00676378524928693,-0.0143293082218643,0.0121847299553405,0.874039062458768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42532,0.000352149954941148,0.00223509454709924,-0.00402863535737337,0.00473293526725566,0.874809979487539
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39987,0.000642767536346308,0.00409148455395992,-0.00737654218941513,0.00866207726210775,0.875169878966858
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,42229,-0.00172654078707417,0.0110832690476795,-0.023449748120526,0.0199966665463777,0.876209620809762
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40350,-0.000864865255048016,0.00581834151343636,-0.0122688146213833,0.0105390841112873,0.881836736627359
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,39987,-0.00103651884961799,0.00700239719530564,-0.014761217352417,0.0126881796531811,0.882327042775318
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,42518,0.000630565097055834,0.00426326285673735,-0.00772543010214936,0.00898656029626103,0.882418646639004
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,40206,-0.00126803698451557,0.0087143278796781,-0.0183481196286846,0.0158120456596535,0.88430951300654
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42673,0.000990634757140438,0.00685512885129988,-0.0124454177914073,0.0144266873056882,0.885099910992087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,40352,0.000541418862273822,0.00399454532999193,-0.00728788998451036,0.00837072770905801,0.892187744143343
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40187,-0.000532525544178144,0.00395514373110183,-0.00828460725713773,0.00721955616878144,0.892897981023189
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,39987,0.000592251279149288,0.00444667836900486,-0.00812323832410023,0.00930774088239881,0.894045924700862
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42191,0.000902328649146022,0.00703007298571297,-0.0128766144028514,0.0146812717011434,0.897871869772299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40104,0.000565477416267671,0.00445279347553157,-0.00816199779577421,0.00929295262830956,0.898947601216073
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40042,-0.000583408290604031,0.00468024051995826,-0.00975667970972221,0.00858986312851415,0.900800193492018
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,42441,0.000938233786569746,0.00758628492204226,-0.0139308846606331,0.0158073522337726,0.90157448323669
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42518,-0.000381013436970398,0.00331881641289935,-0.00688589360625312,0.00612386673231232,0.90860219943212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40206,0.000789812063346151,0.00689534112216688,-0.0127250565361009,0.0143046806627932,0.908809564252532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40104,-0.000718409959320196,0.00641465374167399,-0.0132911312930012,0.0118543113743608,0.910829330836529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39987,-0.00073928753846791,0.00663596265044931,-0.0137457743333486,0.0122671992564127,0.911296296701924
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40411,0.0012392560367618,0.0111353520118238,-0.0205860339064129,0.0230645459799365,0.911388183097477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,39987,-0.000540462305209823,0.0050173063069244,-0.0103743826667817,0.00929345805636201,0.914220111544006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42466,0.000625468197367786,0.00584741681909536,-0.0108354687680591,0.0120864051627947,0.91481846385224
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,40042,0.000731155113344776,0.00688927946435348,-0.012771832636788,0.0142341428634776,0.915481645405249
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39966,-0.000517005038892863,0.00521974627113965,-0.0107477077303266,0.00971369765254085,0.921102061282731
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39972,0.000809564671154956,0.00846549596107102,-0.0157828074125443,0.0174019367548542,0.923815343891658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40432,-0.000357955724385515,0.00394953085732718,-0.00809903620474679,0.00738312475597576,0.927786248543915
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39987,-0.000728359258278447,0.00807463877693595,-0.0165546512610729,0.015097932744516,0.928127316695394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,42256,-0.000587981479091335,0.00676620146983263,-0.0138497363599633,0.0126737734017806,0.930752499379625
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,42531,0.000413971076208866,0.0047906537481552,-0.00897571027017533,0.00980365242259306,0.931140021905993
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,42256,-0.00084062685711392,0.00980953882961744,-0.0200673229631641,0.0183860692489363,0.931710317817302
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42590,-0.0011421354849065,0.0133527373829348,-0.0273135007554588,0.0250292297856458,0.931836808365274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39987,-0.000513923752327189,0.00601448233187233,-0.012302309122797,0.0112744616181426,0.931907048297721
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40042,-0.000495816026506851,0.00646456362307066,-0.0131663607277254,0.0121747286747116,0.938865588362437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41831,-0.000236529922407059,0.00308720269967208,-0.00628744721376434,0.00581438736895023,0.938930036845424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,42377,0.000717156281781676,0.00945087478496499,-0.0178065582967497,0.0192408708603131,0.939513707916525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40384,0.000304994362922913,0.00408573535605692,-0.00770304693494865,0.00831303566079448,0.940495651059525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40125,-0.00199362878478468,0.0283946118070257,-0.0576470679265551,0.0536598103569857,0.944026591649015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40042,-0.000411043429163659,0.00598277762407891,-0.0121372875723583,0.011315200714031,0.945226144528609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40104,0.000289293824247948,0.0043762248234218,-0.00828810682965879,0.00886669447815468,0.947294807873787
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40019,-0.000389010096245471,0.00600515305395312,-0.0121591100819936,0.0113810898895026,0.948350854891847
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,42229,0.000220250075478837,0.00341282091996081,-0.00646887892764434,0.00690937907860202,0.948544370879026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40089,0.00024069247500387,0.00387092133110845,-0.00734631333396868,0.00782769828397642,0.950420920714758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42466,0.00016876599817643,0.00274459854656534,-0.00521064715309163,0.00554817914944449,0.950969720248897
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42490,0.000722914555432342,0.0124258852206858,-0.0236318204771118,0.0250776495879765,0.953607628696213
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,40019,0.000291149408311856,0.00502372607170731,-0.00955535369223447,0.0101376525088582,0.953785643613824
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,40042,0.000415074067927088,0.00766125409067219,-0.0146009839497904,0.0154311320856446,0.956794071126246
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39987,-0.000313854633827446,0.0060501793186402,-0.0121722060983622,0.0115444968307073,0.958629046260856
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,40019,-0.000192690436834956,0.00403562557193747,-0.00810251655783241,0.00771713568416249,0.961918476084283
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40350,-0.000218510896682549,0.00459728304941676,-0.0092291856735394,0.0087921638801743,0.962091319106688
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,42377,-5.87336601482493e-05,0.00125620810231606,-0.00252090154068773,0.00240343422039123,0.962709424642372
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39987,-0.000293719513490446,0.00655768333708707,-0.0131467788541811,0.0125593398272002,0.964275417970925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40019,-0.000150495005485599,0.00356539654082209,-0.0071386722254969,0.0068376822145257,0.966332154821805
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,40042,-0.000494509549064331,0.011750303980592,-0.0235251053510247,0.0225360862528961,0.966431847643433
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,42580,0.000675022289767277,0.0162095303399032,-0.0310956571764429,0.0324457017559775,0.966783481328634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40042,0.000245283731647036,0.006140143779957,-0.0117893980770687,0.0122799655403628,0.968135673019368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40432,0.000106160073050351,0.0028558438522935,-0.00549129387744491,0.00570361402354561,0.970347785625387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40350,0.000494550267081447,0.01556334515763,-0.0300096062418734,0.0309987067760363,0.974650772398469
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42229,-0.000165943712652935,0.00547519190140055,-0.010897319839398,0.0105654324140921,0.975821647888384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,40322,0.00021540964763184,0.00753307635436834,-0.0145494200069301,0.0149802393021938,0.977187971917736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,40104,-8.54493065678085e-05,0.00303730551813817,-0.00603856812211862,0.005867669508983,0.977556381298039
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40125,0.000164041979740872,0.00724186812897434,-0.0140300195530488,0.0143581035125306,0.981928367911809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42444,5.65523870274974e-05,0.0027409841987569,-0.00531577664253602,0.00542888141659101,0.983539407539214
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42536,0.000122764891999887,0.00682456585460032,-0.0132533841830167,0.0134989139670165,0.98564815757916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42229,0.000226936668391755,0.0128906615441301,-0.0250387599581032,0.0254926332948867,0.98595444946588
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40104,9.09889177200195e-05,0.00573296579758558,-0.0111456240455477,0.0113276018809878,0.98733745434804
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,42229,-0.000139726501706521,0.00922413070655788,-0.01821902268656,0.0179395696831469,0.987914393221547
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42444,-2.67326403578737e-05,0.00316623283912838,-0.0062325490050495,0.00617908372433375,0.993263633399857
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40206,-4.43456100597624e-05,0.00845599439000008,-0.0166180946144599,0.0165294033943404,0.995815783394328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40428,1.64742891179149e-05,0.00314700132084633,-0.00615164829974089,0.00618459687797672,0.995823252981962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40428,7.51669916752609e-05,0.0148509769100682,-0.0290327477520583,0.0291830817354088,0.995961680382106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40104,-1.12737096112962e-05,0.00369710604509053,-0.00725760155798874,0.00723505413876615,0.997567043338088
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,40019,6.84090189134595e-06,0.00364451316060569,-0.00713640489289581,0.00715008669667851,0.998502373156568
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40432,1.63033241905608e-06,0.0029874896491006,-0.00585384937981812,0.00585711004465623,0.999564588260792
